Search by PubMed Identification
PMID | Data | Article Title | Citation | Organization | Data Download |
---|---|---|---|---|---|
22998443 | 69 | Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B. | J Med Chem 55: 9312-30 (2012) | CNRS | 2D 3D TSV |
22998419 | 47 | Conformational restriction approach toß-secretase (BACE1) inhibitors: effect of a cyclopropane ring to induce an alternative binding mode. | J Med Chem 55: 8838-58 (2012) | Shionogi & Co., Ltd | 2D 3D TSV |
22996261 | 11 | Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidase. | Drug Metab Dispos 41: 24-9 (2012) | Washington State University | 2D 3D TSV |
22995819 | 4 | Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine. | Eur J Med Chem 56: 246-253 (2012) | TBA | 2D 3D TSV |
22995624 | 20 | Discovery of novel dihydroimidazothiazole derivatives as p53-MDM2 protein-protein interaction inhibitors: synthesis, biological evaluation and structure-activity relationships. | Bioorg Med Chem Lett 22: 6338-42 (2012) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
22995620 | 60 | Identification of a potent and metabolically stable series of fluorinated diphenylpyridylethanamine-based cholesteryl ester transfer protein inhibitors. | Bioorg Med Chem Lett 22: 6503-8 (2012) | Bristol-Myers Squibb Co. | 2D 3D TSV |
22995619 | 22 | Trypsin resistance of a decapeptide KISS1R agonist containing an N¿-methylarginine substitution. | Bioorg Med Chem Lett 22: 6328-32 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22995617 | 7 | Substrate-like water soluble lipase inhibitors from Filipendula kamtschatica. | Bioorg Med Chem Lett 22: 6410-2 (2012) | Hokkaido University | 2D 3D TSV |
22995061 | 37 | Opioid activity profiles of oversimplified peptides lacking in the protonable N-terminus. | J Med Chem 55: 10292-6 (2012) | University of Bologna | 2D 3D TSV |
22994852 | 3 | Identification and Characterization of Small Molecule Inhibitors of a Plant Homeodomain Finger. | Biochemistry 51: 8293-306 (2012) | University of Wisconsin | 2D 3D TSV |
22994801 | 7 | Synthesis and paroxonase activities of novel bromophenols. | J Enzyme Inhib Med Chem 28: 1073-9 (2013) | Atatürk University | 2D 3D TSV |
22994608 | 12 | Synthesis and characterization of phenolic Mannich bases and effects of these compounds on human carbonic anhydrase isozymes I and II. | J Enzyme Inhib Med Chem 28: 337-42 (2013) | Dumlupinar University | 2D 3D TSV |
22992107 | 34 | Modified acidic nonsteroidal anti-inflammatory drugs as dual inhibitors of mPGES-1 and 5-LOX. | J Med Chem 55: 8958-62 (2012) | Eberhard-Karls University | 2D 3D TSV |
22992024 | 21 | Synthesis, evaluation, and radiolabeling of new potent positive allosteric modulators of the metabotropic glutamate receptor 2 as potential tracers for positron emission tomography imaging. | J Med Chem 55: 8685-99 (2012) | Janssen-Cilag S.A. | 2D 3D TSV |
22991951 | 10 | Novel cytidine-based orotidine-5'-monophosphate decarboxylase inhibitors with an unusual twist. | J Med Chem 55: 9988-97 (2012) | University Health Network | 2D 3D TSV |
22989913 | 18 | Curcumin is an inhibitor of calcium/calmodulin dependent protein kinase II. | Bioorg Med Chem 20: 6040-7 (2012) | Rajiv Gandhi Centre for Biotechnology | 2D 3D TSV |
22989912 | 4 | Novel amide- and sulfonamide-based aromatic ethanolamines: effects of various substituents on the inhibition of acid and neutral ceramidases. | Bioorg Med Chem 20: 6162-70 (2012) | Humboldt Universit£t zu Berlin | 2D 3D TSV |
22989911 | 16 | Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoates. | Bioorg Med Chem 20: 6080-8 (2012) | Cardiff University | 2D 3D TSV |
22989910 | 56 | Characterization, bioinformatic analysis and dithiocarbamate inhibition studies of two newa-carbonic anhydrases, CAH1 and CAH2, from the fruit fly Drosophila melanogaster. | Bioorg Med Chem 21: 1516-21 (2013) | University of Tampere and Tampere University Hospital | 2D 3D TSV |
22989533 | 28 | Discovery of potent inhibitors of receptor protein tyrosine phosphatase sigma through the structure-based virtual screening. | Bioorg Med Chem Lett 22: 6333-7 (2012) | Sejong University | 2D 3D TSV |
22989379 | 8 | Synthesis and biological evaluation of 1a,25-dihydroxyvitamin D3 analogues with a long side chain at C12 and short C17 side chains. | J Med Chem 55: 8642-56 (2012) | Universidad de Santiago de Compostela | 2D 3D TSV |
22989333 | 43 | Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation. | J Med Chem 55: 9331-45 (2012) | Merck Research Laboratories | 2D 3D TSV |
22985961 | 99 | Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists. | Bioorg Med Chem 20: 6097-108 (2012) | GlaxoSmithKline | 2D 3D TSV |
22985959 | 26 | Selection, synthesis, and anti-inflammatory evaluation of the arylidene malonate derivatives as TLR4 signaling inhibitors. | Bioorg Med Chem 20: 6073-9 (2012) | University of Colorado at Boulder | 2D 3D TSV |
22985958 | 7 | Potent small molecule Hedgehog agonists induce VEGF expression in vitro. | Bioorg Med Chem 20: 6465-81 (2012) | Universit£t Leipzig | 2D 3D TSV |
22985853 | 22 | Multisubstituted quinoxalines and pyrido[2,3-d]pyrimidines: synthesis and SAR study as tyrosine kinase c-Met inhibitors. | Bioorg Med Chem Lett 22: 6368-72 (2012) | China Pharmaceutical University | 2D 3D TSV |
22985112 | 49 | Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. | J Med Chem 55: 9416-33 (2012) | Genentech | 2D 3D TSV |
22985069 | 18 | Structure-based discovery of highly selective phosphodiesterase-9A inhibitors and implications for inhibitor design. | J Med Chem 55: 8549-58 (2012) | Sun Yat-sen University | 2D 3D TSV |
22984987 | 24 | Discovery of diverse human dihydroorotate dehydrogenase inhibitors as immunosuppressive agents by structure-based virtual screening. | J Med Chem 55: 8341-9 (2012) | State Key Laboratory of Bioreactor Engineering | 2D 3D TSV |
22984902 | 59 | Selective fluorescent nonpeptidic antagonists for vasopressin V2 GPCR: application to ligand screening and oligomerization assays. | J Med Chem 55: 8588-602 (2012) | University of Strasburg | 2D 3D TSV |
22984865 | 43 | Spirocyclic sulfamides asß-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer's disease: utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitors. | J Med Chem 55: 9224-39 (2012) | Pfizer Inc | 2D 3D TSV |
22984835 | 66 | Identification of high-affinity P2Y12 antagonists based on a phenylpyrazole glutamic acid piperazine backbone. | J Med Chem 55: 8615-29 (2012) | Sanofi-Aventis Deutschland GmbH | 2D 3D TSV |
22984809 | 111 | Pharmacokinetic benefits of 3,4-dimethoxy substitution of a phenyl ring and design of isosteres yielding orally available cathepsin K inhibitors. | J Med Chem 55: 8827-37 (2012) | AstraZeneca | 2D 3D TSV |
22984634 | 16 | Substrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen Probes. | ACS Med Chem Lett 3: 759-763 (2012) | TBA | 2D 3D TSV |
22983304 | 4 | Metabolic chiral inversion of brivanib and its relevance to safety and pharmacology. | Drug Metab Dispos 40: 2374-80 (2012) | Bristol-Myers Squibb Co. | 2D 3D TSV |
22982527 | 6 | Synthesis and biological activities of 4-substituted pyrrolo[2,3-a]carbazole Pim kinase inhibitors. | Eur J Med Chem 56: 225-236 (2012) | TBA | 2D 3D TSV |
22982525 | 32 | Synthesis and biological evaluation of selective and potent cyclin-dependent kinase inhibitors. | Eur J Med Chem 56: 210-216 (2012) | TBA | 2D 3D TSV |
22981333 | 103 | Preparation and optimization of new 4-(morpholin-4-yl)-(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives as PI3Kß inhibitors. | Bioorg Med Chem Lett 22: 6381-4 (2012) | Sanofi | 2D 3D TSV |
22981332 | 58 | Optimization of an ether series of mGlu5 positive allosteric modulators: molecular determinants of MPEP-site interaction crossover. | Bioorg Med Chem Lett 22: 6481-5 (2012) | Vanderbilt University Medical Center | 2D 3D TSV |
22981331 | 14 | Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease. | Bioorg Med Chem Lett 22: 6498-502 (2012) | Sun Yat-sen University | 2D 3D TSV |
22981330 | 7 | Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry. | Bioorg Med Chem Lett 22: 6401-4 (2012) | Universit£ degli Studi di Parma | 2D 3D TSV |
22980219 | 55 | Design and synthesis of pyrrolo[3,2-d]pyrimidine HER2/EGFR dual inhibitors: improvement of the physicochemical and pharmacokinetic profiles for potent in vivo anti-tumor efficacy. | Bioorg Med Chem 20: 6171-80 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22980218 | 2 | Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity. | Bioorg Med Chem 20: 6144-53 (2012) | National Taiwan University Hospital | 2D 3D TSV |
22978849 | 13 | Molecular mechanisms of acquired proteasome inhibitor resistance. | J Med Chem 55: 10317-27 (2012) | University of California San Diego | 2D 3D TSV |
22978824 | 17 | Multitarget-directed benzylideneindanone derivatives: anti-ß-amyloid (Aß) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease. | J Med Chem 55: 8483-92 (2012) | Sun Yat-sen University | 2D 3D TSV |
22978415 | 8 | Conformational Adaptation Drives Potent, Selective and Durable Inhibition of the Human Protein Methyltransferase DOT1L. | Chem Biol Drug Des 80: 971-80 (2012) | Epizyme Inc | 2D 3D TSV |
22975593 | 62 | Oncoepigenomics: making histone lysine methylation count. | Eur J Med Chem 56: 179-194 (2012) | TBA | 2D 3D TSV |
22975302 | 45 | Serum stability of selected decapeptide agonists of KISS1R using pseudopeptides. | Bioorg Med Chem Lett 22: 6391-6 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22975301 | 128 | Azetidinyl oxadiazoles as potent mGluR5 positive allosteric modulators. | Bioorg Med Chem Lett 22: 6469-74 (2012) | Lundbeck Research USA | 2D 3D TSV |
22974493 | 13 | Purification and characterization of carbonic anhydrase from sheep kidney and effects of sulfonamides on enzyme activity. | Bioorg Med Chem 21: 1522-5 (2013) | Agri Ibrahim Cecen University | 2D 3D TSV |
22974355 | 3 | Effect of daurisoline on HERG channel electrophysiological function and protein expression. | J Nat Prod 75: 1539-45 (2012) | Huazhong University of Science and Technology | 2D 3D TSV |
22974325 | 54 | Identification of multiple 5-HT4 partial agonist clinical candidates for the treatment of Alzheimer's disease. | J Med Chem 55: 9240-54 (2012) | Pfizer Inc | 2D 3D TSV |
22971011 | 26 | Design, synthesis, and structure-activity relationships of novel pyrazolo[5,1-b]thiazole derivatives as potent and orally active corticotropin-releasing factor 1 receptor antagonists. | J Med Chem 55: 8450-63 (2012) | Eisai Co., Ltd | 2D 3D TSV |
22967811 | 62 | Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold. | Bioorg Med Chem 20: 5738-44 (2012) | Tianjin Medical University | 2D 3D TSV |
22967810 | 102 | Synthesis of quinolinomorphinan derivatives as highly selectived opioid receptor ligands. | Bioorg Med Chem 20: 5810-31 (2012) | Kitasato University | 2D 3D TSV |
22967796 | 8 | Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates. | Eur J Med Chem 56: 155-165 (2012) | TBA | 2D 3D TSV |
22967236 | 2 | Borrelidin, a potent antifungal agent: insight into the antifungal mechanism against Phytophthora sojae. | J Agric Food Chem 60: 9874-81 (2012) | Northeast Agricultural University | 2D 3D TSV |
22966938 | 20 | cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues: part 2. | J Med Chem 55: 8477-82 (2012) | Universit£ di Chieti-Pescara G. d'Annunzio | 2D 3D TSV |
22963764 | 17 | Discovery of 1H-pyrrolo[2,3-c]pyridine-7-carboxamides as novel, allosteric mGluR5 antagonists. | Bioorg Med Chem Lett 22: 6454-9 (2012) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
22963135 | 7 | Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore. | J Med Chem 55: 8735-44 (2012) | Shionogi & Co., Ltd. | 2D 3D TSV |
22963087 | 17 | Enhanced anti-influenza agents conjugated with anti-inflammatory activity. | J Med Chem 55: 8493-501 (2012) | National Taiwan University | 2D 3D TSV |
22963052 | 38 | Catechol pyrazolinones as trypanocidals: fragment-based design, synthesis, and pharmacological evaluation of nanomolar inhibitors of trypanosomal phosphodiesterase B1. | J Med Chem 55: 8745-56 (2012) | VU University Amsterdam | 2D 3D TSV |
22961681 | 621 | Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. | Drug Metab Dispos 40: 2332-41 (2012) | AstraZeneca | 2D 3D TSV |
22960696 | 5 | D-proline-based peptidomimetic inhibitors of anthrax lethal factor. | Eur J Med Chem 56: 96-107 (2012) | TBA | 2D 3D TSV |
22959556 | 57 | Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. | Bioorg Med Chem 20: 5705-19 (2012) | Mitsubishi Tanabe Pharma Corporation | 2D 3D TSV |
22959526 | 14 | Identification of novel ?7 nicotinic receptor ligands by in silico screening against the crystal structure of a chimeric ?7 receptor ligand binding domain. | Bioorg Med Chem 20: 5992-6002 (2012) | Bezmialem Vakif University | 2D 3D TSV |
22959249 | 79 | JD-5006 and JD-5037: peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities. | Bioorg Med Chem Lett 22: 6173-80 (2012) | Jenrin Discovery | 2D 3D TSV |
22959248 | 18 | Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitors. | Bioorg Med Chem Lett 22: 6301-5 (2012) | Zhejiang Betapharma | 2D 3D TSV |
22959247 | 20 | Isomannide derivatives as new class of inhibitors for human kallikrein 7. | Bioorg Med Chem Lett 22: 6072-5 (2012) | Universidade Federal do Tri£ngulo Mineiro | 2D 3D TSV |
22959246 | 24 | Camptothecins in tumor homing via an RGD sequence mimetic. | Bioorg Med Chem Lett 22: 6509-12 (2012) | Sigma-Tau Industrie Farmaceutiche Riunite SpA | 2D 3D TSV |
22959245 | 175 | As(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs). | Bioorg Med Chem Lett 22: 6053-8 (2012) | The University of Sydney | 2D 3D TSV |
22959244 | 20 | Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation. | Bioorg Med Chem Lett 22: 6048-52 (2012) | Theravance, Inc. | 2D 3D TSV |
22957923 | 20 | The effect of Pro(2) modifications on the structural and pharmacological properties of endomorphin-2. | J Med Chem 55: 8418-28 (2012) | Biological Research Center of the Hungarian Academy of Sciences | 2D 3D TSV |
22957890 | 174 | Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors. | J Med Chem 55: 8164-77 (2012) | University of Copenhagen | 2D 3D TSV |
22957834 | 8 | Structural basis for the accommodation of bis- and tris-aromatic derivatives in vitamin D nuclear receptor. | J Med Chem 55: 8440-9 (2012) | Institute of Genetics and Molecular and Cellular Biology (IGBMC) | 2D 3D TSV |
22957803 | 156 | 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region. | J Med Chem 55: 8392-408 (2012) | Seoul National University | 2D 3D TSV |
22957724 | 30 | Synthesis and characterization of metal complexes of heterocyclic sulfonamide as carbonic anhydrase inhibitors. | J Enzyme Inhib Med Chem 28: 311-5 (2013) | Dumlupinar University | 2D 3D TSV |
22957721 | 3 | In vitro effects of cinnamic acid derivatives on protein tyrosine phosphatase 1B. | J Enzyme Inhib Med Chem 28: 1067-72 (2013) | Chulalongkorn University | 2D 3D TSV |
22957720 | 5 | Synthesis, biological evaluation and docking studies of new pyrrolo[2,3-d] pyrimidine derivatives as Src family-selective tyrosine kinase inhibitors. | J Enzyme Inhib Med Chem 28: 1080-7 (2013) | Ankara University | 2D 3D TSV |
22954899 | 16 | Novel interleukin-5 inhibitors based on hydroxyethylaminomethyl-4H-chromen-4-one scaffold. | Bioorg Med Chem 20: 5757-62 (2012) | Chungnam National University | 2D 3D TSV |
22954737 | 28 | Pyrazolopyridine inhibitors of B-Raf(V600E). Part 4: rational design and kinase selectivity profile of cell potent type II inhibitors. | Bioorg Med Chem Lett 22: 6237-41 (2012) | Array BioPharma | 2D 3D TSV |
22954736 | 2 | Melanin concentrating hormone receptor 1 (MCHR1) antagonists-Still a viable approach for obesity treatment? | Bioorg Med Chem Lett 22: 6039-47 (2012) | Leo Pharma A/S | 2D 3D TSV |
22954387 | 8 | Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization. | J Med Chem 55: 7998-8006 (2012) | National Institute of Allergy and Infectious Diseases | 2D 3D TSV |
22954357 | 29 | Structure-based design of highly selectiveß-secretase inhibitors: synthesis, biological evaluation, and protein-ligand X-ray crystal structure. | J Med Chem 55: 9195-207 (2012) | Purdue University | 2D 3D TSV |
22951255 | 12 | A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells. | Bioorg Med Chem 20: 5915-27 (2012) | Kyoto University | 2D 3D TSV |
22951114 | 16 | A frozen analogue approach to aminopyridinylimidazoles leading to novel and promising p38 MAP kinase inhibitors. | J Med Chem 55: 8429-39 (2012) | University of Tuebingen | 2D 3D TSV |
22951074 | 11 | Novel aromatase inhibitors by structure-guided design. | J Med Chem 55: 8464-76 (2012) | State University of New York Upstate Medical University | 2D 3D TSV |
22950983 | 81 | Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase. | J Med Chem 55: 7759-71 (2012) | Brandeis University | 2D 3D TSV |
22950366 | 6 | Thrombin inhibitors from the freshwater cyanobacterium Anabaena compacta. | J Nat Prod 75: 1546-52 (2012) | Hokkaido University | 2D 3D TSV |
22949627 | 3 | Reversible disulfide formation of the glutamate carboxypeptidase II inhibitor E2072 results in prolonged systemic exposures in vivo. | Drug Metab Dispos 40: 2315-23 (2012) | Johns Hopkins School of Medicine | 2D 3D TSV |
22946614 | 9 | The design and identification of brain penetrant inhibitors of phosphoinositide 3-kinasea. | J Med Chem 55: 8007-20 (2012) | Genentech | 2D 3D TSV |
22946585 | 19 | Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitors. | J Med Chem 55: 8318-29 (2012) | Universita` degli Studi di Sassari | 2D 3D TSV |
22944772 | 15 | Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization. | Eur J Med Chem 56: 30-38 (2012) | TBA | 2D 3D TSV |
22944335 | 43 | O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-ß aggregation. | Bioorg Med Chem 20: 5884-92 (2012) | Sun Yat-sen University | 2D 3D TSV |
22944334 | 9 | Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase. | Bioorg Med Chem 20: 5763-73 (2012) | Northwestern University | 2D 3D TSV |
22944118 | 27 | Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson's disease model. | Bioorg Med Chem Lett 22: 6286-91 (2012) | Glenmark Pharmaceuticals Limited | 2D 3D TSV |
22944117 | 3 | Ago-allosteric modulators of human glucagon-like peptide 2 receptor. | Bioorg Med Chem Lett 22: 6126-35 (2012) | Eisai Co., Ltd | 2D 3D TSV |
22942319 | 16 | Metabolism and pharmacokinetics of JM6 in mice: JM6 is not a prodrug for Ro-61-8048. | Drug Metab Dispos 40: 2297-306 (2012) | CHDI Management/CHDI Foundation | 2D 3D TSV |
22940704 | 23 | Structure-activity relationship and antitumor activity of thio-benzodiazepines as p53-MDM2 protein-protein interaction inhibitors. | Eur J Med Chem 56: 10-16 (2012) | TBA | 2D 3D TSV |
22940448 | 8 | Rhododendric acid A, a new ursane-type PTP1B inhibitor from the endangered plant Rhododendron brachycarpum G. Don. | Bioorg Med Chem Lett 22: 6116-9 (2012) | Yeungnam University | 2D 3D TSV |
22939697 | 4 | Synthesis, radiolabeling and initial in vivo evaluation of [(11)C]KSM-01 for imaging PPAR-a receptors. | Bioorg Med Chem Lett 22: 6233-6 (2012) | Washington University | 2D 3D TSV |
22939696 | 85 | Phenethyl nicotinamides, a novel class of Na(V)1.7 channel blockers: structure and activity relationship. | Bioorg Med Chem Lett 22: 6108-15 (2012) | AstraZeneca | 2D 3D TSV |
22939234 | 31 | Potent and orally efficacious benzothiazole amides as TRPV1 antagonists. | Bioorg Med Chem Lett 22: 6205-11 (2012) | AstraZeneca | 2D 3D TSV |
22939233 | 23 | Benzimidazoles as benzamide replacements within cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists. | Bioorg Med Chem Lett 22: 6181-4 (2012) | Bristol-Myers Squibb Co. | 2D 3D TSV |
22938786 | 86 | Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors. | Bioorg Med Chem 20: 5864-83 (2012) | Dainippon Sumitomo Pharma Co., Ltd | 2D 3D TSV |
22938723 | 4 | Oxygenation of monoenoic fatty acids by CYP175A1, an orphan cytochrome P450 from Thermus thermophilus HB27. | Biochemistry 51: 7880-90 (2012) | Tata Institute of Fundamental Research | 2D 3D TSV |
22938093 | 14 | Structures and mechanisms of antitumor agents: xestoquinones uncouple cellular respiration and disrupt HIF signaling in human breast tumor cells. | J Nat Prod 75: 1553-9 (2012) | University of Mississippi | 2D 3D TSV |
22938049 | 29 | Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors. | J Med Chem 55: 8188-92 (2012) | Korea Institute of Science and Technology | 2D 3D TSV |
22938030 | 22 | EC144 is a potent inhibitor of the heat shock protein 90. | J Med Chem 55: 7786-95 (2012) | Biogen Idec Inc | 2D 3D TSV |
22934600 | 1 | Potent HGF/c-Met axis inhibitors from Eucalyptus globulus: the coupling of phloroglucinol and sesquiterpenoid is essential for the activity. | J Med Chem 55: 8183-7 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22934575 | 124 | Discovery and preclinical pharmacology of a selective ATP-competitive Akt inhibitor (GDC-0068) for the treatment of human tumors. | J Med Chem 55: 8110-27 (2012) | Array BioPharma Inc | 2D 3D TSV |
22934537 | 4 | Plakilactones from the marine sponge Plakinastrella mamillaris. Discovery of a new class of marine ligands of peroxisome proliferator-activated receptor¿. | J Med Chem 55: 8303-17 (2012) | Universit£ di Napoli Federico II | 2D 3D TSV |
22932317 | 4 | Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferase. | Bioorg Med Chem Lett 22: 6242-7 (2012) | Yale University | 2D 3D TSV |
22932316 | 8 | Amide-based derivatives ofß-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects. | Bioorg Med Chem Lett 22: 6200-4 (2012) | University of Sydney | 2D 3D TSV |
22932315 | 28 | An investigation into the structure-activity relationships associated with the systematic modification of theß(2)-adrenoceptor agonist indacaterol. | Bioorg Med Chem Lett 22: 6280-5 (2012) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
22932313 | 9 | Design and synthesis of diarylamines and diarylethers as cytotoxic antitumor agents. | Bioorg Med Chem Lett 22: 6224-8 (2012) | Beijing Institute of Pharmacology & Toxicology | 2D 3D TSV |
22932312 | 4 | 2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani. | Bioorg Med Chem Lett 22: 6185-9 (2012) | University of Puerto Rico | 2D 3D TSV |
22931526 | 31 | Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells. | J Med Chem 55: 8193-7 (2012) | Sapienza University of Rome | 2D 3D TSV |
22931505 | 69 | Chemokine receptor antagonists. | J Med Chem 55: 9363-92 (2012) | National Heart and Lung Institute | 2D 3D TSV |
22930276 | 25 | Predicting the drug interaction potential of AMG 853, a dual antagonist of the D-prostanoid and chemoattractant receptor-homologous molecule expressed on T helper 2 cells receptors. | Drug Metab Dispos 40: 2239-49 (2012) | Amgen Inc | 2D 3D TSV |
22929233 | 72 | A focused sulfated glycoconjugate Ugi library for probing heparan sulfate-binding angiogenic growth factors. | Bioorg Med Chem Lett 22: 6190-4 (2012) | The University of Queensland | 2D 3D TSV |
22929232 | 89 | Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors. | Bioorg Med Chem Lett 22: 6212-7 (2012) | Amgen Inc | 2D 3D TSV |
22929231 | 3 | Ethylenediamine diacetate (EDDA) mediated synthesis of aurones under ultrasound: their evaluation as inhibitors of SIRT1. | Bioorg Med Chem Lett 22: 6160-5 (2012) | University of Hyderabad Campus | 2D 3D TSV |
22928967 | 12 | Inhibition of hypoxia inducible factor-2 transcription: isolation of active modulators from marine sponges. | J Nat Prod 75: 1632-6 (2012) | National Cancer Institute-Frederick | 2D 3D TSV |
22928944 | 12 | Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands toa4ß2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligands. | J Med Chem 55: 8028-37 (2012) | University of Illinois at Chicago | 2D 3D TSV |
22928914 | 104 | Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease. | J Med Chem 55: 9156-69 (2012) | Amgen Inc | 2D 3D TSV |
22928876 | 10 | Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation. | J Med Chem 55: 7978-87 (2012) | Georgia State University | 2D 3D TSV |
22926225 | 200 | The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of aryloxyethyl- and arylthioethyl- piperidines and pyrrolidines as a novel class of potent 5-HT7 receptor antagonists. | Eur J Med Chem 56: 348-360 (2012) | TBA | 2D 3D TSV |
22926069 | 28 | Phenylalanine derivatives as GPR142 agonists for the treatment of type II diabetes. | Bioorg Med Chem Lett 22: 6218-23 (2012) | Amgen Inc | 2D 3D TSV |
22926067 | 22 | Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivatives. | Bioorg Med Chem Lett 22: 6256-60 (2012) | University of Lisbon | 2D 3D TSV |
22924815 | 97 | Design and synthesis ofß-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction ofß-amyloid peptides. | J Med Chem 55: 9346-61 (2012) | AstraZeneca | 2D 3D TSV |
22924785 | 85 | Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L. | J Med Chem 55: 8066-74 (2012) | Baylor College of Medicine | 2D 3D TSV |
22924757 | 16 | Structure-activity relationships in human Toll-like receptor 8-active 2,3-diamino-furo[2,3-c]pyridines. | J Med Chem 55: 8137-51 (2012) | University of Kansas | 2D 3D TSV |
22924734 | 87 | Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the treatment of | J Med Chem 55: 8091-109 (2012) | Pfizer Inc | 2D 3D TSV |
22924688 | 128 | PI3Kd and PI3K¿ as targets for autoimmune and inflammatory diseases. | J Med Chem 55: 8559-81 (2012) | Amgen Inc | 2D 3D TSV |
22924434 | 4 | Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions. | J Med Chem 55: 9393-413 (2012) | University of Oxford | 2D 3D TSV |
22924342 | 15 | Potential use of selective and nonselective Pim kinase inhibitors for cancer therapy. | J Med Chem 55: 8199-208 (2012) | Cylene Pharmaceuticals | 2D 3D TSV |
22924094 | 41 | Metabotropic glutamate receptor 5 negative allosteric modulators as novel tools for in vivo investigation. | ACS Med Chem Lett 3: 544-549 (2012) | TBA | 2D 3D TSV |
22921745 | 1 | [¹8F]FE@SNAP-A new PET tracer for the melanin concentrating hormone receptor 1 (MCHR1): microfluidic and vessel-based approaches. | Bioorg Med Chem 20: 5936-40 (2012) | Medical University of Vienna | 2D 3D TSV |
22921743 | 4 | Discovery of structurally-diverse inhibitor scaffolds by high-throughput screening of a fragment library with dimethylarginine dimethylaminohydrolase. | Bioorg Med Chem 20: 5550-8 (2012) | University of Texas | 2D 3D TSV |
22921742 | 11 | Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid ?-protein. | Bioorg Med Chem 20: 5844-9 (2012) | University of Tsukuba | 2D 3D TSV |
22921279 | 2 | Armeniaspiroles, a new class of antibacterials: Antibacterial activities and total synthesis of 5-chloro-Armeniaspirole A. | Bioorg Med Chem Lett 22: 6292-6 (2012) | Sanofi Research & Development | 2D 3D TSV |
22921089 | 62 | Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity. | J Med Chem 55: 8075-90 (2012) | National Institute of Diabetes and Digestive and Kidney Diseases | 2D 3D TSV |
22921080 | 42 | 2-Substituted 4,5-dihydrothiazole-4-carboxylic acids are novel inhibitors of metallo-ß-lactamases. | Bioorg Med Chem Lett 22: 6229-32 (2012) | Baylor College of Medicine | 2D 3D TSV |
22920150 | 35 | An aromatic region to induce a switch between agonism and inverse agonism at the ghrelin receptor. | J Med Chem 55: 7437-49 (2012) | Universit£t Leipzig | 2D 3D TSV |
22920039 | 9 | Crystal structure of human aurora B in complex with INCENP and VX-680. | J Med Chem 55: 7841-8 (2012) | University of Oxford | 2D 3D TSV |
22917520 | 45 | Discovery of liver selective non-steroidal glucocorticoid receptor antagonist as novel antidiabetic agents. | Bioorg Med Chem Lett 22: 5857-62 (2012) | Zydus Research Centre | 2D 3D TSV |
22917519 | 106 | Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C). | Bioorg Med Chem Lett 22: 5811-3 (2012) | University of Copenhagen | 2D 3D TSV |
22916727 | 18 | Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activity. | J Med Chem 55: 8152-63 (2012) | Hokkaido University | 2D 3D TSV |
22916707 | 76 | 7-Alkyl-3-benzylcoumarins: a versatile scaffold for the development of potent and selective cannabinoid receptor agonists and antagonists. | J Med Chem 55: 7967-77 (2012) | University of Bonn | 2D 3D TSV |
22913577 | 43 | Pd-catalyzed direct C-H bond functionalization of spirocyclics1 ligands: generation of a pharmacophore model and analysis of the reverse binding mode by docking into a 3D homology model of thes1 receptor. | J Med Chem 55: 8047-65 (2012) | Institut f£r Pharmazeutische und Medizinische Chemie der Westf£lischen Wilhelms-Universit£t M£nster | 2D 3D TSV |
22913544 | 12 | Bis(arylvinyl)pyrazines, -pyrimidines, and -pyridazines as imaging agents for tau fibrils andß-amyloid plaques in Alzheimer's disease models. | J Med Chem 55: 9170-80 (2012) | Technische Universit£t Darmstadt | 2D 3D TSV |
22913511 | 91 | Discovery of (2S)-1-[4-(2-{6-amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a purine-based Hsp90 inhibitor. | J Med Chem 55: 7480-501 (2012) | Myrexis Inc. | 2D 3D TSV |
22913487 | 4 | Structural analysis of bengamide derivatives as inhibitors of methionine aminopeptidases. | J Med Chem 55: 8021-7 (2012) | Indiana University School of Medicine | 2D 3D TSV |
22910224 | 11 | Discovery of pyrrolo[3,2-c]quinoline-4-one derivatives as novel hedgehog signaling inhibitors. | Bioorg Med Chem 20: 5496-506 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22910138 | 96 | Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII. | Eur J Med Chem 56: 282-291 (2012) | TBA | 2D 3D TSV |
22910137 | 1 | Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c]carbazoles as a new class of anti-cancer agents. | Eur J Med Chem 56: 292-300 (2012) | TBA | 2D 3D TSV |
22910039 | 66 | Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activator. | Bioorg Med Chem Lett 22: 5936-41 (2012) | Vanderbilt University Medical Center | 2D 3D TSV |
22910038 | 2 | Phenolic compounds as antiangiogenic CMG2 inhibitors from Costa Rican endophytic fungi. | Bioorg Med Chem Lett 22: 5885-8 (2012) | Harvard Medical School | 2D 3D TSV |
22909088 | 6 | Noncyclam tetraamines inhibit CXC chemokine receptor type 4 and target glioma-initiating cells. | J Med Chem 55: 7560-70 (2012) | Universitat Ramon Llull | 2D 3D TSV |
22905906 | 10 | Synthesis, crystal structure, in vitro acetohydroxyacid synthase inhibition, in vivo herbicidal activity, and 3D-QSAR of new asymmetric aryl disulfides. | J Agric Food Chem 60: 8286-93 (2012) | Nankai University | 2D 3D TSV |
22905713 | 9 | Identification, synthesis, and biological evaluation of 6-[(6R)-2-(4-fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2H)-one (AS1940477), a potent p38 MAP kinase inhibitor. | J Med Chem 55: 7772-85 (2012) | Astellas Pharma Inc | 2D 3D TSV |
22904561 | 6 | Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands. | Drug Metab Dispos 40: 2174-84 (2012) | University of Arkansas for Medical Sciences | 2D 3D TSV |
22902659 | 4 | Ras inhibition via direct Ras binding--is there a path forward? | Bioorg Med Chem Lett 22: 5766-76 (2012) | Genentech | 2D 3D TSV |
22902658 | 31 | Exploration of the structure-activity relationship of the diaryl anilide class of ligands for translocator protein--potential novel positron emitting tomography imaging agents. | Bioorg Med Chem Lett 22: 5795-800 (2012) | GE Healthcare | 2D 3D TSV |
22902656 | 42 | Novel triazines as potent and selective phosphodiesterase 10A inhibitors. | Bioorg Med Chem Lett 22: 5876-84 (2012) | Pfizer Inc | 2D 3D TSV |
22902653 | 99 | Modulation of cofilin phosphorylation by inhibition of the Lim family kinases. | Bioorg Med Chem Lett 22: 5995-8 (2012) | Bristol-Myers Squibb Research and Development | 2D 3D TSV |
22901900 | 92 | Discovery and optimization of a series of liver X receptor antagonists. | Bioorg Med Chem Lett 22: 5966-70 (2012) | Amgen Inc | 2D 3D TSV |
22901899 | 15 | Novel oxysterols activate the Hedgehog pathway and induce osteogenesis. | Bioorg Med Chem Lett 22: 5893-7 (2012) | Fate Therapeutics | 2D 3D TSV |
22901672 | 15 | UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety. | Bioorg Med Chem 20: 5483-95 (2012) | Bar-Ilan University | 2D 3D TSV |
22901671 | 43 | Synthesis and pharmacological evaluation of indolinone derivatives as novel ghrelin receptor antagonists. | Bioorg Med Chem 20: 5623-36 (2012) | Sanofi Research | 2D 3D TSV |
22901670 | 61 | Synthesis, biological evaluation, and molecular docking of N-{3-[3-(9-methyl-9H-carbazol-3-yl)-acryloyl]-phenyl}-benzamide/amide derivatives as xanthine oxidase and tyrosinase inhibitors. | Bioorg Med Chem 20: 5649-57 (2012) | Solapur University | 2D 3D TSV |
22901393 | 11 | Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase. | Bioorg Med Chem Lett 22: 5889-92 (2012) | University of California | 2D 3D TSV |
22901392 | 27 | A novel aminopeptidase N inhibitor developed by virtual screening approach. | Bioorg Med Chem Lett 22: 5863-9 (2012) | Shandong Academy of Sciences | 2D 3D TSV |
22901390 | 44 | Synthesis and biological activity of pyridopyridazin-6-one p38a MAP kinase inhibitors. Part 2. | Bioorg Med Chem Lett 22: 5979-83 (2012) | Merck Research Laboratories | 2D 3D TSV |
22901389 | 28 | Structure-based design of 7-azaindole-pyrrolidine amides as inhibitors of 11ß-hydroxysteroid dehydrogenase type I. | Bioorg Med Chem Lett 22: 5909-14 (2012) | Merck Serono | 2D 3D TSV |
22901388 | 76 | Inhibition ofa-class cytosolic human carbonic anhydrases I, II, IX and XII, andß-class fungal enzymes by carboxylic acids and their derivatives: new isoform-I selective nanomolar inhibitors. | Bioorg Med Chem Lett 22: 5801-6 (2012) | Universit£ di Sassari | 2D 3D TSV |
22901387 | 18 | Discovery of 6-substituted 4-anilinoquinazolines with dioxygenated rings as novel EGFR tyrosine kinase inhibitors. | Bioorg Med Chem Lett 22: 5870-5 (2012) | Nanjing University | 2D 3D TSV |
22901310 | 18 | Structure activity relationship studies of natural product chemokine receptor CCR5 antagonist anibamine toward the development of novel anti prostate cancer agents. | Eur J Med Chem 55: 395-408 (2012) | Virginia Commonwealth University | 2D 3D TSV |
22901043 | 9 | Probing the peripheral site of human butyrylcholinesterase. | Biochemistry 51: 7046-53 (2012) | Dalhousie University | 2D 3D TSV |
22898529 | 58 | Discovery of 1-(ß-amino substituted-ß-alanyl)-N,N-dimethylindoline-2-carboxamides as novel nonpeptide antagonists of nociceptin/orphanin FQ receptor: efficient design, synthesis, and structure-activity relationship studies. | Eur J Med Chem 55: 228-42 (2012) | Pfizer Inc | 2D 3D TSV |
22898255 | 22 | Identification and synthesis of substituted pyrrolo[2,3-d]pyrimidines as novel firefly luciferase inhibitors. | Bioorg Med Chem 20: 5473-82 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22898254 | 9 | Discovery of the investigational drug TAK-441, a pyrrolo[3,2-c]pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: modification of the core skeleton for improved solubility. | Bioorg Med Chem 20: 5507-17 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22897946 | 34 | N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3. | Bioorg Med Chem Lett 22: 5948-51 (2012) | University of Ljubljana | 2D 3D TSV |
22897945 | 15 | Synthesis and evaluation of novel 2-pyridone derivatives as inhibitors of phosphodiesterase3 (PDE3): a target for heart failure and platelet aggregation. | Bioorg Med Chem Lett 22: 6010-5 (2012) | Indian Institute of Chemical Technology | 2D 3D TSV |
22897611 | 2 | Discovery of diarylhydantoins as new selective androgen receptor modulators. | J Med Chem 55: 8225-35 (2012) | GALAPAGOS, Parc Biocitech | 2D 3D TSV |
22897589 | 100 | Selective class I phosphoinositide 3-kinase inhibitors: optimization of a series of pyridyltriazines leading to the identification of a clinical candidate, AMG 511. | J Med Chem 55: 7796-816 (2012) | Amgen Inc | 2D 3D TSV |
22897496 | 69 | Targeting the hinge glycine flip and the activation loop: novel approach to potent p38a inhibitors. | J Med Chem 55: 7862-74 (2012) | Eberhard Karls University T£bingen | 2D 3D TSV |
22894757 | 69 | Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts. | J Med Chem 55: 7920-39 (2012) | F. Hoffmann-La Roche Inc | 2D 3D TSV |
22894736 | 99 | Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment. | J Med Chem 55: 7875-82 (2012) | The Hebrew University of Jerusalem | 2D 3D TSV |
22894131 | 4 | Water mediated ligand functional group cooperativity: the contribution of a methyl group to binding affinity is enhanced by a COO(-) group through changes in the structure and thermodynamics of the hydration waters of ligand-thermolysin complexes. | J Med Chem 55: 8283-302 (2012) | The State University of New York | 2D 3D TSV |
22893598 | 12 | A Novel Approach to the Discovery of Small-Molecule Ligands of CDK2. | Chembiochem 13: 2128-36 (2012) | Moffitt Cancer Center | 2D 3D TSV |
22892213 | 168 | Natural product coumarins that inhibit human carbonic anhydrases. | Bioorg Med Chem 21: 1539-43 (2013) | Griffith University | 2D 3D TSV |
22892116 | 30 | Discovery of tetrahydropyridopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia. | Bioorg Med Chem Lett 22: 5903-8 (2012) | Merck Research Laboratories | 2D 3D TSV |
22891752 | 18 | Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors. | J Med Chem 55: 7525-45 (2012) | Universidade Federal do Rio de Janeiro | 2D 3D TSV |
22891675 | 46 | Design and characterization of a selenium-containing inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa), a zinc-containing metalloprotease. | J Med Chem 55: 7696-705 (2012) | Showa Pharmaceutical University | 2D 3D TSV |
22891645 | 83 | Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT). | J Med Chem 55: 7061-79 (2012) | GlaxoSmithKline | 2D 3D TSV |
22889803 | 19 | Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors. | Bioorg Med Chem Lett 22: 5919-23 (2012) | AstraZeneca | 2D 3D TSV |
22889562 | 3 | Synthesis, cytotoxicity of new 4-arylidene curcumin analogues and their multi-functions in inhibition of both NF-¿B and Akt signalling. | Eur J Med Chem 55: 346-57 (2012) | Sun Yat-sen University | 2D 3D TSV |
22889560 | 16 | The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives. | Eur J Med Chem 55: 358-74 (2012) | University of Patras | 2D 3D TSV |
22889387 | 2 | Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor. | J Med Chem 55: 7719-35 (2012) | Universit£ di Ferrara | 2D 3D TSV |
22889351 | 40 | Discovery of tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. | J Med Chem 55: 7828-40 (2012) | Chugai Pharmaceutical Co. Ltd | 2D 3D TSV |
22889281 | 36 | Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidate. | J Med Chem 55: 7472-9 (2012) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
22884991 | 9 | Antiplasmodial activities of 4-aminoquinoline-statine compounds. | Bioorg Med Chem Lett 22: 5915-8 (2012) | Universit£ degli Studi di Milano | 2D 3D TSV |
22884989 | 42 | Phosphodiesterase inhibitors. Part 4: design, synthesis and structure-activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-4,4-dimethylpyrazolones. | Bioorg Med Chem Lett 22: 5833-8 (2012) | Kyorin Pharmaceutical Co., Ltd | 2D 3D TSV |
22884988 | 49 | Discovery and optimization of a novel series of GPR142 agonists for the treatment of type 2 diabetes mellitus. | Bioorg Med Chem Lett 22: 5942-7 (2012) | Amgen Inc | 2D 3D TSV |
22884355 | 31 | Design, synthesis and structure-activity relationships of novel benzoxazolone derivatives as 18 kDa translocator protein (TSPO) ligands. | Bioorg Med Chem 20: 5568-82 (2012) | Dainippon Sumitomo Pharma Co., Ltd | 2D 3D TSV |
22884354 | 36 | Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. | Bioorg Med Chem 20: 5928-35 (2012) | Korea Research Institute of Bioscience and Biotechnology | 2D 3D TSV |
22884353 | 15 | Design of potent bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase via targeted interactions with the active site 'capping' phenyls. | Bioorg Med Chem 20: 5583-91 (2012) | McGill University | 2D 3D TSV |
22883029 | 80 | The alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 is highly susceptible to inhibition by sulfonamides. | Bioorg Med Chem 21: 1534-8 (2013) | Universit£ degli Studi di Firenze | 2D 3D TSV |
22883027 | 1 | Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors. | Bioorg Med Chem 20: 5527-36 (2012) | Shandong University | 2D 3D TSV |
22883026 | 34 | Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 3. Evaluation of 5-amino-linked thiazolo[5,4-d]pyrimidine and thiazolo[5,4-b]pyridine derivatives. | Bioorg Med Chem 20: 5600-15 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22882897 | 7 | Synthesis, in vitro Biological Evaluation and Molecular Docking Studies of Benzimidamides as Potential BACE1 Inhibitors. | Chem Biol Drug Des 80: 775-80 (2012) | Peking University Health Science Center | 2D 3D TSV |
22882119 | 4 | A new class of selective and potent 7-dehydrocholesterol reductase inhibitors. | J Med Chem 55: 7614-22 (2012) | Martin-Luther-Universit£t Halle-Wittenberg | 2D 3D TSV |
22882079 | 26 | Synthesis and evaluation of silanediols as highly selective uncompetitive inhibitors of human neutrophil elastase. | J Med Chem 55: 7900-8 (2012) | Aarhus University | 2D 3D TSV |
22881866 | 57 | Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual screening of a fragment library. | J Med Chem 55: 7417-24 (2012) | University of Ljubljana | 2D 3D TSV |
22877871 | 3 | Synthesis and biological evaluation of tyrosine modified analogues of thea4ß7 integrin inhibitor biotin-R8ERY. | Bioorg Med Chem 20: 5139-49 (2012) | University of Auckland | 2D 3D TSV |
22877636 | 60 | Discovery of XL888: a novel tropane-derived small molecule inhibitor of HSP90. | Bioorg Med Chem Lett 22: 5396-404 (2012) | Exelixis Inc | 2D 3D TSV |
22877635 | 6 | Set-up of a new series of HDAC inhibitors: the 5,11-dihydrodibenzo[b,e]azepin-6-ones as privileged structures. | Bioorg Med Chem Lett 22: 5360-2 (2012) | Menarini Ricerche Pomezia | 2D 3D TSV |
22877633 | 28 | Highly potent aminopyridines as Syk kinase inhibitors. | Bioorg Med Chem Lett 22: 5419-23 (2012) | Rhône-Poulenc Rorer | 2D 3D TSV |
22877632 | 49 | Design of inhibitors of Helicobacter pylori glutamate racemase as selective antibacterial agents: incorporation of imidazoles onto a core pyrazolopyrimidinedione scaffold to improve bioavailabilty. | Bioorg Med Chem Lett 22: 5600-7 (2012) | AstraZeneca | 2D 3D TSV |
22877630 | 46 | Synthesis and structure-activity relationship of (1-halo-2-naphthyl) carbamate-based inhibitors of KIAA1363 (NCEH1/AADACL1). | Bioorg Med Chem Lett 22: 5748-51 (2012) | ActivX Biosciences Inc | 2D 3D TSV |
22877629 | 42 | 2-Phenylamino-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1¿) inhibitors. | Bioorg Med Chem Lett 22: 5392-5 (2012) | Amgen Inc | 2D 3D TSV |
22877245 | 6 | Bioisosteric transformations and permutations in the triazolopyrimidine scaffold to identify the minimum pharmacophore required for inhibitory activity against Plasmodium falciparum dihydroorotate dehydrogenase. | J Med Chem 55: 7425-36 (2012) | University of Washington | 2D 3D TSV |
22877157 | 356 | 3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: highly potent and selective inhibitors of the type 5 17-ß-hydroxysteroid dehydrogenase AKR1C3. | J Med Chem 55: 7746-58 (2012) | University of Auckland | 2D 3D TSV |
22877085 | 33 | Potent and highly selective benzimidazole inhibitors of PI3-kinase delta. | J Med Chem 55: 7686-95 (2012) | Genentech | 2D 3D TSV |
22876979 | 2 | Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1. | J Med Chem 55: 7378-91 (2012) | Wayne State University | 2D 3D TSV |
22876881 | 72 | Discovery and in vivo evaluation of dual PI3Kß/d inhibitors. | J Med Chem 55: 7667-85 (2012) | Amgen Inc | 2D 3D TSV |
22873824 | 4 | Halicloic acids A and B isolated from the marine sponge Haliclona sp. collected in the Philippines inhibit indoleamine 2,3-dioxygenase. | J Nat Prod 75: 1451-8 (2012) | University of British Columbia | 2D 3D TSV |
22873709 | 45 | Design, synthesis, and biological evaluation of novel transrepression-selective liver X receptor (LXR) ligands with 5,11-dihydro-5-methyl-11-methylene-6H-dibenz[b,e]azepin-6-one skeleton. | J Med Chem 55: 7360-77 (2012) | The University of Tokyo | 2D 3D TSV |
22873688 | 10 | Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist. | J Med Chem 55: 7623-35 (2012) | Bar-Ilan University | 2D 3D TSV |
22871582 | 29 | Design, synthesis, and structure-activity relationships of a series of 2-Ar-8-methyl-5-alkylaminoquinolines as novel CRF1 receptor antagonists. | Bioorg Med Chem Lett 22: 5372-8 (2012) | Eisai Co., Ltd | 2D 3D TSV |
22871580 | 6 | Near-infrared fluorescent divalent RGD ligand for integrinavß3-targeted optical imaging. | Bioorg Med Chem Lett 22: 5405-9 (2012) | Washington University | 2D 3D TSV |
22871578 | 44 | High-affinity and selective dopamine D3 receptor full agonists. | Bioorg Med Chem Lett 22: 5612-7 (2012) | University of Michigan | 2D 3D TSV |
22871134 | 34 | Design, synthesis and evaluation of new thiazole-piperazines as acetylcholinesterase inhibitors. | J Enzyme Inhib Med Chem 28: 1040-7 (2013) | Anadolu University | 2D 3D TSV |
22868229 | 2 | A fluorescent reporter of ATP binding-competent receptor kinases. | Bioorg Med Chem Lett 22: 5532-5 (2012) | University of Miami | 2D 3D TSV |
22868228 | 57 | N-1-Alkyl-2-oxo-2-aryl amides as novel antagonists of the TRPA1 receptor. | Bioorg Med Chem Lett 22: 5485-92 (2012) | AstraZeneca | 2D 3D TSV |
22867529 | 14 | Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors. | Eur J Med Chem 61: 84-94 (2013) | Chinese Academy of Sciences | 2D 3D TSV |
22867097 | 1 | Inhibition of human topoisomerases I and II by simocyclinone D8. | J Nat Prod 75: 1485-9 (2012) | University of Minnesota Medical School | 2D 3D TSV |
22866979 | 19 | Mineralocorticoid receptor antagonists for the treatment of hypertension and diabetic nephropathy. | J Med Chem 55: 7957-66 (2012) | Pfizer Inc | 2D 3D TSV |
22864521 | 25 | Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B. | Dalton Trans 41: 11116-24 (2012) | Shanxi University | 2D 3D TSV |
22863529 | 31 | Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors. | Bioorg Med Chem 20: 5169-80 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22863527 | 2 | C-N bond formation under Cu-catalysis: synthesis and in vitro evaluation of N-aryl substituted thieno[2,3-d]pyrimidin-4(3H)-ones against chorismate mutase. | Bioorg Med Chem 20: 5127-38 (2012) | University of Hyderabad Campus | 2D 3D TSV |
22863525 | 36 | Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1. | Bioorg Med Chem 20: 5117-26 (2012) | Poznan University of Medical Sciences | 2D 3D TSV |
22863204 | 17 | Structure-based design, synthesis, and biological evaluation of dihydroquinazoline-derived potentß-secretase inhibitors. | Bioorg Med Chem Lett 22: 5460-5 (2012) | Purdue University | 2D 3D TSV |
22863203 | 1 | GSK2578215A; a potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor. | Bioorg Med Chem Lett 22: 5625-9 (2012) | GlaxoSmithKline | 2D 3D TSV |
22863202 | 94 | Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway. | Bioorg Med Chem Lett 22: 5445-50 (2012) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
22862294 | 118 | The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonist. | J Med Chem 55: 7849-61 (2012) | Actelion Pharmaceuticals Ltd | 2D 3D TSV |
22861813 | 42 | Novelß-amino acid derivatives as inhibitors of cathepsin A. | J Med Chem 55: 7636-49 (2012) | Sanofi-Aventis Deutschland GmbH | 2D 3D TSV |
22861193 | 60 | Selective dual inhibitors of CYP19 and CYP11B2: targeting cardiovascular diseases hiding in the shadow of breast cancer. | J Med Chem 55: 7080-9 (2012) | Saarland University & Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) | 2D 3D TSV |
22858142 | 121 | Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from hERG channel inhibition. | Bioorg Med Chem Lett 22: 5563-8 (2012) | AstraZeneca | 2D 3D TSV |
22858141 | 113 | Discovery of triazolopyrimidine-based PDE8B inhibitors: exceptionally ligand-efficient and lipophilic ligand-efficient compounds for the treatment of diabetes. | Bioorg Med Chem Lett 22: 5721-6 (2012) | Pfizer Inc | 2D 3D TSV |
22858139 | 25 | Combining pharmacophore, docking and substructure search approaches to identify and optimize novel B-RafV600E inhibitors. | Bioorg Med Chem Lett 22: 5428-37 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22858099 | 52 | Discovery of potent and selective rhodanine type IKKß inhibitors by hit-to-lead strategy. | Bioorg Med Chem Lett 22: 5668-74 (2012) | Korea University | 2D 3D TSV |
22858098 | 1 | Identification of a novel serum and glucocorticoid regulated kinase-1 (SGK1) ligand from virtual screening. | Bioorg Med Chem Lett 22: 5675-8 (2012) | Northeast Ohio Medical University | 2D 3D TSV |
22858096 | 12 | The development of first Staphylococcus aureus SplB protease inhibitors: phosphonic analogues of glutamine. | Bioorg Med Chem Lett 22: 5574-8 (2012) | Wroclaw University of Technology | 2D 3D TSV |
22854677 | 32 | New cytosine derivatives as inhibitors of DNA methylation. | Eur J Med Chem 55: 243-54 (2012) | Polish Academy of Sciences | 2D 3D TSV |
22854195 | 17 | Transition state analogue inhibitors of human methylthioadenosine phosphorylase and bacterial methylthioadenosine/S-adenosylhomocysteine nucleosidase incorporating acyclic ribooxacarbenium ion mimics. | Bioorg Med Chem 20: 5181-7 (2012) | Industrial Research Limited | 2D 3D TSV |
22853998 | 164 | Design, synthesis and identification of novel benzimidazole derivatives as highly potent NPY Y5 receptor antagonists with attractive in vitro ADME profiles. | Bioorg Med Chem Lett 22: 5498-502 (2012) | Shionogi & Co., Ltd | 2D 3D TSV |
22853997 | 3 | Orally available pyridinylpyrimidine derivatives as novel RANKL-induced osteoclastogenesis inhibitors. | Bioorg Med Chem Lett 22: 5681-4 (2012) | Astellas Pharma Inc | 2D 3D TSV |
22853995 | 57 | 4-Substituted boro-proline dipeptides: synthesis, characterization, and dipeptidyl peptidase IV, 8, and 9 activities. | Bioorg Med Chem Lett 22: 5536-40 (2012) | Tufts University School of Medicine | 2D 3D TSV |
22853993 | 18 | A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: from in silico screening to cyclodextrin formulation. | Bioorg Med Chem Lett 22: 5579-83 (2012) | University of Siena | 2D 3D TSV |
22853801 | 7 | New positron emission tomography (PET) radioligand for imagings-1 receptors in living subjects. | J Med Chem 55: 8272-82 (2012) | Stanford University | 2D 3D TSV |
22850212 | 30 | Selected chromone derivatives as inhibitors of monoamine oxidase. | Bioorg Med Chem Lett 22: 5480-4 (2012) | North-West University | 2D 3D TSV |
22850210 | 20 | Exploration of ring size in a series of cyclic vicinal diamines withs1 receptor affinity. | Bioorg Med Chem Lett 22: 5493-7 (2012) | The University of Sydney | 2D 3D TSV |
22850208 | 60 | Dipeptidyl peptidase-4 inhibitor withß-amino amide scaffold: synthesis, SAR and biological evaluation. | Bioorg Med Chem Lett 22: 5545-9 (2012) | Dong-A Pharm. Co., Ltd | 2D 3D TSV |
22849725 | 28 | Discovery of the first thumb pocket 1 NS5B polymerase inhibitor (BILB 1941) with demonstrated antiviral activity in patients chronically infected with genotype 1 hepatitis C virus (HCV). | J Med Chem 55: 7650-66 (2012) | Boehringer Ingelheim (Canada) Ltd | 2D 3D TSV |
22849615 | 2 | Synthesis and study of 2-(pyrrolesulfonylmethyl)-N-arylimines: a new class of inhibitors for human glutathione transferase A1-1. | J Med Chem 55: 6802-13 (2012) | Agricultural University of Athens | 2D 3D TSV |
22846798 | 48 | Chemoenzymatic synthesis and evaluation of 3-azabicyclo[3.2.0]heptane derivatives as dopaminergic ligands. | Eur J Med Chem 55: 255-61 (2012) | University of Tartu | 2D 3D TSV |
22845329 | 2 | Thiazoline peptides and a tris-phenethyl urea from Didemnum molle with anti-HIV activity. | J Nat Prod 75: 1436-40 (2012) | University of Utah | 2D 3D TSV |
22845053 | 100 | Structure-functional selectivity relationship studies ofß-arrestin-biased dopamine D2 receptor agonists. | J Med Chem 55: 7141-53 (2012) | University of North Carolina at Chapel Hill | 2D 3D TSV |
22844551 | 8 | Inhibitors for Bacterial Cell-Wall Recycling. | ACS Med Chem Lett 3: 238-242 (2012) | TBA | 2D 3D TSV |
22841436 | 51 | Novel 2-methoxyacylhydrazones as potent, selective PDE10A inhibitors with activity in animal models of schizophrenia. | Bioorg Med Chem Lett 22: 5595-9 (2012) | Omeros Corp. | 2D 3D TSV |
22841006 | 5 | Click-based synthesis of triazolobithiazole ?F508-CFTR correctors for cystic fibrosis. | Bioorg Med Chem 20: 5247-53 (2012) | University of California Davis | 2D 3D TSV |
22840775 | 7 | Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening. | Chem Biol 19: 875-82 (2012) | Yale University School of Medicine | 2D 3D TSV |
22840695 | 52 | Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine. | Eur J Med Chem 55: 94-107 (2012) | NeurAxon Inc | 2D 3D TSV |
22837811 | 12 | Discovery of Imidazoquinolines with Toll-Like Receptor 7/8 Independent Cytokine Induction. | ACS Med Chem Lett 3: 501-504 (2012) | TBA | 2D 3D TSV |
22836190 | 8 | Discovery and biological evaluation of novel 4-amino-2-phenylpyrimidine derivatives as potent and orally active GPR119 agonists. | Bioorg Med Chem 20: 5235-46 (2012) | Astellas Pharma Inc | 2D 3D TSV |
22835872 | 6 | Design, synthesis and molecular simulation studies of dihydrostilbene derivatives as potent tyrosinase inhibitors. | Bioorg Med Chem Lett 22: 5523-6 (2012) | University of Athens | 2D 3D TSV |
22835870 | 29 | Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family. | Bioorg Med Chem Lett 22: 5352-9 (2012) | AstraZeneca | 2D 3D TSV |
22835719 | 3 | Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2. | Eur J Med Chem 55: 58-66 (2012) | Universit£ degli Studi del Piemonte Orientale A. Avogadro | 2D 3D TSV |
22834902 | 30 | Discovery of a novel noniminosugar acida glucosidase chaperone series. | J Med Chem 55: 7546-59 (2012) | National Center for Advancing Translational Sciences | 2D 3D TSV |
22834877 | 119 | Current landscape of phosphodiesterase 10A (PDE10A) inhibition. | J Med Chem 55: 7299-331 (2012) | Pfizer Inc | 2D 3D TSV |
22832322 | 40 | Synthesis and structure-activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold. | Bioorg Med Chem Lett 22: 5714-20 (2012) | Amgen Inc | 2D 3D TSV |
22832319 | 4 | Synthesis and biological evaluation of novel oxindole derivatives for imaging neurofibrillary tangles in Alzheimer's disease. | Bioorg Med Chem Lett 22: 5700-3 (2012) | Kyoto University | 2D 3D TSV |
22832315 | 85 | Structure and activity relationship in the (S)-N-chroman-3-ylcarboxamide series of voltage-gated sodium channel blockers. | Bioorg Med Chem Lett 22: 5618-24 (2012) | AstraZeneca | 2D 3D TSV |
22832311 | 75 | N-Aryl pyrrolidinonyl oxadiazoles as potent mGluR5 positive allosteric modulators. | Bioorg Med Chem Lett 22: 5658-62 (2012) | Lundbeck Research USA, Inc. | 2D 3D TSV |
22831803 | 9 | New hypotheses for the binding mode of 4- and 7-substituted indazoles in the active site of neuronal nitric oxide synthase. | Bioorg Med Chem 20: 5296-304 (2012) | Universit£ de Caen Basse-Normandie | 2D 3D TSV |
22831802 | 9 | Small molecules that protect against ?-amyloid-induced cytotoxicity by inhibiting aggregation of ?-amyloid. | Bioorg Med Chem 20: 4921-35 (2012) | Korea Institute of Science and Technology | 2D 3D TSV |
22831801 | 8 | Virtual screening leads to the discovery of novel non-nucleotide P2Y1 receptor antagonists. | Bioorg Med Chem 20: 5254-61 (2012) | National Institutes of Health | 2D 3D TSV |
22831800 | 32 | Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities. | Bioorg Med Chem 20: 4901-14 (2012) | Meiji Pharmaceutical University | 2D 3D TSV |
22831799 | 22 | Syntheses and in vitro evaluation of decalinvesamicol analogues as potential imaging probes for vesicular acetylcholine transporter (VAChT). | Bioorg Med Chem 20: 4936-41 (2012) | Kanazawa University | 2D 3D TSV |
22827615 | 2 | Stabilization and structural alteration of the G-quadruplex DNA made from the human telomeric repeat mediated by Tröger's base based novel benzimidazole derivatives. | J Med Chem 55: 7460-71 (2012) | India Institute of Science | 2D 3D TSV |
22827572 | 67 | Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). | J Med Chem 55: 7193-207 (2012) | GlaxoSmithKline | 2D 3D TSV |
22827545 | 11 | Identifying novel adenosine receptor ligands by simultaneous proteochemometric modeling of rat and human bioactivity data. | J Med Chem 55: 7010-20 (2012) | Leiden/Amsterdam Center for Drug Research | 2D 3D TSV |
22824762 | 39 | Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group. | Bioorg Med Chem 20: 5033-41 (2012) | Mitsubishi Tanabe Pharma Corporation | 2D 3D TSV |
22824761 | 4 | Synthesis, biological evaluation, and molecular docking studies of 2,5-substituted-1,4-benzoquinone as novel urease inhibitors. | Bioorg Med Chem 20: 4889-94 (2012) | Liaoning Normal University | 2D 3D TSV |
22823910 | 2 | Discovery of ligands for ADP-ribosyltransferases via docking-based virtual screening. | J Med Chem 55: 7706-18 (2012) | Ume£ University | 2D 3D TSV |
22822714 | 6 | Synthesis and evaluation of novela-fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyl oxime (ABP688) derivatives as metabotropic glutamate receptor subtype 5 PET radiotracers. | J Med Chem 55: 7154-62 (2012) | Institute of Technology (ETH) Zurich | 2D 3D TSV |
22822035 | 10 | Mechanistic studies on the absorption and disposition of scutellarin in humans: selective OATP2B1-mediated hepatic uptake is a likely key determinant for its unique pharmacokinetic characteristics. | Drug Metab Dispos 40: 2009-20 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22819942 | 2 | Synthesis of benzo-annulated tryptanthrins and their biological properties. | Bioorg Med Chem 20: 4962-7 (2012) | Yeungnam University | 2D 3D TSV |
22819766 | 173 | SAR studies around a series of triazolopyridines as potent and selective PI3K¿ inhibitors. | Bioorg Med Chem Lett 22: 5257-63 (2012) | Cellzome Ltd | 2D 3D TSV |
22819764 | 35 | Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR. | Bioorg Med Chem Lett 22: 5208-14 (2012) | Spanish National Cancer Research Centre (CNIO) | 2D 3D TSV |
22819505 | 46 | Discovery and characterization of novel allosteric FAK inhibitors. | Eur J Med Chem 61: 49-60 (2013) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22819191 | 17 | Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents. | Bioorg Med Chem 20: 4895-900 (2012) | Changzhou University | 2D 3D TSV |
22818971 | 3 | (+)-Pinoresinol is a putative hypoglycemic agent in defatted sesame (Sesamum indicum) seeds though inhibitinga-glucosidase. | Bioorg Med Chem Lett 22: 5215-7 (2012) | Chulalongkorn University | 2D 3D TSV |
22818849 | 36 | Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease. | Eur J Med Chem 55: 23-31 (2012) | P. J. Safarik University | 2D 3D TSV |
22818848 | 29 | Novel oxazolo[4,5-g]quinazolin-2(1H)-ones: dual inhibitors of EGFR and Src protein tyrosine kinases. | Eur J Med Chem 55: 39-48 (2012) | China Pharmaceutical University | 2D 3D TSV |
22818082 | 41 | The optimization of pyridazinone series of glucan synthase inhibitors. | Bioorg Med Chem Lett 22: 5268-71 (2012) | Merck Research Laboratories | 2D 3D TSV |
22818040 | 26 | Synthesis and biological evaluation of novel C-indolylxylosides as sodium-dependent glucose co-transporter 2 inhibitors. | Eur J Med Chem 55: 32-8 (2012) | National Health Research Institutes | 2D 3D TSV |
22817559 | 4 | Metaproterenol, isoproterenol, and their bisdimethylcarbamate derivatives as human cholinesterase inhibitors. | J Med Chem 55: 6716-23 (2012) | Institute for Medical Research and Occupational Health | 2D 3D TSV |
22815313 | 10 | Acetylenic linkers in lead compounds: a study of the stability of the propargyl-linked antifolates. | Drug Metab Dispos 40: 2002-8 (2012) | University of Connecticut | 2D 3D TSV |
22815312 | 3 | Quantitative prediction of CYP2B6 induction by estradiol during pregnancy: potential explanation for increased methadone clearance during pregnancy. | Drug Metab Dispos 41: 270-4 (2013) | Amgen | 2D 3D TSV |
22814212 | 10 | Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV. | Bioorg Med Chem Lett 22: 5150-6 (2012) | AstraZeneca | 2D 3D TSV |
22813531 | 141 | Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitro. | J Med Chem 55: 7262-72 (2012) | University of California | 2D 3D TSV |
22809559 | 31 | Synthesis and biological evaluation of analogs of the marine alkaloids granulatimide and isogranulatimide. | Eur J Med Chem 54: 626-36 (2012) | Universit£ Paul Sabatier | 2D 3D TSV |
22809456 | 2 | Discovery of piragliatin--first glucokinase activator studied in type 2 diabetic patients. | J Med Chem 55: 7021-36 (2012) | Hoffmann-La Roche Inc | 2D 3D TSV |
22809299 | 4 | A straightforward approach for engineering efficacy and selectivity at GPCRs. | J Med Chem 55: 6687-8 (2012) | Universit£ degli Studi di Siena | 2D 3D TSV |
22809106 | 4 | Synthesis, inhibitory activity and molecular docking studies of two Cu(II) complexes against Helicobacter pylori urease. | J Enzyme Inhib Med Chem 27: 528-32 (2012) | Wuhan Textile University | 2D 3D TSV |
22808911 | 18 | Conformation-specific effects of Raf kinase inhibitors. | J Med Chem 55: 7332-41 (2012) | Takeda California Inc | 2D 3D TSV |
22803959 | 196 | Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the rat. | J Med Chem 55: 7114-40 (2012) | Boehringer Ingelheim Pharmaceuticals Inc | 2D 3D TSV |
22803810 | 79 | Development of o-chlorophenyl substituted pyrimidines as exceptionally potent aurora kinase inhibitors. | J Med Chem 55: 7392-416 (2012) | Moffitt Cancer Center | 2D 3D TSV |
22803662 | 7 | Synthesis, antielastase, antioxidant and radical scavenging activities of 4-(aza substituted) methylene substituted dihydroxy coumarines. | J Enzyme Inhib Med Chem 28: 870-5 (2013) | Giresun University | 2D 3D TSV |
22801646 | 49 | 4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacy. | Bioorg Med Chem Lett 22: 5222-6 (2012) | GlaxoSmithKline | 2D 3D TSV |
22801643 | 6 | Selective non-lipid modulator of LPA5 activity in human platelets. | Bioorg Med Chem Lett 22: 5239-43 (2012) | Sanofi-Aventis Deutschland GmbH | 2D 3D TSV |
22801642 | 2 | Discovery of 1-[4-(N-benzylamino)phenyl]-3-phenylurea derivatives as non-peptidic selective SUMO-sentrin specific protease (SENP)1 inhibitors. | Bioorg Med Chem Lett 22: 5169-73 (2012) | Gakushuin University | 2D 3D TSV |
22800535 | 5 | Carbonylhydrazide-based molecular tongs inhibit wild-type and mutated HIV-1 protease dimerization. | J Med Chem 55: 6762-75 (2012) | Universit£ Paris-Sud 11 | 2D 3D TSV |
22800498 | 26 | Rational design of a low molecular weight, stable, potent, and long-lasting GPR103 aza-ß3-pseudopeptide agonist. | J Med Chem 55: 7516-24 (2012) | Institute for Research and Innovation in Biomedicine (IRIB) | 2D 3D TSV |
22796349 | 34 | Rapid and efficient synthesis of a novel series of substituted aminobenzosuberone derivatives as potent, selective, non-peptidic neutral aminopeptidase inhibitors. | Bioorg Med Chem 20: 4942-53 (2012) | Universit£ de Haute Alsace | 2D 3D TSV |
22796184 | 53 | The SAR analysis of TRPV1 agonists with thea-methylated B-region. | Bioorg Med Chem Lett 22: 5227-31 (2012) | Seoul National University | 2D 3D TSV |
22796182 | 7 | Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1. | Bioorg Med Chem Lett 22: 5317-21 (2012) | University of Siena | 2D 3D TSV |
22796181 | 51 | C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor. | Bioorg Med Chem Lett 22: 5322-5 (2012) | University of Hawaii at Manoa | 2D 3D TSV |
22795900 | 3 | Identification of new¿-hydroxybutenolides that preferentially inhibit the activity of mPGES-1. | Bioorg Med Chem 20: 5012-6 (2012) | University of Salerno | 2D 3D TSV |
22795831 | 73 | Synthesis of C-4-modified zanamivir analogs as neuraminidase inhibitors and their anti-AIV activities. | Eur J Med Chem 54: 764-70 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22795665 | 24 | Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease. | Eur J Med Chem 54: 750-63 (2012) | Universit£ de Sfax | 2D 3D TSV |
22795629 | 59 | Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1. | Bioorg Med Chem Lett 22: 5264-7 (2012) | University of Washington | 2D 3D TSV |
22795332 | 66 | Optimisation of imidazole compounds as selective TAAR1 agonists: discovery of RO5073012. | Bioorg Med Chem Lett 22: 5244-8 (2012) | F. Hoffmann-La Roche Inc | 2D 3D TSV |
22795331 | 51 | Pyrimidinopyrimidine inhibitors of ketohexokinase: exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket. | Bioorg Med Chem Lett 22: 5326-9 (2012) | Janssen Pharmaceutical Companies of Johnson & Johnson L.L.C. | 2D 3D TSV |
22793665 | 190 | Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selectivea4ß2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders. | J Med Chem 55: 9181-94 (2012) | Targacept Inc | 2D 3D TSV |
22793499 | 19 | Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor. | J Med Chem 55: 7054-60 (2012) | University of Oxford | 2D 3D TSV |
22793372 | 66 | Discovery of a series of 2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)acetamides as novel molecular switches that modulate modes of K(v)7.2 (KCNQ2) channel pharmacology: identification of (S)-2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)butanamide (ML252) as a potent, brain penetrant K(v)7.2 channel inhibitor. | J Med Chem 55: 6975-9 (2012) | Vanderbilt University Medical Center | 2D 3D TSV |
22793255 | 16 | Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening. | J Med Chem 55: 7208-18 (2012) | Universit£ Libre de Bruxelles | 2D 3D TSV |
22789708 | 15 | Benzimidazole-2-one: a novel anchoring principle for antagonizing p53-Mdm2. | Bioorg Med Chem 21: 3982-95 (2013) | University of Pittsburgh | 2D 3D TSV |
22789707 | 8 | Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases. | Bioorg Med Chem 20: 5027-32 (2012) | Groningen Research Institute of Pharmacy | 2D 3D TSV |
22789706 | 38 | Synthesis and in vitro evaluation ofa-synuclein ligands. | Bioorg Med Chem 20: 4625-34 (2012) | Washington University | 2D 3D TSV |
22789427 | 1 | Inhibition of VEGF transcription through blockade of the hypoxia inducible factor-1?-p300 interaction by a small molecule. | Bioorg Med Chem Lett 22: 5249-52 (2012) | Korea Institute of Science and Technology | 2D 3D TSV |
22788964 | 2 | Designing allosteric regulators of thrombin. Monosulfated benzofuran dimers selectively interact with Arg173 of exosite 2 to induce inhibition. | J Med Chem 55: 6888-97 (2012) | Virginia Commonwealth University | 2D 3D TSV |
22788932 | 18 | Identification and characterization of human apurinic/apyrimidinic endonuclease-1 inhibitors. | Biochemistry 51: 6246-59 (2012) | University of Pittsburgh | 2D 3D TSV |
22788843 | 46 | Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndrome. | J Med Chem 55: 6629-33 (2012) | Saarland University and Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) | 2D 3D TSV |
22784805 | 260 | Synthesizing Selective Agonists for the ?7 Nicotinic Receptor with in situ Click-Chemistry on Acetylcholine Binding Protein Templates. | Taylor Research Group (2014) | University of California San Diego | 2D 3D TSV |
22784640 | 36 | Discovery of ITX 4520: a highly potent orally bioavailable hepatitis C virus entry inhibitor. | Bioorg Med Chem Lett 22: 4955-61 (2012) | iTherX Pharmaceuticals, Inc. | 2D 3D TSV |
22784008 | 100 | Synthesis and biological evaluation of the 1-arylpyrazole class ofs(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862). | J Med Chem 55: 8211-24 (2012) | Esteve | 2D 3D TSV |
22783984 | 4 | Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: further structure-activity relationships, in vivo studies, and preliminary toxicity profiling. | J Med Chem 55: 6948-67 (2012) | Universit£ di Siena | 2D 3D TSV |
22781190 | 102 | Synthesis and evaluation of aplysinopsin analogs as inhibitors of human monoamine oxidase A and B. | Bioorg Med Chem Lett 22: 4926-9 (2012) | University of Mississippi | 2D 3D TSV |
22780961 | 3 | Predicting new indications for approved drugs using a proteochemometric method. | J Med Chem 55: 6832-48 (2012) | Georgetown University Medical Center | 2D 3D TSV |
22780914 | 35 | Design and discovery of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943), a selective brain penetrant PDE9A inhibitor for the treatment of cognitive disorders. | J Med Chem 55: 9045-54 (2012) | Pfizer Inc | 2D 3D TSV |
22779702 | 53 | Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases. | J Med Chem 55: 6898-915 (2012) | Universit£ degli Studi di Siena | 2D 3D TSV |
22779424 | 31 | Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): antibacterial agents with an improved safety profile. | J Med Chem 55: 6916-33 (2012) | AstraZeneca | 2D 3D TSV |
22778800 | 24 | Rational Drug Design Leading to the Identification of a Potent 5-HT(2C) Agonist Lacking 5-HT(2B) Activity. | ACS Med Chem Lett 2: 929-932 (2011) | TBA | 2D 3D TSV |
22776417 | 7 | Synthesis and biological evaluation of novel unsaturated carboxysteroids as human 5a-reductase inhibitors: a legitimate approach. | Eur J Med Chem 54: 728-39 (2012) | Panjab University | 2D 3D TSV |
22775474 | 9 | Geranylphenazinediol, an acetylcholinesterase inhibitor produced by a Streptomyces species. | J Nat Prod 75: 1400-4 (2012) | Kieler Wirkstoff-Zentrum (KiWiZ) at the Helmholtz-Zenrum f�r Ozeanforschung GEOMAR | 2D 3D TSV |
22775345 | 74 | Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups. | J Med Chem 55: 6776-83 (2012) | Istituto di Biostrutture e Bioimmagini-CNR | 2D 3D TSV |
22775318 | 3 | Double-headed sulfur-linked amino acids as first inhibitors for betaine-homocysteine S-methyltransferase 2. | J Med Chem 55: 6822-31 (2012) | Academy of Sciences of the Czech Republic | 2D 3D TSV |
22771232 | 18 | Design, synthesis, biochemical studies, cellular characterization, and structure-based computational studies of small molecules targeting the urokinase receptor. | Bioorg Med Chem 20: 4760-73 (2012) | Indiana University | 2D 3D TSV |
22771010 | 3 | An efficient synthesis of 3-OBn-6ß,14-epoxy-bridged opiates from naltrexone and identification of a related dual MOR inverse agonist/KOR agonist. | Bioorg Med Chem Lett 22: 6801-5 (2012) | University of New England | 2D 3D TSV |
22771009 | 9 | Discovery of MEK/PI3K dual inhibitor via structure-based virtual screening. | Bioorg Med Chem Lett 22: 4946-50 (2012) | Sejong University | 2D 3D TSV |
22771008 | 4 | Crystal structure of phosphoethanolamine methyltransferase from Plasmodium falciparum in complex with amodiaquine. | Bioorg Med Chem Lett 22: 4990-3 (2012) | Washington University | 2D 3D TSV |
22771007 | 64 | Design, synthesis, modeling, biological evaluation and photoaffinity labeling studies of novel series of photoreactive benzamide probes for histone deacetylase 2. | Bioorg Med Chem Lett 22: 5025-30 (2012) | University of Illinois at Chicago | 2D 3D TSV |
22770928 | 15 | The potential role of anibamine, a natural product CCR5 antagonist, and its analogues as leads toward development of anti-ovarian cancer agents. | Bioorg Med Chem Lett 22: 5093-7 (2012) | Virginia Commonwealth University | 2D 3D TSV |
22770610 | 2 | Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay. | Eur J Med Chem 61: 41-8 (2013) | Martin-Luther-University Halle-Wittenberg | 2D 3D TSV |
22770609 | 11 | The binding of C5-alkynyl and alkylfurano[2,3-d]pyrimidine glucopyranonucleosides to glycogen phosphorylase b: synthesis, biochemical and biological assessment. | Eur J Med Chem 54: 740-9 (2012) | University of Thessaly | 2D 3D TSV |
22770608 | 35 | Synthesis and in vitro biological evaluation of 2,6,9-trisubstituted purines targeting multiple cyclin-dependent kinases. | Eur J Med Chem 61: 61-72 (2013) | Palack£ University | 2D 3D TSV |
22770607 | 54 | Potent direct inhibitors of factor Xa based on the tetrahydroisoquinoline scaffold. | Eur J Med Chem 54: 771-83 (2012) | Virginia Commonwealth University | 2D 3D TSV |
22770529 | 7 | Novel trisubstituted harmine derivatives with original in vitro anticancer activity. | J Med Chem 55: 6489-501 (2012) | University of Namur (FUNDP) | 2D 3D TSV |
22770500 | 219 | 3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models. | J Med Chem 55: 6866-80 (2012) | AstraZeneca | 2D 3D TSV |
22766219 | 67 | Discovery and SAR of orally efficacious tetrahydropyridopyridazinone PARP inhibitors for the treatment of cancer. | Bioorg Med Chem 20: 4635-45 (2012) | Abbott Laboratories | 2D 3D TSV |
22765901 | 43 | Synthesis and SAR studies of bicyclic amine series GPR119 agonists. | Bioorg Med Chem Lett 22: 5123-8 (2012) | Sanwa Kagaku Kenkyusho Co., Ltd | 2D 3D TSV |
22765900 | 24 | Conformationally-restricted cyclic sulfones as potent and selective mTOR kinase inhibitors. | Bioorg Med Chem Lett 22: 5114-7 (2012) | Pfizer Inc | 2D 3D TSV |
22765895 | 72 | Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitors. | Bioorg Med Chem Lett 22: 4967-74 (2012) | Amgen Inc | 2D 3D TSV |
22765894 | 223 | The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors. | Bioorg Med Chem Lett 22: 4979-85 (2012) | Exelixis Inc | 2D 3D TSV |
22765893 | 32 | Discovery and optimization of novel purines as potent and selective CB2 agonists. | Bioorg Med Chem Lett 22: 4962-6 (2012) | Eli Lilly and Company | 2D 3D TSV |
22765892 | 48 | Benzoxazole and benzothiazole amides as novel pharmacokinetic enhancers of HIV protease inhibitors. | Bioorg Med Chem Lett 22: 4998-5002 (2012) | Janssen Infectious Diseases-Diagnostics BVBA | 2D 3D TSV |
22765237 | 28 | Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells. | J Med Chem 55: 6306-15 (2012) | McGill University | 2D 3D TSV |
22764122 | 9 | Targeting Tumour Proliferation with a Small-Molecule Inhibitor of AICAR Transformylase Homodimerization. | Chembiochem 13: 1628-34 (2012) | University of Southampton | 2D 3D TSV |
22763369 | 1 | Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 2. Synthesis and characterization of a novel imide-type prodrug for improving oral absorption. | Bioorg Med Chem 20: 4680-92 (2012) | Takeda Pharmaceutical Company Limited | 2D 3D TSV |
22763201 | 1 | Oxoquinoline acyclonucleoside phosphonate analogues as a new class of specific inhibitors of human immunodeficiency virus type 1. | Bioorg Med Chem Lett 22: 5055-8 (2012) | Universidade Federal Fluminense | 2D 3D TSV |
22762530 | 2 | Conformationally-locked N-glycosides with selectiveß-glucosidase inhibitory activity: identification of a new non-iminosugar-type pharmacological chaperone for Gaucher disease. | J Med Chem 55: 6857-65 (2012) | Universitat Rovira i Virgili | 2D 3D TSV |
22761000 | 123 | Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment. | J Appl Toxicol 32: 858-66 (2012) | Jagiellonian University | 2D 3D TSV |
22759374 | 3 | Identification of Type-II Inhibitors Using Kinase Structures. | Chem Biol Drug Des 80: 657-64 (2012) | Pfizer Inc | 2D 3D TSV |
22758660 | 2 | Saquayamycins G-K, cytotoxic angucyclines from Streptomyces sp. Including two analogues bearing the aminosugar rednose. | J Nat Prod 75: 1383-92 (2012) | University of Kentucky | 2D 3D TSV |
22754607 | 6 | S-Farnesyl-Thiopropionic Acid (FTPA) Triazoles as Potent Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase. | ACS Med Chem Lett 3: 15-19 (2012) | TBA | 2D 3D TSV |
22753086 | 6 | Kinetics Studies on the Inhibition Mechanism of Pancreatic α-Amylase by Glycoconjugated 1H-1,2,3-Triazoles: A New Class of Inhibitors with Hypoglycemiant Activity. | Chembiochem 13: 1584-93 (2012) | Yonsei University | 2D 3D TSV |
22752007 | 1 | Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver. | Drug Metab Dispos 40: 1917-26 (2012) | Toyama Prefectural University | 2D 3D TSV |
22750139 | 28 | Methylation of imidazoline related compounds leads to loss ofa2-adrenoceptor affinity. Synthesis and biological evaluation of selective I1 imidazoline receptor ligands. | Bioorg Med Chem 20: 4710-5 (2012) | University of Strasburg | 2D 3D TSV |
22750138 | 8 | ¿-amino-ß-fluorocyclopropanecarboxylic acids as a new tool for drug development: synthesis of glutamic acid analogs and agonist activity towards metabotropic glutamate receptor 4. | Bioorg Med Chem 20: 4716-26 (2012) | INSA de Rouen and Universit£ de Rouen | 2D 3D TSV |
22750010 | 30 | Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists. | Bioorg Med Chem 20: 4661-7 (2012) | China Pharmaceutical University | 2D 3D TSV |
22749871 | 92 | Development of novel M1 antagonist scaffolds through the continued optimization of the MLPCN probe ML012. | Bioorg Med Chem Lett 22: 5035-40 (2012) | Vanderbilt University Medical Center | 2D 3D TSV |
22749870 | 48 | Discovery of benzylisothioureas as potent divalent metal transporter 1 (DMT1) inhibitors. | Bioorg Med Chem Lett 22: 5108-13 (2012) | Xenon Pharmaceuticals Inc | 2D 3D TSV |
22749869 | 82 | Discovery and optimization of novel fatty acid transport protein 1 (FATP1) inhibitors. | Bioorg Med Chem Lett 22: 5067-70 (2012) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
22749826 | 28 | Discovery and structure-activity relationships of urea derivatives as potent and novel CCR3 antagonists. | Bioorg Med Chem Lett 22: 4951-4 (2012) | Toray Industries Inc | 2D 3D TSV |
22749643 | 69 | Structure-based optimization of oxadiazole-based GSK-3 inhibitors. | Eur J Med Chem 61: 26-40 (2013) | Technische Universit£t Darmstadt | 2D 3D TSV |
22749641 | 15 | Synthesis and evaluation of carbocyanine dyes as PRMT inhibitors and imaging agents. | Eur J Med Chem 54: 647-59 (2012) | Georgia State University | 2D 3D TSV |
22749640 | 36 | Doing the methylene shuffle--further insights into the inhibition of mitotic kinesin Eg5 with S-trityl L-cysteine. | Eur J Med Chem 54: 483-98 (2012) | University of Strathclyde | 2D 3D TSV |
22749422 | 43 | Synthesis and structure-activity relationships of pyrido[3,2-b]pyrazin-3(4H)-ones and pteridin-7(8H)-ones as corticotropin-releasing factor-1 receptor antagonists. | Bioorg Med Chem Lett 22: 4986-9 (2012) | Bristol-Myers Squibb Co. | 2D 3D TSV |
22749420 | 13 | Efficient synthesis and 5-LOX/COX-inhibitory activity of some 3-hydroxybenzo[b]thiophene-2-carboxylic acid derivatives. | Bioorg Med Chem Lett 22: 5031-4 (2012) | University of Hamburg | 2D 3D TSV |
22749419 | 22 | Design and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3Ka and mTOR. | Bioorg Med Chem Lett 22: 5098-103 (2012) | Pfizer Inc | 2D 3D TSV |
22749391 | 72 | Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligands. | Eur J Med Chem 54: 660-8 (2012) | Boehringer Ingelheim RCV GmbH & Co KG | 2D 3D TSV |
22749282 | 12 | Design and synthesis of novel p38a MAP kinase inhibitors: discovery of pyrazole-benzyl ureas bearing 2-molpholinopyrimidine moiety. | Bioorg Med Chem Lett 22: 5118-22 (2012) | Toray Industries Inc | 2D 3D TSV |
22749281 | 1 | Synthesis and in vitro evaluation of [18F](R)-FEPAQ: a potential PET ligand for VEGFR2. | Bioorg Med Chem Lett 22: 5104-7 (2012) | Columbia University College of Physicians and Surgeons | 2D 3D TSV |
22749278 | 16 | Diazaspirocyclic compounds as selective ligands for thea4ß2 nicotinic acetylcholine receptor. | Bioorg Med Chem Lett 22: 5089-92 (2012) | Targacept Inc | 2D 3D TSV |
22749190 | 23 | Wake-promoting agents: search for next generation modafinil: part IV. | Eur J Med Chem 54: 949-51 (2012) | Cephalon (France) | 2D 3D TSV |
22749189 | 24 | Inhibitors of the TAM subfamily of tyrosine kinases: synthesis and biological evaluation. | Eur J Med Chem 61: 2-25 (2013) | Institut Curie | 2D 3D TSV |
22748707 | 8 | Synthesis and biological evaluation of new N-acyl-homoserine-lactone analogues, based on triazole and tetrazole scaffolds, acting as LuxR-dependent quorum sensing modulators. | Bioorg Med Chem 20: 4727-36 (2012) | INSA Lyon | 2D 3D TSV |
22748706 | 52 | Design, synthesis, and pharmacological evaluation of novel tetrahydroprotoberberine derivatives: selective inhibitors of dopamine D1 receptor. | Bioorg Med Chem 20: 4862-71 (2012) | Shenyang Pharmaceutical University | 2D 3D TSV |
22748705 | 2 | Total synthesis of grassystatin A, a probe for cathepsin E function. | Bioorg Med Chem 20: 4774-80 (2012) | Fudan University | 2D 3D TSV |
22748377 | 1 | Synthesis and evaluation of the quorum sensing inhibitory effect of substituted triazolyldihydrofuranones. | Bioorg Med Chem 20: 4737-43 (2012) | Ghent University | 2D 3D TSV |
22747598 | 33 | Structure-based design of potent Bcl-2/Bcl-xL inhibitors with strong in vivo antitumor activity. | J Med Chem 55: 6149-61 (2012) | University of Michigan | 2D 3D TSV |
22746350 | 41 | Design, synthesis, and biological evaluation of nonsteroidal cycloalkane[d]isoxazole-containing androgen receptor modulators. | J Med Chem 55: 6316-27 (2012) | University of Eastern Finland | 2D 3D TSV |
22746324 | 8 | Synthesis and evaluation of substituted chroman-4-one and chromone derivatives as sirtuin 2-selective inhibitors. | J Med Chem 55: 7104-13 (2012) | University of Gothenburg | 2D 3D TSV |
22746295 | 91 | Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) as an antiinflammatory target: discovery and in vivo activity of selective pyrazolo[1,5-a]pyrimidine inhibitors using a focused library and structure-based optimization approach. | J Med Chem 55: 6700-15 (2012) | Teijin Pharma Ltd. | 2D 3D TSV |
22746274 | 4 | Design and in vitro activities of N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents. | J Med Chem 55: 6738-50 (2012) | Emory University | 2D 3D TSV |
22743085 | 21 | Experimental and 'in silico' analysis of the effect of pH on HIV-1 protease inhibitor affinity: implications for the charge state of the protein ionogenic groups. | Bioorg Med Chem 20: 4838-47 (2012) | Universidad de Santiago de Compostela | 2D 3D TSV |
22742909 | 24 | Essential structure of opioid¿ receptor agonist nalfurafine for binding to the¿ receptor 2: synthesis of decahydro(iminoethano)phenanthrene derivatives and their pharmacologies. | Bioorg Med Chem Lett 22: 5071-4 (2012) | Kitasato University | 2D 3D TSV |
22742641 | 113 | (1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritis. | J Med Chem 55: 6363-74 (2012) | AstraZeneca | 2D 3D TSV |
22742586 | 13 | Synthesis and nicotinic acetylcholine receptor in vitro and in vivo pharmacological properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues of 2'-fluoro-3'-(4-nitrophenyl)deschloroepibatidine. | J Med Chem 55: 6512-22 (2012) | Research Triangle Institute | 2D 3D TSV |
22742537 | 3 | Ligand-based design, synthesis, and biological evaluation of 2-aminopyrimidines, a novel series of receptor for advanced glycation end products (RAGE) inhibitors. | J Med Chem 55: 9120-35 (2012) | Seoul National University | 2D 3D TSV |
22739090 | 86 | Novel tricyclic indeno[2,1-d]pyrimidines with dual antiangiogenic and cytotoxic activities as potent antitumor agents. | Bioorg Med Chem 20: 4217-25 (2012) | Duquesne University | 2D 3D TSV |
22739089 | 42 | Synthesis and evaluation of in vitro bioactivity for vesicular acetylcholine transporter inhibitors containing two carbonyl groups. | Bioorg Med Chem 20: 4422-9 (2012) | Washington University | 2D 3D TSV |
22739087 | 3 | Structure-based design of rhodanine-based acylsulfonamide derivatives as antagonists of the anti-apoptotic Bcl-2 protein. | Bioorg Med Chem 20: 4194-200 (2012) | Soochow University | 2D 3D TSV |
22739085 | 29 | Novel 5-substituted benzyloxy-2-arylbenzofuran-3-carboxylic acids as calcium activated chloride channel inhibitors. | Bioorg Med Chem 20: 4237-44 (2012) | Kurukshetra University | 2D 3D TSV |
22739084 | 15 | Synthesis and SAR-study for novel arylpiperazine derivatives of 5-arylidenehydantoin with ??-adrenoceptor antagonistic properties. | Bioorg Med Chem 20: 4245-57 (2012) | Jagiellonian University Medical College | 2D 3D TSV |
22738639 | 6 | Contribution of indazolinone tautomers to kinase activity. | Bioorg Med Chem Lett 22: 4502-5 (2012) | Abbott Laboratories | 2D 3D TSV |
22738638 | 59 | Assay and inhibition of diacylglycerol lipase activity. | Bioorg Med Chem Lett 22: 4585-92 (2012) | Northeastern University | 2D 3D TSV |
22738637 | 19 | Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptor. | Bioorg Med Chem Lett 22: 5084-8 (2012) | Vanderbilt University Medical Center | 2D 3D TSV |
22738635 | 87 | Discovery of novel PI3K¿/d inhibitors as potential agents for inflammation. | Bioorg Med Chem Lett 22: 4546-9 (2012) | Cellzome Ltd | 2D 3D TSV |
22738633 | 4 | 'Click' synthesis of a triazole-based inhibitor of Met functions in cancer cells. | Bioorg Med Chem Lett 22: 4693-6 (2012) | Universit£ degli Studi di Milano | 2D 3D TSV |
22738631 | 6 | New farnesyltransferase inhibitors in the phenothiazine series. | Bioorg Med Chem Lett 22: 4517-22 (2012) | Al. I. Cuza University of Iasi | 2D 3D TSV |
22738630 | 76 | Structure-based optimization of aminopyridines as PKC¿ inhibitors. | Bioorg Med Chem Lett 22: 4645-9 (2012) | Vertex Pharmaceuticals Inc | 2D 3D TSV |
22738629 | 47 | CCLab--a multi-objective genetic algorithm based combinatorial library design software and an application for histone deacetylase inhibitor design. | Bioorg Med Chem Lett 22: 4540-5 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22738628 | 38 | Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors. | Bioorg Med Chem Lett 22: 4550-4 (2012) | University of Li£ge | 2D 3D TSV |
22738356 | 2 | Antidiabetic compounds from Sarracenia purpurea used traditionally by the Eeyou Istchee Cree First Nation. | J Nat Prod 75: 1284-8 (2012) | University of Ottawa | 2D 3D TSV |
22738316 | 35 | Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo. | J Med Chem 55: 6375-80 (2012) | Universit£ degli Studi di Bari A. Moro | 2D 3D TSV |
22738293 | 7 | Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. | J Med Chem 55: 6391-402 (2012) | University of Lille | 2D 3D TSV |
22738271 | 250 | 7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as selective CB(2) cannabinoid receptor ligands: structural investigations around a novel class of full agonists. | J Med Chem 55: 6608-23 (2012) | Universit£ di Ferrara | 2D 3D TSV |
22738238 | 29 | Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice. | J Med Chem 55: 6467-77 (2012) | University of North Carolina at Chapel Hill | 2D 3D TSV |
22737278 | 44 | Structure-Activity Relationship for Thiirane-Based Gelatinase Inhibitors. | ACS Med Chem Lett 3: 490-495 (2012) | TBA | 2D 3D TSV |
22734674 | 81 | The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cancer. | J Med Chem 55: 6523-40 (2012) | Amgen Inc | 2D 3D TSV |
22734650 | 6 | Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic. | J Med Chem 55: 6554-65 (2012) | Massachusetts General Hospital | 2D 3D TSV |
22734622 | 78 | Synthesis and evaluation of aryl-naloxamide opiate analgesics targeting truncated exon 11-associatedµ opioid receptor (MOR-1) splice variants. | J Med Chem 55: 6352-62 (2012) | Memorial Sloan-Kettering Cancer Center | 2D 3D TSV |
22732695 | 26 | Design and synthesis of potent antagonists containing rigid spirocyclic privileged structures for the CGRP receptor. | Bioorg Med Chem Lett 22: 4719-22 (2012) | Bristol-Myers Squibb R & D | 2D 3D TSV |
22731815 | 14 | Virtual screening identifies novel sulfonamide inhibitors of ecto-5'-nucleotidase. | J Med Chem 55: 6576-81 (2012) | Rheinische Friedrich-Wilhelms-Universit£t | 2D 3D TSV |
22727780 | 17 | Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1). | Bioorg Med Chem 20: 4290-302 (2012) | The State University of New York | 2D 3D TSV |
22727779 | 6 | Bisubstrate analog inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: new lead exhibits a distinct binding mode. | Bioorg Med Chem 20: 4303-9 (2012) | National Cancer Institute | 2D 3D TSV |
22727645 | 42 | The synthesis and SAR of calcitonin gene-related peptide (CGRP) receptor antagonists derived from tyrosine surrogates. Part 1. | Bioorg Med Chem Lett 22: 4723-7 (2012) | Bristol-Myers Squibb Research & Development | 2D 3D TSV |
22727644 | 43 | Synthesis and structure-activity relationship studies of 1,3-disubstituted 2-propanols as BACE-1 inhibitors. | Bioorg Med Chem Lett 22: 4740-4 (2012) | University of South Florida | 2D 3D TSV |
22727640 | 68 | Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases. | Bioorg Med Chem Lett 22: 4599-604 (2012) | AstraZeneca | 2D 3D TSV |
22727639 | 24 | Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: development of a highly selective and more potent in vitro probe. | Bioorg Med Chem Lett 22: 4532-5 (2012) | Vanderbilt University School of Medicine | 2D 3D TSV |
22727637 | 85 | Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitors. | Bioorg Med Chem Lett 22: 4528-31 (2012) | Abbott Laboratories | 2D 3D TSV |
22727448 | 16 | Synthesis and biological evaluation of novel (-)-Cercosporamide derivatives as potent selective PPAR¿ modulators. | Eur J Med Chem 54: 522-33 (2012) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
22727447 | 8 | Design and synthesis of new (E)-cinnamic N-acylhydrazones as potent antitrypanosomal agents. | Eur J Med Chem 54: 512-21 (2012) | Instituto de Tecnologia em F£rmacos - Farmanguinhos | 2D 3D TSV |
22727372 | 14 | Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenylamino)phenyl)propyl scaffold. | Bioorg Med Chem 20: 4201-7 (2012) | Cardiff University | 2D 3D TSV |
22727371 | 22 | Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT1 receptor antagonists. | Bioorg Med Chem 20: 4208-16 (2012) | School of Chemical Engineering & the Environment | 2D 3D TSV |
22727369 | 6 | Design, synthesis, biological evaluation and molecular modeling of novel 1,3,4-oxadiazole derivatives based on Vanillic acid as potential immunosuppressive agents. | Bioorg Med Chem 20: 4226-36 (2012) | Nanjing University | 2D 3D TSV |
22726934 | 58 | Design and optimization of novel (2S,4S,5S)-5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxy-2-isopropylhexanamides as renin inhibitors. | Bioorg Med Chem Lett 22: 4561-6 (2012) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
22726931 | 113 | 3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3). | Bioorg Med Chem Lett 22: 4654-9 (2012) | National Health Research Institutes | 2D 3D TSV |
22726930 | 7 | Novel BACE1 inhibitors possessing a 5-nitroisophthalic scaffold at the P2 position. | Bioorg Med Chem Lett 22: 4640-4 (2012) | Kobe Gakuin University | 2D 3D TSV |
22726929 | 118 | Novel 2-(2-(benzylthio)-1H-benzo[d]imidazol-1-yl)acetic acids: discovery and hit-to-lead evolution of a selective CRTh2 receptor antagonist chemotype. | Bioorg Med Chem Lett 22: 4660-4 (2012) | Actelion Pharmaceuticals Ltd | 2D 3D TSV |
22726925 | 216 | Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease. | Bioorg Med Chem Lett 22: 4613-8 (2012) | Cellzome Ltd | 2D 3D TSV |
22726924 | 14 | Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV. | Bioorg Med Chem Lett 22: 4839-43 (2012) | AstraZeneca | 2D 3D TSV |
22726686 | 4 | Acyclic Immucillin Phosphonates: Second-Generation Inhibitors of Plasmodium falciparum Hypoxanthine- Guanine-Xanthine Phosphoribosyltransferase. | Chem Biol 19: 721-30 (2012) | Albert Einstein College of Medicine | 2D 3D TSV |
22726671 | 8 | Neoflavonoids and Tetrahydroquinolones as Possible Cancer Chemopreventive Agents. | Chem Biol Drug Des 80: 616-624 (2012) | Central Institute of Medicinal and Aromatic Plants | 2D 3D TSV |
22726458 | 28 | Synthesis and Biological Evaluation of 3-thiazolocoumarinyl Schiff-base Derivatives as Cholinesterase Inhibitors. | Chem Biol Drug Des 80: 605-15 (2012) | COMSATS Institute of Information Technology | 2D 3D TSV |
22725979 | 23 | Synthesis of novel N-branched acyclic nucleoside phosphonates as potent and selective inhibitors of human, Plasmodium falciparum and Plasmodium vivax 6-oxopurine phosphoribosyltransferases. | J Med Chem 55: 6209-23 (2012) | Academy of Sciences of the Czech Republic | 2D 3D TSV |
22724510 | 84 | Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases. | J Med Chem 55: 6639-43 (2012) | University of Oxford | 2D 3D TSV |
22724451 | 23 | Free fatty acid receptor 1 (FFA1/GPR40) agonists: mesylpropoxy appendage lowers lipophilicity and improves ADME properties. | J Med Chem 55: 6624-8 (2012) | University of Southern Denmark | 2D 3D TSV |
22724433 | 76 | A new class of highly potent and selective endomorphin-1 analogues containinga-methylene-ß-aminopropanoic acids (map). | J Med Chem 55: 6224-36 (2012) | Lanzhou University | 2D 3D TSV |
22721924 | 16 | Design, synthesis and antitumor activities of novel bis-aryl ureas derivatives as Raf kinase inhibitors. | Bioorg Med Chem 20: 4323-9 (2012) | Academy of Military Medical Sciences | 2D 3D TSV |
22721713 | 200 | Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines. | Bioorg Med Chem Lett 22: 4681-5 (2012) | Ecole Nationale Sup£rieure de Chimie de Montpellier | 2D 3D TSV |
22720744 | 8 | Urea-based inhibitors of Trypanosoma brucei methionyl-tRNA synthetase: selectivity and in vivo characterization. | J Med Chem 55: 6342-51 (2012) | University of Washington | 2D 3D TSV |
22715973 | 32 | 1,2,3-Triazole-containing uracil derivatives with excellent pharmacokinetics as a novel class of potent human deoxyuridine triphosphatase inhibitors. | J Med Chem 55: 6427-37 (2012) | Taiho Pharmaceutical Co., Ltd | 2D 3D TSV |
22712652 | 23 | New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors. | J Med Chem 55: 6634-8 (2012) | Sapienza University of Rome | 2D 3D TSV |
22712585 | 106 | Azapeptide analogues of the growth hormone releasing peptide 6 as cluster of differentiation 36 receptor ligands with reduced affinity for the growth hormone secretagogue receptor 1a. | J Med Chem 55: 6502-11 (2012) | Universit£ de Montr£al | 2D 3D TSV |
22712432 | 5 | Identification, synthesis, and biological evaluation of the metabolites of 3-amino-6-(3'-aminopropyl)-5H-indeno[1,2-c]isoquinoline-5,11-(6H)dione (AM6-36), a promising rexinoid lead compound for the development of cancer chemotherapeutic and chemopreventive agents. | J Med Chem 55: 5965-81 (2012) | The University of Illinois at Chicago | 2D 3D TSV |
22711749 | 1 | The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5. | Drug Metab Dispos 40: 1834-45 (2012) | Vanderbilt University Medical Center | 2D 3D TSV |
22708927 | 14 | Selective mode of action of guanidine-containing non-peptides at human NPFF receptors. | J Med Chem 55: 6124-36 (2012) | Leipzig University | 2D 3D TSV |
22708897 | 100 | Design, synthesis, and biological and structural evaluations of novel HIV-1 protease inhibitors to combat drug resistance. | J Med Chem 55: 6328-41 (2012) | Sanford-Burnham Medical Research Institute | 2D 3D TSV |
22708876 | 106 | Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-ß-alanine (MK-0893) for the treatment of type II diabetes. | J Med Chem 55: 6137-48 (2012) | Merck Research Laboratories | 2D 3D TSV |
22708838 | 13 | Lead optimization of antimalarial propafenone analogues. | J Med Chem 55: 6087-93 (2012) | St. Jude Children's Research Hospital | 2D 3D TSV |
22707871 | 12 | Kinetic studies of novel inhibitors of endomorphin degrading enzymes. | Med Chem Res 21: 1445-1450 (2012) | TBA | 2D 3D TSV |
22705191 | 45 | Inhibition of monoamine oxidase by 8-phenoxymethylcaffeine derivatives. | Bioorg Med Chem 20: 4336-47 (2012) | North-West University | 2D 3D TSV |
22705189 | 24 | Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases. | Bioorg Med Chem 20: 4371-6 (2012) | Imperial College | 2D 3D TSV |
22705188 | 73 | Superacid synthesis of halogen containing N-substituted-4-aminobenzene sulfonamides: new selective tumor-associated carbonic anhydrase inhibitors. | Bioorg Med Chem 21: 1555-63 (2013) | Superacide et Chimie des syst£mes£ team-Universit£ de Poitiers | 2D 3D TSV |
22705022 | 32 | Synthesis, biological evaluation and molecular docking studies of 3-(1,3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity. | Bioorg Med Chem 20: 4430-6 (2012) | Nanjing University | 2D 3D TSV |
22704921 | 34 | Development and evaluation of multifunctional agents for potential treatment of Alzheimer's disease: application to a pyrimidine-2,4-diamine template. | Bioorg Med Chem Lett 22: 4707-12 (2012) | University of Waterloo | 2D 3D TSV |
22704887 | 12 | Synthesis and evaluation of novel potent HCV NS5A inhibitors. | Bioorg Med Chem Lett 22: 4864-8 (2012) | Emory University | 2D 3D TSV |
22704238 | 18 | Design, synthesis and biological evaluation ofß-carboline derivatives as novel inhibitors targeting B-Raf kinase. | Bioorg Med Chem Lett 22: 4783-6 (2012) | China Pharmaceutical University | 2D 3D TSV |
22704236 | 64 | Discovery of novel hedgehog antagonists from cell-based screening: Isosteric modification of p38 bisamides as potent inhibitors of SMO. | Bioorg Med Chem Lett 22: 4907-11 (2012) | AstraZeneca | 2D 3D TSV |
22703704 | 3 | New synthesis and promising neuroprotective role in experimental ischemic stroke of ONO-1714. | Eur J Med Chem 54: 439-46 (2012) | Instituto Cajal (CSIC) | 2D 3D TSV |
22703703 | 6 | In search for new chemical entities as adenosine receptor ligands: development of agents based on benzo-¿-pyrone skeleton. | Eur J Med Chem 54: 914-8 (2012) | Universidade do Porto | 2D 3D TSV |
22698785 | 28 | Highly potent macrocyclic BACE-1 inhibitors incorporating a hydroxyethylamine core: design, synthesis and X-ray crystal structures of enzyme inhibitor complexes. | Bioorg Med Chem 20: 4377-89 (2012) | Link£ping University | 2D 3D TSV |
22698782 | 16 | Synthesis and biological evaluation of N-aryl salicylamides with a hydroxamic acid moiety at 5-position as novel HDAC-EGFR dual inhibitors. | Bioorg Med Chem 20: 4405-12 (2012) | Xi'an Jiaotong University | 2D 3D TSV |
22698084 | 99 | Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2. | J Med Chem 55: 6176-93 (2012) | Genentech | 2D 3D TSV |
22697905 | 21 | N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity. | J Med Chem 55: 6111-23 (2012) | GlaxoSmithKline | 2D 3D TSV |
22696418 | 36 | Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes. | Drug Metab Dispos 40: 1797-802 (2012) | University of Kansas | 2D 3D TSV |
22695182 | 4 | Hyrtioreticulins A-E, indole alkaloids inhibiting the ubiquitin-activating enzyme, from the marine sponge Hyrtios reticulatus. | Bioorg Med Chem 20: 4437-42 (2012) | Kumamoto University | 2D 3D TSV |
22695132 | 56 | Identification of a duald OR antagonist/µ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d). | Bioorg Med Chem Lett 22: 4869-72 (2012) | Janssen Research and Development LLC | 2D 3D TSV |
22695131 | 24 | Inhibition of therapeutically important polymerases with high affinity bis-intercalators. | Bioorg Med Chem Lett 22: 4844-8 (2012) | University of Missouri | 2D 3D TSV |
22695126 | 98 | Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases. | Bioorg Med Chem Lett 22: 4750-5 (2012) | Abbott Laboratories | 2D 3D TSV |
22694270 | 5 | Isolation and structural elucidation of cyclic tetrapeptides from Onychocola sclerotica. | J Nat Prod 75: 1210-4 (2012) | Fundacion MEDINA | 2D 3D TSV |
22694147 | 17 | Nanomolar potency and metabolically stable inhibitors of kidney urea transporter UT-B. | J Med Chem 55: 5942-50 (2012) | San Francisco State University | 2D 3D TSV |
22694121 | 5 | An ultrahigh affinity d-peptide antagonist Of MDM2. | J Med Chem 55: 6237-41 (2012) | University of Maryland | 2D 3D TSV |
22694093 | 16 | Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors. | J Med Chem 55: 5749-59 (2012) | National Institute of Biological Sciences | 2D 3D TSV |
22691057 | 32 | Discovery of a potent, selective, and orally bioavailable acidic 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD1) inhibitor: discovery of 2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic acid (AZD4017). | J Med Chem 55: 5951-64 (2012) | AstraZeneca | 2D 3D TSV |
22690646 | 6 | Structure and bioassay of triterpenoids and steroids isolated from Sinocalamus affinis. | J Nat Prod 75: 1160-6 (2012) | Chinese Academy of Medical Sciences and Peking Union Medical College | 2D 3D TSV |
22689580 | 90 | Simple Pseudo-dipeptides with a P2' Glutamate: A NOVEL INHIBITOR FAMILY OF MATRIX METALLOPROTEASES AND OTHER METZINCINS. | J Biol Chem 287: 26647-56 (2012) | Commissariat á l'Energie Atomique | 2D 3D TSV |
22688609 | 2 | Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro. | Drug Metab Dispos 40: 1778-84 (2012) | Diakonhjemmet Hospital | 2D 3D TSV |
22687744 | 24 | Lead optimization of a sulfonylurea-based piperazine pyridazinone series of glucan synthase inhibitors. | Bioorg Med Chem Lett 22: 4896-9 (2012) | Albany Molecular Research, Inc. (AMRI) | 2D 3D TSV |
22687439 | 51 | Synthesis and carbonic anhydrase inhibitory properties of novel bromophenols and their derivatives including natural products: vidalol B. | Eur J Med Chem 54: 423-8 (2012) | Atat£rk University | 2D 3D TSV |
22686946 | 12 | Cytotoxic and potent CYP1 inhibitors from the marine algae Cymopolia barbata. | Org Med Chem Lett 2: 21 (2012) | University of the West Indies | 2D 3D TSV |
22686657 | 60 | Selective nitrile inhibitors to modulate the proteolytic synergism of cathepsins S and F. | J Med Chem 55: 5982-6 (2012) | University of Bonn | 2D 3D TSV |
22685215 | 1 | Mechanism-based inactivation of cytochrome P450 2B6 by methadone through destruction of prosthetic heme. | Drug Metab Dispos 40: 1765-70 (2012) | University of Michigan | 2D 3D TSV |
22683343 | 27 | Design, synthesis and structure-activity relationships of 5-alkylaminolquinolines as a novel series of CRF1 receptor antagonists. | Bioorg Med Chem Lett 22: 4756-61 (2012) | Eisai Co., Ltd | 2D 3D TSV |
22683242 | 47 | Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors. | Eur J Med Chem 54: 311-23 (2012) | University of Salerno | 2D 3D TSV |
22683241 | 33 | Synthesis and biological evaluation of isoxazole, oxazole, and oxadiazole containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors. | Eur J Med Chem 54: 324-42 (2012) | Piramal Healthcare Limited | 2D 3D TSV |
22683222 | 21 | Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749. | Bioorg Med Chem Lett 22: 4849-53 (2012) | Theravance, Inc. | 2D 3D TSV |
22682919 | 26 | Furin inhibitors: importance of the positive formal charge and beyond. | Bioorg Med Chem 20: 4462-71 (2012) | Torrey Pines Institute for Molecular Studies | 2D 3D TSV |
22682301 | 15 | Structure-activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway inhibitor and anti-cancer agent. | Bioorg Med Chem 20: 4590-7 (2012) | Emory University CSI | 2D 3D TSV |
22682300 | 11 | Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles. | Bioorg Med Chem 20: 4514-21 (2012) | University of Copenhagen | 2D 3D TSV |
22680612 | 11 | Synthesis and biological evaluation of an orally active glycosylated endomorphin-1. | J Med Chem 55: 5859-67 (2012) | The University of Queensland | 2D 3D TSV |
22679214 | 13 | Evaluation of P450 inhibition and induction by artemisinin antimalarials in human liver microsomes and primary human hepatocytes. | Drug Metab Dispos 40: 1757-64 (2012) | University of Washington | 2D 3D TSV |
22677529 | 3 | Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: the hydrophobic side chain influences type A subtype selectivity. | Bioorg Med Chem 20: 4582-9 (2012) | University of Alabama at Birmingham | 2D 3D TSV |
22677527 | 38 | Deconstructing 14-phenylpropyloxymetopon: minimal requirements for binding to mu opioid receptors. | Bioorg Med Chem 20: 4556-63 (2012) | University of Maryland | 2D 3D TSV |
22677319 | 64 | Hit-to-lead investigation of a series of novel combined dopamine D2 and muscarinic M1 receptor ligands with putative antipsychotic and pro-cognitive potential. | Bioorg Med Chem Lett 22: 5134-40 (2012) | H. Lundbeck A/S | 2D 3D TSV |
22677318 | 8 | Synthesis of pacidamycin analogues via an Ugi-multicomponent reaction. | Bioorg Med Chem Lett 22: 4810-5 (2012) | Shionogi & Co., Ltd | 2D 3D TSV |
22677317 | 23 | Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors. | Bioorg Med Chem Lett 22: 4769-72 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22677316 | 35 | Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor. | Bioorg Med Chem Lett 22: 4281-7 (2012) | Pfizer Inc | 2D 3D TSV |
22677314 | 14 | Xanthine oxidase inhibitory activity of constituents of Cinnamomum cassia twigs. | Bioorg Med Chem Lett 22: 4625-8 (2012) | National Institute of Medicinal Materials | 2D 3D TSV |
22677030 | 29 | New chromene scaffolds for adenosine A(2A) receptors: synthesis, pharmacology and structure-activity relationships. | Eur J Med Chem 54: 303-10 (2012) | Universidade do Minho | 2D 3D TSV |
22676247 | 8 | Synthesis and biological evaluation of 1-benzylidene-3,4-dihydronaphthalen-2-one as a new class of microtubule-targeting agents. | J Med Chem 55: 5720-33 (2012) | Second Military Medical University | 2D 3D TSV |
22676210 | 116 | Design, synthesis, and biological evaluation of novel disubstituted dibenzosuberones as highly potent and selective inhibitors of p38 mitogen activated protein kinase. | J Med Chem 55: 5868-77 (2012) | Eberhard-Karls University | 2D 3D TSV |
22672803 | 57 | Design, synthesis and biological evaluation of novel imidazopyridines as potential antidiabetic GSK3ß inhibitors. | Bioorg Med Chem Lett 22: 4221-4 (2012) | CrystalGenomics, Inc. | 2D 3D TSV |
22672799 | 16 | Potent and selective inhibitors of PI3Kd: obtaining isoform selectivity from the affinity pocket and tryptophan shelf. | Bioorg Med Chem Lett 22: 4296-302 (2012) | Genentech | 2D 3D TSV |
22668600 | 200 | Mono-/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV. | Bioorg Med Chem 21: 1564-9 (2013) | Universit£ degli Studi di Firenze | 2D 3D TSV |
22664127 | 19 | Antagonists of 5-HT6 receptors. Substituted 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[3,4-e]pyrimidines and 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[4,3-d]pyrimidines-Synthesis and 'structure-activity' relationship. | Bioorg Med Chem Lett 22: 4273-80 (2012) | Chemical Diversity Research Institute | 2D 3D TSV |
22663155 | 2 | Gambogic acid deactivates cytosolic and mitochondrial thioredoxins by covalent binding to the functional domain. | J Nat Prod 75: 1108-16 (2012) | China Pharmaceutical University | 2D 3D TSV |
22662288 | 11 | HIV-1 Integrase Inhibitor-Inspired Antibacterials Targeting Isoprenoid Biosynthesis. | ACS Med Chem Lett 3: 402-406 (2012) | TBA | 2D 3D TSV |
22662287 | 116 | Discovery of Novel Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia. | ACS Med Chem Lett 3: 129-134 (2012) | TBA | 2D 3D TSV |
22659092 | 2 | Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10. | Drug Metab Dispos 40: 1736-43 (2012) | Gdansk University of Technology | 2D 3D TSV |
22658862 | 41 | Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase. | Bioorg Med Chem Lett 22: 4341-7 (2012) | Advinus Therapeutics Ltd | 2D 3D TSV |
22658558 | 10 | Synthesis and evaluation of novel tropane derivatives as potential PET imaging agents for the dopamine transporter. | Bioorg Med Chem Lett 22: 4303-6 (2012) | Beijing Normal University | 2D 3D TSV |
22658537 | 76 | Natural products as a gold mine for selective matrix metalloproteinases inhibitors. | Bioorg Med Chem 20: 4164-71 (2012) | East China University of Science and Technology | 2D 3D TSV |
22652255 | 50 | C-Aryl 5a-carba-ß-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes. | Bioorg Med Chem 20: 4117-27 (2012) | Chugai Pharmaceutical Co. Ltd | 2D 3D TSV |
22652254 | 21 | Beta-carboline alkaloids derived from the ascidian Synoicum sp. | Bioorg Med Chem 20: 4082-7 (2012) | Seoul National University | 2D 3D TSV |
22652225 | 27 | A novel class of small-molecule caspase-3 inhibitors prepared by multicomponent reactions. | Eur J Med Chem 54: 232-8 (2012) | Southern Medical University | 2D 3D TSV |
22652053 | 6 | Syntheses and biological activities of sulfoximine-based acyclic triaryl olefins. | Bioorg Med Chem Lett 22: 4307-9 (2012) | RWTH Aachen University | 2D 3D TSV |
22651858 | 74 | Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors. | J Med Chem 55: 5774-83 (2012) | Universit£ Catholique de Louvain | 2D 3D TSV |
22651823 | 57 | Diazine indole acetic acids as potent, selective, and orally bioavailable antagonists of chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2) for the treatment of allergic inflammatory diseases. | J Med Chem 55: 5088-109 (2012) | Pfizer Inc | 2D 3D TSV |
22650618 | 4 | Rediocide A, an Insecticide, induces G-protein-coupled receptor desensitization via activation of conventional protein kinase C. | J Nat Prod 75: 1058-62 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22650325 | 39 | Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein. | J Med Chem 55: 6645-68 (2012) | University of Southern California | 2D 3D TSV |
22650305 | 64 | Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitors. | J Med Chem 55: 6162-75 (2012) | Bristol-Myers Squibb Co. | 2D 3D TSV |
22650177 | 12 | Design and synthesis of a novel series of bicyclic heterocycles as potent¿-secretase modulators. | J Med Chem 55: 9089-106 (2012) | Janssen Pharmaceutical Companies of Johnson & Johnson L.L.C. | 2D 3D TSV |
22647881 | 2 | Substrate analog studies of the ?-regiospecificity of Mycobacterium tuberculosis cholesterol metabolizing cytochrome P450 enzymes CYP124A1, CYP125A1 and CYP142A1. | Bioorg Med Chem 20: 4064-81 (2012) | University of California San Francisco | 2D 3D TSV |
22647721 | 19 | Synthesis and evaluation of pyridylbenzofuran, pyridylbenzothiazole and pyridylbenzoxazole derivatives as ¹?F-PET imaging agents for ?-amyloid plaques. | Bioorg Med Chem Lett 22: 4332-7 (2012) | AstraZeneca | 2D 3D TSV |
22647219 | 1 | Docking, synthesis and pharmacological activity of novel urea-derivatives designed as p38 MAPK inhibitors. | Eur J Med Chem 54: 264-71 (2012) | Universidade Federal do Rio de Janeiro | 2D 3D TSV |
22647217 | 57 | Discovery and structure-activity analysis of selective estrogen receptor modulators via similarity-based virtual screening. | Eur J Med Chem 54: 188-96 (2012) | East China University of Science and Technology | 2D 3D TSV |
22646221 | 11 | Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase. | J Med Chem 55: 5734-48 (2012) | National Center for Advancing Translation Sciences | 2D 3D TSV |
22645149 | 12 | Novel Anti-inflammatory Activity of Epoxyazadiradione against Macrophage Migration Inhibitory Factor: INHIBITION OF TAUTOMERASE AND PROINFLAMMATORY ACTIVITIES OF MACROPHAGE MIGRATION INHIBITORY FACTOR. | J Biol Chem 287: 24844-61 (2012) | Council of Scientific and Industrial Research (CSIR) Indian Institute of Chemical Biology | 2D 3D TSV |
22645092 | 15 | Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs. | Drug Metab Dispos 40: 1686-97 (2012) | Pfizer Inc | 2D 3D TSV |
22642587 | 2 | Langkolide, a 32-membered macrolactone antibiotic produced by Streptomyces sp. Acta 3062. | J Nat Prod 75: 1018-24 (2012) | Technische Universit£t Berlin | 2D 3D TSV |
22642365 | 62 | Structure-activity relationship study of N6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterizatio | J Med Chem 55: 5826-40 (2012) | Wayne State University | 2D 3D TSV |
22642319 | 1 | Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors. | J Med Chem 55: 5933-41 (2012) | University of Illinois at Chicago | 2D 3D TSV |
22642300 | 160 | Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors. | J Med Chem 55: 5760-73 (2012) | Kyoto Prefectural University of Medicine | 2D 3D TSV |
22642259 | 22 | Design, synthesis, and pharmacological evaluation of glutamate carboxypeptidase II (GCPII) inhibitors based on thioalkylbenzoic acid scaffolds. | J Med Chem 55: 5922-32 (2012) | Eisai Inc. | 2D 3D TSV |
22633833 | 5 | Rational design, synthesis, and pharmacological properties of pyranochalcone derivatives as potent anti-inflammatory agents. | Eur J Med Chem 54: 272-80 (2012) | Sichuan University | 2D 3D TSV |
22633692 | 51 | Fused tricyclic indoles as S1P1 agonists with robust efficacy in animal models of autoimmune disease. | Bioorg Med Chem Lett 22: 4404-9 (2012) | Arena Pharmaceuticals | 2D 3D TSV |
22633691 | 42 | Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents. | Bioorg Med Chem Lett 22: 4462-6 (2012) | Sun Yat-sen University | 2D 3D TSV |
22633688 | 30 | Small molecule tertiary amines as agonists of the nuclear hormone receptor Rev-erba. | Bioorg Med Chem Lett 22: 4413-7 (2012) | The Scripps Research Institute | 2D 3D TSV |
22633008 | 4 | Biochemical and pharmacological evaluation of 4-hydroxychromen-2-ones bearing polar C-3 substituents as anticoagulants. | Eur J Med Chem 54: 144-58 (2012) | University of Kragujevac | 2D 3D TSV |
22632936 | 42 | Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitors. | Bioorg Med Chem Lett 22: 4377-85 (2012) | Myrexis Inc | 2D 3D TSV |
22632934 | 8 | Click chemistry-derived bivalent quinine inhibitors of P-glycoprotein-mediated cellular efflux. | Bioorg Med Chem Lett 22: 4410-2 (2012) | Purdue University | 2D 3D TSV |
22632933 | 65 | Fragment-based discovery of hydroxy-indazole-carboxamides as novel small molecule inhibitors of Hsp90. | Bioorg Med Chem Lett 22: 4396-403 (2012) | Merck Serono | 2D 3D TSV |
22632094 | 26 | Molecular determinants of selectivity and efficacy at the dopamine D3 receptor. | J Med Chem 55: 6689-99 (2012) | National Institute on Drug Abuse-Intramural Research Program | 2D 3D TSV |
22630076 | 38 | Synthesis and anticholinesterase activities of novel 1,3,4-thiadiazole based compounds. | J Enzyme Inhib Med Chem 28: 816-23 (2013) | University of Life Sciences | 2D 3D TSV |
22630073 | 12 | Susceptibility of cord blood antioxidant enzymes glutathione reductase, glutathione peroxidase and glutathione S-transferase to different antibiotics: in vitro approach. | J Enzyme Inhib Med Chem 28: 824-9 (2013) | Ondokuz Mayis University | 2D 3D TSV |
22626654 | 7 | Synthesis, crystal structures and electronic properties of isomers of chloro-pyridinylvinyl-1H-indoles. | Eur J Med Chem 54: 95-102 (2012) | University of Namur (FUNDP) | 2D 3D TSV |
22626552 | 2 | Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca²¿ channel blockers with analgesic activity. | Bioorg Med Chem 20: 4128-39 (2012) | Abbott Laboratories | 2D 3D TSV |
22626259 | 59 | Discovery of novel PI3-kinased specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibition. | J Med Chem 55: 5887-900 (2012) | Genentech | 2D 3D TSV |
22625994 | 28 | Structure-activity studies on the spiroketal moiety of a simplified analogue of debromoaplysiatoxin with antiproliferative activity. | J Med Chem 55: 5614-26 (2012) | Kyoto University | 2D 3D TSV |
22624960 | 1 | AM-8553: a novel MDM2 inhibitor with a promising outlook for potential clinical development. | J Med Chem 55: 4934-5 (2012) | University of Michigan Comprehensive Cancer Center | 2D 3D TSV |
22624880 | 16 | Tacrine-silibinin codrug shows neuro- and hepatoprotective effects in vitro and pro-cognitive and hepatoprotective effects in vivo. | J Med Chem 55: 5231-42 (2012) | Universit£t Regensburg | 2D 3D TSV |
22621689 | 1 | Dual inhibitors for aspartic proteases HIV-1 PR and renin: advancements in AIDS-hypertension-diabetes linkage via molecular dynamics, inhibition assays, and binding free energy calculations. | J Med Chem 55: 5784-96 (2012) | National Hellenic Research Foundation | 2D 3D TSV |
22621623 | 44 | Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts. | J Med Chem 55: 5591-600 (2012) | University of Manchester | 2D 3D TSV |
22621422 | 2 | ¹²5I-radiolabeled morpholine-containing arginine-glycine-aspartate (RGD) ligand ofavß3 integrin as a molecular imaging probe for angiogenesis. | J Med Chem 55: 5024-33 (2012) | University of Florence | 2D 3D TSV |
22621397 | 39 | Irreversible protein kinase inhibitors: balancing the benefits and risks. | J Med Chem 55: 6243-62 (2012) | Covalution Pharma BV | 2D 3D TSV |
22621375 | 17 | Factors influencing the specificity of inhibitor binding to the human and malaria parasite dihydroorotate dehydrogenases. | J Med Chem 55: 5841-50 (2012) | University of Leeds | 2D 3D TSV |
22617492 | 56 | Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists. | Bioorg Med Chem Lett 22: 3890-4 (2012) | Scripps Florida | 2D 3D TSV |
22617490 | 23 | Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonists. | Bioorg Med Chem Lett 22: 4198-202 (2012) | Cephalon Inc | 2D 3D TSV |
22616902 | 165 | Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition. | J Med Chem 55: 5270-90 (2012) | Ludwig Center for Cancer Research of the University of Lausanne | 2D 3D TSV |
22613176 | 1 | Covalent modification and time-dependent inhibition of human CYP2E1 by the meta-isomer of acetaminophen. | Drug Metab Dispos 40: 1460-5 (2012) | Pacific University Oregon | 2D 3D TSV |
22613098 | 3 | Novel Cruzain Inhibitors for the Treatment of Chagas' Disease. | Chem Biol Drug Des 80: 398-405 (2012) | University of California San Diego | 2D 3D TSV |
22612866 | 123 | Protein-ligand crystal structures can guide the design of selective inhibitors of the FGFR tyrosine kinase. | J Med Chem 55: 5003-12 (2012) | AstraZeneca | 2D 3D TSV |
22612268 | 12 | Ligand binding stepwise disrupts water network in thrombin: enthalpic and entropic changes reveal classical hydrophobic effect. | J Med Chem 55: 6094-110 (2012) | Philipps University Marburg | 2D 3D TSV |
22608965 | 186 | The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38a MAP kinase inhibitor for the treatment of inflammatory diseases. | Bioorg Med Chem Lett 22: 3879-83 (2012) | AstraZeneca | 2D 3D TSV |
22608963 | 109 | The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity. | Bioorg Med Chem Lett 22: 3895-9 (2012) | AstraZeneca | 2D 3D TSV |
22608962 | 59 | Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes. | Bioorg Med Chem Lett 22: 3873-8 (2012) | AstraZeneca | 2D 3D TSV |
22608961 | 46 | Identification of a phenylacylsulfonamide series of dual Bcl-2/Bcl-xL antagonists. | Bioorg Med Chem Lett 22: 3946-50 (2012) | Bristol-Myers Squibb Research | 2D 3D TSV |
22608920 | 4 | Synthesis and evaluation of 11ß-(4-substituted phenyl) estradiol analogs: transition from estrogen receptor agonists to antagonists. | Bioorg Med Chem 20: 3768-80 (2012) | Northeastern University | 2D 3D TSV |
22608919 | 3 | 5-(5-(6-[(11)C]methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl)pyridin-2-yl)-1H-indole as a potential PET radioligand for imaging cerebrala7-nAChR in mice. | Bioorg Med Chem 20: 3698-702 (2012) | The Johns Hopkins University School of Medicine | 2D 3D TSV |
22608762 | 25 | Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors. | Eur J Med Chem 54: 123-36 (2012) | Shanghai Institute of Pharmaceutical Industry | 2D 3D TSV |
22608393 | 64 | Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonists. | Bioorg Med Chem Lett 22: 3951-6 (2012) | Bristol-Myers Squibb Research | 2D 3D TSV |
22608391 | 12 | Towards a KCC2 blocker pharmacophore model. | Bioorg Med Chem Lett 22: 3978-82 (2012) | UCB Pharma SA | 2D 3D TSV |
22607880 | 54 | Identification of novel benzimidazole derivatives as inhibitors of leukotriene biosynthesis by virtual screening targeting 5-lipoxygenase-activating protein (FLAP). | Bioorg Med Chem 20: 3728-41 (2012) | Gazi University | 2D 3D TSV |
22607877 | 38 | Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors. | Bioorg Med Chem 20: 3807-15 (2012) | Shandong University | 2D 3D TSV |
22607697 | 1 | Implications of binding mode and active site flexibility for inhibitor potency against the salicylate synthase from Mycobacterium tuberculosis. | Biochemistry 51: 4868-79 (2012) | The University of Auckland | 2D 3D TSV |
22607684 | 50 | 7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s2) receptor ligands. | Bioorg Med Chem Lett 22: 4059-63 (2012) | The University of Sydney | 2D 3D TSV |
22607683 | 19 | 5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP. | Bioorg Med Chem Lett 22: 4038-43 (2012) | University of Texas Medical Branch | 2D 3D TSV |
22607682 | 47 | Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitor. | Bioorg Med Chem Lett 22: 4163-8 (2012) | AstraZeneca | 2D 3D TSV |
22607677 | 8 | Identification of chalcones as potent and selective PDE5A1 inhibitors. | Bioorg Med Chem Lett 22: 3983-7 (2012) | Youai Co., Ltd | 2D 3D TSV |
22607676 | 47 | Synthesis and SAR of selective small molecule neuropeptide Y Y2 receptor antagonists. | Bioorg Med Chem Lett 22: 3916-20 (2012) | The Scripps Research Institute | 2D 3D TSV |
22607675 | 28 | Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity. | Bioorg Med Chem Lett 22: 3988-92 (2012) | University of Lille | 2D 3D TSV |
22607673 | 34 | Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAM. | Bioorg Med Chem Lett 22: 3921-5 (2012) | Vanderbilt University Medical Center | 2D 3D TSV |
22607672 | 28 | MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in rats. | Bioorg Med Chem Lett 22: 3941-5 (2012) | Merck Research Laboratories | 2D 3D TSV |
22607670 | 34 | Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D2 and 5-hydroxytryptamine 5HT(1A) receptors. | Bioorg Med Chem Lett 22: 3967-72 (2012) | University of Belgrade | 2D 3D TSV |
22607669 | 45 | Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors. | Bioorg Med Chem Lett 22: 4033-7 (2012) | Biogen Idec Inc | 2D 3D TSV |
22607668 | 66 | N-Methyl-3-(tetrahydro-2H-pyran-4-yl)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamides as a novel class of cannabinoid receptors agonists with low CNS penetration. | Bioorg Med Chem Lett 22: 3884-9 (2012) | AstraZeneca | 2D 3D TSV |
22607231 | 1 | Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2. | J Nat Prod 75: 1051-7 (2012) | University of Southampton Faculty of Medicine | 2D 3D TSV |
22607152 | 7 | Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development. | J Med Chem 55: 6669-86 (2012) | Universit£ degli Studi di Napoli Federico II | 2D 3D TSV |
22607122 | 38 | Discovery of highly potent human deoxyuridine triphosphatase inhibitors based on the conformation restriction strategy. | J Med Chem 55: 5483-96 (2012) | Taiho Pharmaceutical Co., Ltd | 2D 3D TSV |
22606365 | 5 | Non-iminosugar glucocerebrosidase small molecule chaperones. | Medchemcomm 3: 56-60 (2012) | National Human Genome Research Institute | 2D 3D TSV |
22595177 | 14 | Discovery of novel EGFR tyrosine kinase inhibitors by structure-based virtual screening. | Bioorg Med Chem Lett 22: 4004-9 (2012) | East China University of Science and Technology | 2D 3D TSV |
22595176 | 31 | Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitors. | Bioorg Med Chem Lett 22: 4089-93 (2012) | Amgen Inc | 2D 3D TSV |
22595175 | 18 | N-Acyl and N-sulfonyloxazolidine-2,4-diones are pseudo-irreversible inhibitors of serine proteases. | Bioorg Med Chem Lett 22: 3993-7 (2012) | University of Lisbon | 2D 3D TSV |
22595174 | 9 | Pre-steady state kinetic analysis of cyclobutyl derivatives of 2'-deoxyadenosine 5'-triphosphate as inhibitors of HIV-1 reverse transcriptase. | Bioorg Med Chem Lett 22: 4064-7 (2012) | Yale University | 2D 3D TSV |
22595173 | 68 | The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1). | Bioorg Med Chem Lett 22: 3935-40 (2012) | Pharmaxis Ltd. | 2D 3D TSV |
22594690 | 80 | A selective, orally bioavailable 1,2,4-triazolo[1,5-a]pyridine-based inhibitor of Janus kinase 2 for use in anticancer therapy: discovery of CEP-33779. | J Med Chem 55: 5243-54 (2012) | Cephalon Inc | 2D 3D TSV |
22594609 | 30 | Structure-activity relationship study of selective excitatory amino acid transporter subtype 1 (EAAT1) inhibitor 2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (UCPH-101) and absolute configurational assignment using infrared and vibrational circ | J Med Chem 55: 5403-12 (2012) | University of Copenhagen | 2D 3D TSV |
22593037 | 8 | Potent inhibition of human sulfotransferase 1A1 by 17a-ethinylestradiol: role of 3'-phosphoadenosine 5'-phosphosulfate binding and structural rearrangements in regulating inhibition and activity. | Drug Metab Dispos 40: 1588-95 (2012) | University of Alabama at Birmingham | 2D 3D TSV |
22591730 | 22 | Thieno[3,2-d]pyrimidin-4(3H)-one derivatives as PDK1 inhibitors discovered by fragment-based screening. | Bioorg Med Chem Lett 22: 4023-7 (2012) | S*BIO Pte Ltd | 2D 3D TSV |
22591648 | 78 | Evaluation of synthetic acridones and 4-quinolinones as potent inhibitors of cathepsins L and V. | Eur J Med Chem 54: 10-21 (2012) | Universidade Federal de S£o Carlos | 2D 3D TSV |
22591441 | 29 | Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modeling. | J Med Chem 55: 5536-45 (2012) | Genentech | 2D 3D TSV |
22591402 | 127 | Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors. | J Med Chem 55: 5901-21 (2012) | Argenta Discovery Ltd | 2D 3D TSV |
22591317 | 5 | Impacts of some antibiotics on human serum paraoxonase 1 activity. | J Enzyme Inhib Med Chem 28: 758-64 (2013) | Atatürk University | 2D 3D TSV |
22591063 | 12 | Synthesis and nicotinic receptor activity of chemical space analogues of N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chlorobenzamide (PNU-282,987) and 1,4-diazabicyclo[3.2.2]nonane-4-carboxylic acid 4-bromophenyl ester (SSR180711). | J Med Chem 55: 4605-18 (2012) | University of Berne | 2D 3D TSV |
22589534 | 28 | Discovery of a Novel Allosteric Modulator of 5-HT3 Receptors: INHIBITION AND POTENTIATION OF CYS-LOOP RECEPTOR SIGNALING THROUGH A CONSERVED TRANSMEMBRANE INTERSUBUNIT SITE. | J Biol Chem 287: 25241-54 (2012) | University of Copenhagen | 2D 3D TSV |
22587986 | 26 | The development, characterization, and application of an OATP1B1 inhibition assay in drug discovery. | Drug Metab Dispos 40: 1641-8 (2012) | Bristol-Myers Squibb Co. | 2D 3D TSV |
22587443 | 55 | Synthesis and structure-activity relationships of pyrazolo[1,5-a]pyridine derivatives: potent and orally active antagonists of corticotropin-releasing factor 1 receptor. | J Med Chem 55: 5255-69 (2012) | Eisai Co., Ltd | 2D 3D TSV |
22583779 | 6 | Synthesis, in vitro and in silico screening of ethyl 2-(6-substituted benzo[d]thiazol-2-ylamino)-2-oxoacetates as protein-tyrosine phosphatase 1B inhibitors. | Eur J Med Chem 53: 346-55 (2012) | Universidad Aut£noma del Estado de Morelos | 2D 3D TSV |
22583669 | 1 | Synthesis, biological evaluation and 3D-QSAR studies of novel 4,5-dihydro-1H-pyrazole niacinamide derivatives as BRAF inhibitors. | Bioorg Med Chem 20: 3746-55 (2012) | Nanjing University | 2D 3D TSV |
22583618 | 8 | Kappa agonist CovX-Bodies. | Bioorg Med Chem Lett 22: 4173-8 (2012) | Pfizer Inc | 2D 3D TSV |
22583617 | 12 | E297G mutated bile salt export pump (BSEP) function enhancers derived from GW4064: structural development study and separation from farnesoid X receptor-agonistic activity. | Bioorg Med Chem Lett 22: 3962-6 (2012) | The University of Tokyo | 2D 3D TSV |
22583616 | 67 | Identification of benzoxazole analogs as novel, S1P(3) sparing S1P(1) agonists. | Bioorg Med Chem Lett 22: 3973-7 (2012) | GlaxoSmithKline | 2D 3D TSV |
22583019 | 6 | Substrates for efficient fluorometric screening employing the NAD-dependent sirtuin 5 lysine deacylase (KDAC) enzyme. | J Med Chem 55: 5582-90 (2012) | Technical University of Denmark | 2D 3D TSV |
22582973 | 21 | Integrated virtual screening for the identification of novel and selective peroxisome proliferator-activated receptor (PPAR) scaffolds. | J Med Chem 55: 4978-89 (2012) | Trinity College | 2D 3D TSV |
22582136 | 8 | Hydrophobic Interactions Improve Selectivity to ERa for Ben-zothiophene SERMs. | ACS Med Chem Lett 3: 207-210 (2012) | TBA | 2D 3D TSV |
22579620 | 36 | Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy. | Bioorg Med Chem 20: 3816-27 (2012) | Peking University | 2D 3D TSV |
22579615 | 19 | Synthesis and evaluation of boronic acids as inhibitors of Penicillin Binding Proteins of classes A, B and C. | Bioorg Med Chem 20: 3915-24 (2012) | Universit£ de Li£ge | 2D 3D TSV |
22579487 | 53 | Synthesis and structure-activity relationship of aminopyridines with substituted benzoxazoles as c-Met kinase inhibitors. | Bioorg Med Chem Lett 22: 4044-8 (2012) | Korea Research Institute of Chemical Technology | 2D 3D TSV |
22579486 | 80 | Acylprolinamides: a new class of peptide deformylase inhibitors with in vivo antibacterial activity. | Bioorg Med Chem Lett 22: 4028-32 (2012) | GlaxoSmithKline | 2D 3D TSV |
22579484 | 6 | Ethyl 2,4,6-trihydroxybenzoate is an agonistic ligand for liver X receptor that induces cholesterol efflux from macrophages without affecting lipid accumulation in HepG2 cells. | Bioorg Med Chem Lett 22: 4094-9 (2012) | Korea University | 2D 3D TSV |
22579422 | 31 | Structure-activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors. | Bioorg Med Chem Lett 22: 4153-8 (2012) | Zalicus Pharmaceuticals Ltd | 2D 3D TSV |
22579420 | 45 | Total synthesis and dual PPARa/¿ agonist effects of amorphastilbol and its synthetic derivatives. | Bioorg Med Chem Lett 22: 4122-6 (2012) | Korea Institute of Science and Technology | 2D 3D TSV |
22579419 | 23 | Depigmenting activities of kojic acid derivatives without tyrosinase inhibitory activities. | Bioorg Med Chem Lett 22: 4159-62 (2012) | Hanyang University | 2D 3D TSV |
22578786 | 40 | Microwave assisted synthesis of spirocyclic pyrrolidines -s1 receptor ligands with modified benzene-N-distance. | Eur J Med Chem 53: 327-36 (2012) | Institut f£r Pharmazeutische und Medizinische Chemie | 2D 3D TSV |
22578490 | 35 | Synthesis and evaluation of 4- and 5-pyridazin-3-one phenoxypropylamine analogues as histamine-3 receptor antagonists. | Bioorg Med Chem 20: 3880-6 (2012) | Cephalon Inc | 2D 3D TSV |
22578460 | 4 | Identification of blapsins A and B as potent small-molecule 14-3-3 inhibitors from the insect Blaps japanensis. | Bioorg Med Chem Lett 22: 4179-81 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22578458 | 84 | Evaluation of endo- and exo-aryl-substitutions and central scaffold modifications on diphenyl substituted alkanes as 5-lipoxygenase activating protein inhibitors. | Bioorg Med Chem Lett 22: 4133-8 (2012) | Merck Research Laboratories | 2D 3D TSV |
22575869 | 61 | Structure-activity relationship of a series of non peptidic RGD integrin antagonists targetinga5ß1: part 1. | Bioorg Med Chem Lett 22: 4111-6 (2012) | AstraZeneca | 2D 3D TSV |
22575532 | 2 | Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitors. | Eur J Med Chem 53: 229-34 (2012) | Fudan University | 2D 3D TSV |
22575050 | 40 | Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities. | J Med Chem 55: 5337-49 (2012) | Korea Advanced Institute of Science and Technology (KAIST) | 2D 3D TSV |
22575017 | 1 | Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding. | J Med Chem 55: 5121-9 (2012) | University of Minnesota Health Sciences Center | 2D 3D TSV |
22574973 | 36 | Identification of a crucial amino acid in the helix position 6.51 of human tachykinin neurokinin 1 and 3 receptors contributing to the insurmountable mode of antagonism by dual NK1/NK3 antagonists. | J Med Chem 55: 5061-76 (2012) | F. Hoffmann-La Roche Inc | 2D 3D TSV |
22572583 | 49 | Structure guided P1' modifications of HEA derivedß-secretase inhibitors for the treatment of Alzheimer's disease. | Bioorg Med Chem Lett 22: 3607-11 (2012) | Envoy Therapeutics | 2D 3D TSV |
22572580 | 26 | Synthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents. | Bioorg Med Chem Lett 22: 3589-93 (2012) | Nanjing University | 2D 3D TSV |
22572579 | 38 | Thieno[3,2-b]thiophene-2-carboxylic acid derivatives as GPR35 agonists. | Bioorg Med Chem Lett 22: 4148-52 (2012) | Corning Inc. | 2D 3D TSV |
22572578 | 124 | Structure-activity relationship of a series of non peptidic RGD integrin antagonists targetinga5ß1: part 2. | Bioorg Med Chem Lett 22: 4117-21 (2012) | AstraZeneca | 2D 3D TSV |
22571451 | 46 | Indole-2-carboxamides as allosteric modulators of the cannabinoid CB1 receptor. | J Med Chem 55: 5627-31 (2012) | Sapienza University of Rome | 2D 3D TSV |
22570300 | 3 | Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1. | Chembiochem 13: 1291-6 (2012) | Frederick National Laboratory for Cancer Research | 2D 3D TSV |
22568637 | 158 | Water-soluble pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as human A3 adenosine receptor antagonists. | J Med Chem 55: 5380-90 (2012) | Universit£ di Ferrara | 2D 3D TSV |
22564381 | 27 | Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of Farnesoid X Receptor (FXR) agonists. | Bioorg Med Chem 20: 3429-45 (2012) | Universit£ di Perugia | 2D 3D TSV |
22564380 | 624 | Activity landscape modeling of PPAR ligands with dual-activity difference maps. | Bioorg Med Chem 20: 3523-32 (2012) | Universidad Nacional Aut£noma de M£xico | 2D 3D TSV |
22564207 | 44 | Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinase. | J Med Chem 55: 4580-93 (2012) | Cephalon Inc | 2D 3D TSV |
22563729 | 80 | Discovery of the first irreversible small molecule inhibitors of the interaction between the vitamin D receptor and coactivators. | J Med Chem 55: 4640-51 (2012) | University of Wisconsin-Milwaukee | 2D 3D TSV |
22563707 | 27 | A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design. | J Med Chem 55: 5311-25 (2012) | Radboud University Nijmegen Medical Centre | 2D 3D TSV |
22560838 | 7 | Radiosynthesis of a¹8F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivo. | Bioorg Med Chem 20: 3410-21 (2012) | Helmholtz-Zentrum Dresden-Rossendorf | 2D 3D TSV |
22560627 | 70 | 2-Anilino-4-(benzimidazol-2-yl)pyrimidines--a multikinase inhibitor scaffold with antiproliferative activity toward cancer cell lines. | Eur J Med Chem 53: 254-63 (2012) | Technische Universit£t Braunschweig | 2D 3D TSV |
22560585 | 16 | Discovery and evaluation of selective N-type calcium channel blockers: 6-unsubstituted-1,4-dihydropyridine-5-carboxylic acid derivatives. | Bioorg Med Chem Lett 22: 3639-42 (2012) | Ajinomoto Pharmaceuticals Co. Ltd | 2D 3D TSV |
22560583 | 48 | Design, synthesis, and structure-activity relationships of novel spiro-piperidines as acetyl-CoA carboxylase inhibitors. | Bioorg Med Chem Lett 22: 3643-7 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22560567 | 82 | Discovery of XL413, a potent and selective CDC7 inhibitor. | Bioorg Med Chem Lett 22: 3727-31 (2012) | Exelixis Inc | 2D 3D TSV |
22560473 | 16 | Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part I: aminoalkoxypyrimidine carboxamides. | Bioorg Med Chem Lett 22: 3693-8 (2012) | Vertex Pharmaceuticals Inc | 2D 3D TSV |
22560471 | 10 | Use of libraries to access new chemical space: applications to CRTH2. | Bioorg Med Chem Lett 22: 3682-7 (2012) | Pfizer Inc | 2D 3D TSV |
22560469 | 25 | Synthesis and SAR of tetrahydroisoquinolines as Rev-erba agonists. | Bioorg Med Chem Lett 22: 3739-42 (2012) | The Scripps Research Institute | 2D 3D TSV |
22559926 | 6 | Preparation of 3-substituted-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amines as RET kinase inhibitors. | J Med Chem 55: 4872-6 (2012) | University of Gothenburg | 2D 3D TSV |
22559880 | 52 | Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions. | J Med Chem 55: 4847-60 (2012) | National Institute of Diabetes and Digestive and Kidney Diseases | 2D 3D TSV |
22554495 | 10 | Synthesis and in vitro characterization of trans- and cis-[(18)F]-4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]-3-fluoropiperidine-1-carboxylates as new potential PET radiotracer candidates for the NR2B subtype N-methyl-D-aspartate receptor. | Eur J Med Chem 53: 408-15 (2012) | Institute of Biomedical Imaging (I2BM) | 2D 3D TSV |
22554206 | 33 | Discovery of pyrroloaminopyrazoles as novel PAK inhibitors. | J Med Chem 55: 4728-39 (2012) | Pfizer Inc | 2D 3D TSV |
22552196 | 17 | Novel diamide insecticides: sulfoximines, sulfonimidamides and other new sulfonimidoyl derivatives. | Bioorg Med Chem Lett 22: 3800-6 (2012) | Syngenta Crop Protection Muenchwilen AG | 2D 3D TSV |
22552195 | 34 | Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses. | Bioorg Med Chem Lett 22: 3688-92 (2012) | Chosun University | 2D 3D TSV |
22552008 | 7 | Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. | Leukemia 26: 2326-35 (2012) | Celgene | 2D 3D TSV |
22551631 | 18 | Automated generation of turn mimetics: proof of concept study for the MC4 receptor. | Bioorg Med Chem 20: 3565-74 (2012) | Neurocrine Biosciences Inc | 2D 3D TSV |
22551629 | 72 | Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors. | Bioorg Med Chem 20: 3575-83 (2012) | ZAFES/LiFF/OSF Goethe-University Frankfurt | 2D 3D TSV |
22551018 | 68 | Discovery of checkpoint kinase inhibitor (S)-5-(3-fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by structure-based design and optimization of thiophenecarboxamide ureas. | J Med Chem 55: 5130-42 (2012) | AstraZeneca | 2D 3D TSV |
22548457 | 60 | Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonists. | J Med Chem 55: 5391-402 (2012) | Universit£ degli Studi di Siena | 2D 3D TSV |
22548439 | 9 | Rapid identification of a novel small molecule phosphodiesterase 10A (PDE10A) tracer. | J Med Chem 55: 4776-87 (2012) | Amgen Inc | 2D 3D TSV |
22548365 | 293 | Structure-based design of a novel series of potent, selective inhibitors of the class I phosphatidylinositol 3-kinases. | J Med Chem 55: 5188-219 (2012) | Amgen Inc | 2D 3D TSV |
22548342 | 210 | Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase¿ inhibitors. | J Med Chem 55: 5467-82 (2012) | Exelixis Inc | 2D 3D TSV |
22546675 | 24 | Wake promoting agents: search for next generation modafinil, lessons learned: part III. | Bioorg Med Chem Lett 22: 3751-3 (2012) | Cephalon Inc | 2D 3D TSV |
22546671 | 9 | Investigation of the binding pocket of human hematopoietic prostaglandin (PG) D2 synthase (hH-PGDS): a tale of two waters. | Bioorg Med Chem Lett 22: 3795-9 (2012) | Pfizer Inc | 2D 3D TSV |
22546668 | 30 | Structure-activity relationships and molecular modeling of the N-(3-pivaloyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl] thiourea template for TRPV1 antagonism. | Bioorg Med Chem Lett 22: 3656-60 (2012) | Seoul National University | 2D 3D TSV |
22546206 | 162 | Synthesis and evaluation of¿-lactam analogs of PGE2 as EP4 and EP2/EP4 agonists. | Bioorg Med Chem 20: 3502-22 (2012) | Minase Research Institute | 2D 3D TSV |
22546204 | 9 | Recent developments and biological activities of thiazolidinone derivatives: a review. | Bioorg Med Chem 20: 3378-95 (2012) | Dr. Hari Singh Gour University | 2D 3D TSV |
22545941 | 14 | Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors. | J Enzyme Inhib Med Chem 28: 717-26 (2013) | Shandong University | 2D 3D TSV |
22545939 | 5 | Synthesis, activity evaluation, and docking analysis of barbituric acid aryl hydrazone derivatives as RSK2 inhibitors. | J Enzyme Inhib Med Chem 28: 747-52 (2013) | East China University of Science and Technology | 2D 3D TSV |
22545924 | 44 | Targeting GSK3 from Ustilago maydis: Type-II Kinase Inhibitors as Potential Antifungals. | ACS Chem Biol 7: 1257-67 (2012) | Technische Universität Dortmund | 2D 3D TSV |
22545772 | 100 | Use of small-molecule crystal structures to address solubility in a novel series of G protein coupled receptor 119 agonists: optimization of a lead and in vivo evaluation. | J Med Chem 55: 5361-79 (2012) | AstraZeneca | 2D 3D TSV |
22543028 | 39 | Design and synthesis of new tetrahydroquinolines derivatives as CETP inhibitors. | Bioorg Med Chem Lett 22: 3671-5 (2012) | Eli Lilly and Company | 2D 3D TSV |
22543026 | 6 | Kinase inhibitory potencies and in vitro antiproliferative activities of N-10 substituted pyrrolo[2,3-a]carbazole derivatives. | Bioorg Med Chem Lett 22: 3807-9 (2012) | Clermont Universit£ | 2D 3D TSV |
22542283 | 2 | Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase. | Bioorg Med Chem 20: 3658-65 (2012) | Kobe Pharmaceutical University | 2D 3D TSV |
22542282 | 25 | Discovery of novel indane derivatives as liver-selective thyroid hormone receptorß (TRß) agonists for the treatment of dyslipidemia. | Bioorg Med Chem 20: 3622-34 (2012) | Kissei Pharmaceutical Co., Ltd | 2D 3D TSV |
22542194 | 22 | Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarring. | Bioorg Med Chem Lett 22: 3392-7 (2012) | Pfizer Inc | 2D 3D TSV |
22542107 | 14 | Synthesis and molecular modelling studies of novel carbapeptide analogs for inhibition of HIV-1 protease. | Eur J Med Chem 53: 13-21 (2012) | University of KwaZulu-Natal | 2D 3D TSV |
22542019 | 44 | Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: extending towards theß-exosite. | Bioorg Med Chem Lett 22: 3754-7 (2012) | Fox Chase Chemical Diversity Center | 2D 3D TSV |
22542012 | 155 | The design, synthesis, and biological evaluation of PIM kinase inhibitors. | Bioorg Med Chem Lett 22: 3732-8 (2012) | Exelixis Inc | 2D 3D TSV |
22542010 | 31 | Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition. | Bioorg Med Chem Lett 22: 3781-5 (2012) | Amgen Inc | 2D 3D TSV |
22542009 | 102 | Discovery and optimization of benzenesulfonanilide derivatives as a novel class of 11ß-HSD1 inhibitors. | Bioorg Med Chem Lett 22: 3786-90 (2012) | Amgen Inc | 2D 3D TSV |
22541394 | 30 | Appraisal of GABA and PABA as linker: design and synthesis of novel benzamide based histone deacetylase inhibitors. | Eur J Med Chem 53: 390-7 (2012) | Guru Ghasidas University | 2D 3D TSV |
22541393 | 1 | A variant peptide of buffalo colostrumß-lactoglobulin inhibits angiotensin I-converting enzyme activity. | Eur J Med Chem 53: 211-9 (2012) | University of Mysore | 2D 3D TSV |
22541068 | 73 | Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. | J Med Chem 55: 4740-63 (2012) | Uppsala University | 2D 3D TSV |
22541041 | 84 | Development of LC-MS/MS-based receptor occupancy tracers and positron emission tomography radioligands for the nociceptin/orphanin FQ (NOP) receptor. | J Med Chem 55: 4955-67 (2012) | Eli Lilly and Company | 2D 3D TSV |
22540974 | 67 | A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation. | J Med Chem 55: 4714-27 (2012) | University Hospital M£nster | 2D 3D TSV |
22540945 | 19 | Rational evolution of a novel type of potent and selective proviral integration site in Moloney murine leukemia virus kinase 1 (PIM1) inhibitor from a screening-hit compound. | J Med Chem 55: 5151-64 (2012) | The University of Tokyo | 2D 3D TSV |
22537682 | 6 | Inverse Virtual Screening allows the discovery of the biological activity of natural compounds. | Bioorg Med Chem 20: 3596-602 (2012) | Universit£ di Salerno | 2D 3D TSV |
22537678 | 8 | 3-Deoxy-3,4-dehydro analogs of XM462. Preparation and activity on sphingolipid metabolism and cell fate. | Bioorg Med Chem 20: 3173-9 (2012) | Institute for Advanced Chemistry of Catalonia | 2D 3D TSV |
22537450 | 54 | Discovery of cariprazine (RGH-188): a novel antipsychotic acting on dopamine D3/D2 receptors. | Bioorg Med Chem Lett 22: 3437-40 (2012) | Gedeon Richter Plc | 2D 3D TSV |
22537178 | 5 | Charting, navigating, and populating natural product chemical space for drug discovery. | J Med Chem 55: 5989-6001 (2012) | Max Planck Institute of Molecular Physiology | 2D 3D TSV |
22537153 | 10 | Chemocentric informatics approach to drug discovery: identification and experimental validation of selective estrogen receptor modulators as ligands of 5-hydroxytryptamine-6 receptors and as potential cognition enhancers. | J Med Chem 55: 5704-19 (2012) | University of North Carolina at Chapel Hill | 2D 3D TSV |
22537109 | 25 | Identification of a novel family of BRAF(V600E) inhibitors. | J Med Chem 55: 5220-30 (2012) | University of Pennsylvania | 2D 3D TSV |
22536986 | 12 | Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease. | J Med Chem 55: 4189-204 (2012) | Epichem Pty Ltd | 2D 3D TSV |
22536944 | 91 | Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors. | J Med Chem 55: 4457-78 (2012) | Purdue University | 2D 3D TSV |
22534450 | 36 | The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinase. | Bioorg Med Chem Lett 22: 3387-91 (2012) | Array BioPharma, Inc. | 2D 3D TSV |
22534184 | 87 | Discovery, design and synthesis of Y-shaped peroxisome proliferator-activated receptord agonists as potent anti-obesity agents in vivo. | Eur J Med Chem 53: 190-202 (2012) | Seoul National University | 2D 3D TSV |
22533986 | 181 | Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitors. | J Med Chem 55: 5291-310 (2012) | ArQule Inc | 2D 3D TSV |
22533905 | 2 | Chalcogenopyrylium compounds as modulators of the ATP-binding cassette transporters P-glycoprotein (P-gp/ABCB1) and multidrug resistance protein 1 (MRP1/ABCC1). | J Med Chem 55: 4683-99 (2012) | The State University of New York | 2D 3D TSV |
22533875 | 11 | Mitigating heterocycle metabolism in drug discovery. | J Med Chem 55: 6002-20 (2012) | Amgen Inc | 2D 3D TSV |
22533818 | 84 | Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3a. | J Med Chem 55: 4407-24 (2012) | Technische Universit£t Darmstadt | 2D 3D TSV |
22533316 | 10 | Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells. | J Med Chem 55: 4990-5002 (2012) | Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL) | 2D 3D TSV |
22531045 | 2 | In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties. | Drug Metab Dispos 40: 1263-7 (2012) | Amgen Inc | 2D 3D TSV |
22525315 | 1 | Ianthellamide A, a selective kynurenine-3-hydroxylase inhibitor from the Australian marine sponge Ianthella quadrangulata. | Bioorg Med Chem Lett 22: 3398-401 (2012) | Griffith University | 2D 3D TSV |
22525314 | 159 | Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity. | Bioorg Med Chem Lett 22: 3412-7 (2012) | University of Antwerp (UA) | 2D 3D TSV |
22525313 | 30 | Tetrahydro-naphthols as orally available TRPV1 inhibitors. | Bioorg Med Chem Lett 22: 3408-11 (2012) | Bayer Yakuhin, Ltd | 2D 3D TSV |
22524677 | 6 | Interaction of superoxide dismutase with the glycine zipper regions of ß-amyloid peptides: is there an implication towards Alzheimer's disease and oxidative stress? | J Enzyme Inhib Med Chem 28: 727-33 (2013) | Rhodes University | 2D 3D TSV |
22524676 | 8 | The efficient expression of human fibroblast collagenase in Escherichia coli and the discovery of flavonoid inhibitors. | J Enzyme Inhib Med Chem 28: 741-6 (2013) | East China University of Science and Technology | 2D 3D TSV |
22524527 | 13 | Structure-based design of novel inhibitors of the MDM2-p53 interaction. | J Med Chem 55: 4936-54 (2012) | Amgen Inc | 2D 3D TSV |
22524450 | 24 | Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening. | J Med Chem 55: 4142-58 (2012) | Universit£ di Napoli Federico II | 2D 3D TSV |
22524426 | 281 | Discovery and optimization of new benzimidazole- and benzoxazole-pyrimidone selective PI3Kß inhibitors for the treatment of phosphatase and TENsin homologue (PTEN)-deficient cancers. | J Med Chem 55: 4788-805 (2012) | Sanofi Research & Development | 2D 3D TSV |
22524250 | 12 | Imidazolopiperazines: lead optimization of the second-generation antimalarial agents. | J Med Chem 55: 4244-73 (2012) | Genomics Institute of the Novartis Research Foundation | 2D 3D TSV |
22523618 | 16 | Synthesis and Evaluation of Metabotropic Glutamate Receptor Subtype 5 Antagonists Based on Fenobam(). | ACS Med Chem Lett 2: 882-884 (2011) | TBA | 2D 3D TSV |
22522748 | 1 | Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance. | Drug Metab Dispos 40: 1441-8 (2012) | Pfizer Inc | 2D 3D TSV |
22522007 | 102 | Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability. | Bioorg Med Chem 20: 3255-62 (2012) | Colorado State University | 2D 3D TSV |
22521647 | 56 | Conjugates of 5-isoquinolinesulfonylamides and oligo-D-arginine possess high affinity and selectivity towards Rho kinase (ROCK). | Bioorg Med Chem Lett 22: 3425-30 (2012) | University of Tartu | 2D 3D TSV |
22521646 | 38 | Novel triazolopyridylbenzamides as potent and selective p38a inhibitors. | Bioorg Med Chem Lett 22: 3431-6 (2012) | Rhône-Poulenc Rorer | 2D 3D TSV |
22520630 | 21 | Synthesis, biological evaluation and molecular docking studies of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents. | Bioorg Med Chem 20: 3359-67 (2012) | Nanjing University | 2D 3D TSV |
22520259 | 65 | Identification of ETP-46321, a potent and orally bioavailable PI3Ka,d inhibitor. | Bioorg Med Chem Lett 22: 3460-6 (2012) | Spanish National Cancer Research Centre (CNIO) | 2D 3D TSV |
22520153 | 135 | Benzothiazoles as probes for the 5HT1A receptor and the serotonin transporter (SERT): a search for new dual-acting agents as potential antidepressants. | Eur J Med Chem 53: 124-32 (2012) | Florida A&M University | 2D 3D TSV |
22519963 | 80 | Discovery of a potent and selective GPR120 agonist. | J Med Chem 55: 4511-5 (2012) | University of Southern Denmark | 2D 3D TSV |
22517972 | 40 | Sequential metabolism of AMG 487, a novel CXCR3 antagonist, results in formation of quinone reactive metabolites that covalently modify CYP3A4 Cys239 and cause time-dependent inhibition of the enzyme. | Drug Metab Dispos 40: 1429-40 (2012) | Amgen Inc | 2D 3D TSV |
22516672 | 47 | Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2. | Bioorg Med Chem 20: 3306-16 (2012) | University of Mansoura | 2D 3D TSV |
22516424 | 7 | The synthesis of 2,5-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease. | Eur J Med Chem 53: 374-9 (2012) | University of Belgrade | 2D 3D TSV |
22516282 | 23 | Synthesis and biological activity of 2-aminothiazoles as novel inhibitors of PGE2 production in cells. | Bioorg Med Chem Lett 22: 3567-70 (2012) | The University of Arizona | 2D 3D TSV |
22516281 | 10 | Practical access to four stereoisomers of naftidrofuryl and their binding affinity towards 5-hydroxytryptamine 2A receptor. | Bioorg Med Chem Lett 22: 3441-4 (2012) | China Pharmaceutical University | 2D 3D TSV |
22515405 | 39 | Thiophene bioisosteres of spirocyclics receptor ligands: relationships between substitution pattern ands receptor affinity. | J Med Chem 55: 5350-60 (2012) | Institut f£r Pharmazeutische und Medizinische Chemie der Universit£t M£nster | 2D 3D TSV |
22515328 | 17 | N-(2-oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships. | J Med Chem 55: 4824-36 (2012) | Universit£ degli Studi di Urbino Carlo Bo | 2D 3D TSV |
22512908 | 6 | Synthesis,s1,s2-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes. | Bioorg Med Chem 20: 3323-31 (2012) | National and Kapodistrian University of Athens | 2D 3D TSV |
22512907 | 49 | Discovery of potent and orally bioavailable 17ß-hydroxysteroid dehydrogenase type 3 inhibitors. | Bioorg Med Chem 20: 3242-54 (2012) | Sumitomo Chemical Co., Ltd | 2D 3D TSV |
22512727 | 20 | Synthesis and carbonic anhydrase inhibitory properties of novel coumarin derivatives. | J Enzyme Inhib Med Chem 28: 299-304 (2013) | Inonu University | 2D 3D TSV |
22512696 | 61 | Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease. | J Med Chem 55: 4479-88 (2012) | Institut de Qu£mica Avan£ada de Catalunya (IQAC-CSIC) | 2D 3D TSV |
22512543 | 72 | Tacrine-ferulic acid-nitric oxide (NO) donor trihybrids as potent, multifunctional acetyl- and butyrylcholinesterase inhibitors. | J Med Chem 55: 4309-21 (2012) | China Pharmaceutical University | 2D 3D TSV |
22512505 | 3 | Butyl pocket formation in the vitamin D receptor strongly affects the agonistic or antagonistic behavior of ligands. | J Med Chem 55: 4373-81 (2012) | Showa Pharmaceutical University | 2D 3D TSV |
22512468 | 13 | Selective thyromimetics using receptor and tissue selectivity approaches: prospects for dyslipidemia. | J Med Chem 55: 5649-75 (2012) | Zydus Research Centre | 2D 3D TSV |
22511346 | 1 | Interaction of lapatinib with cytochrome P450 3A5. | Drug Metab Dispos 40: 1414-22 (2012) | National University of Singapore | 2D 3D TSV |
22507964 | 17 | Crystal structures of AKR1C3 containing an N-(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer. | Bioorg Med Chem Lett 22: 3492-7 (2012) | Perelman School of Medicine University of Pennsylvania | 2D 3D TSV |
22507963 | 73 | Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor. | Bioorg Med Chem Lett 22: 3467-72 (2012) | Vanderbilt University Medical Center | 2D 3D TSV |
22507962 | 4 | The central valine concept provides an entry in a new class of non peptide inhibitors of the p53-MDM2 interaction. | Bioorg Med Chem Lett 22: 3498-502 (2012) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
22507960 | 26 | Synthesis and acrosin inhibitory activity of methyl 5-substituted-1H-benzo[d]imidazol-2-yl carbamate derivatives. | Bioorg Med Chem Lett 22: 3554-9 (2012) | Second Military Medical University | 2D 3D TSV |
22507206 | 21 | Discovery of Ipragliflozin (ASP1941): a novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus. | Bioorg Med Chem 20: 3263-79 (2012) | Astellas Pharma Inc | 2D 3D TSV |
22506594 | 20 | Selective inhibition of human type-5 17ß-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis. | J Nat Prod 75: 716-21 (2012) | Gifu Pharmaceutical University | 2D 3D TSV |
22506561 | 68 | Novel steroid inhibitors of glucose 6-phosphate dehydrogenase. | J Med Chem 55: 4431-45 (2012) | University of Manchester | 2D 3D TSV |
22506516 | 29 | Discovery of novel allosteric mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors possessing bidentate Ser212 interactions. | J Med Chem 55: 4594-604 (2012) | Argenta Discovery Ltd | 2D 3D TSV |
22506484 | 6 | Structural modifications that alter the P-glycoprotein efflux properties of compounds. | J Med Chem 55: 4877-95 (2012) | Envoy Therapeutics | 2D 3D TSV |
22506091 | 151 | Dual-Specificity Phosphatase CDC25A/B Inhibitor Identified from a Focused Library with Nonelectrophilic Core Structure. | ACS Med Chem Lett 3: 294-298 (2012) | TBA | 2D 3D TSV |
22503460 | 37 | Structure-activity relationships and key structural feature of pyridyloxybenzene-acylsulfonamides as new, potent, and selective peroxisome proliferator-activated receptor (PPAR)¿ Agonists. | Bioorg Med Chem 20: 3332-58 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22503453 | 59 | The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)-1,3,4-oxadiazol-2-yl)phenyl)benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhancement. | Bioorg Med Chem Lett 22: 3531-4 (2012) | GlaxoSmithKline | 2D 3D TSV |
22503362 | 35 | New description of protein-ligand interactions using a spherical self-organizing map. | Bioorg Med Chem 20: 5410-5 (2012) | Chugai Pharmaceutical Company | 2D 3D TSV |
22503250 | 128 | Synthesis and SAR studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off-target kinase selectivity. | Bioorg Med Chem Lett 22: 3544-9 (2012) | AMRI | 2D 3D TSV |
22503249 | 149 | Modulation of thermo-transient receptor potential (thermo-TRP) channels by thymol-based compounds. | Bioorg Med Chem Lett 22: 3535-9 (2012) | Sapienza University of Rome | 2D 3D TSV |
22503248 | 61 | Identification of a series of 1,3,4-oxadiazol-2-amines as potent alpha-7 agonists with efficacy in the novel object recognition model of cognition. | Bioorg Med Chem Lett 22: 3560-3 (2012) | GlaxoSmithKline | 2D 3D TSV |
22503246 | 32 | Long-acting peptidomimetics based DPP-IV inhibitors. | Bioorg Med Chem Lett 22: 3516-21 (2012) | Zydus Research Centre | 2D 3D TSV |
22503231 | 66 | Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine. | Eur J Med Chem 52: 251-62 (2012) | Laboratorio de Radicales Libres y Qu�mica Computacional (IQOG, CSIC) | 2D 3D TSV |
22500977 | 30 | De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validation. | J Med Chem 55: 4159-68 (2012) | Princeton University | 2D 3D TSV |
22500954 | 99 | Discovery of novel 1,2,4-thiadiazole derivatives as potent, orally active agonists of sphingosine 1-phosphate receptor subtype 1 (S1P(1)). | J Med Chem 55: 4286-96 (2012) | GlaxoSmithKline | 2D 3D TSV |
22497764 | 3 | Preclinical metabolism of LB42908, a novel farnesyl transferase inhibitor, and its effects on the cytochrome P450 isozyme activities. | Bioorg Med Chem Lett 22: 3067-71 (2012) | LG Life Sciences R & D Center | 2D 3D TSV |
22497763 | 120 | Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: part 2. | Bioorg Med Chem Lett 22: 3163-7 (2012) | Dr. Reddy's Laboratories Ltd | 2D 3D TSV |
22497762 | 35 | Triazoloamides as potent¿-secretase modulators with reduced hERG liability. | Bioorg Med Chem Lett 22: 3140-6 (2012) | Merck Research Laboratories | 2D 3D TSV |
22497761 | 59 | Design, synthesis and structure-activity-relationship of 1,5-tetrahydronaphthyridines as CETP inhibitors. | Bioorg Med Chem Lett 22: 3056-62 (2012) | Eli Lilly and Company | 2D 3D TSV |
22497760 | 144 | Discovery of new quinoline ether inhibitors with high affinity and selectivity for PDGFR tyrosine kinases. | Bioorg Med Chem Lett 22: 3050-5 (2012) | AstraZeneca | 2D 3D TSV |
22497444 | 55 | Discovery and characterization of an inhibitor of glucosylceramide synthase. | J Med Chem 55: 4322-35 (2012) | Exelixis Inc | 2D 3D TSV |
22496391 | 40 | Characterization of the in vitro and in vivo metabolism and disposition and cytochrome P450 inhibition/induction profile of saxagliptin in human. | Drug Metab Dispos 40: 1345-56 (2012) | Bristol-Myers Squibb Research | 2D 3D TSV |
22494842 | 18 | The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerization. | Bioorg Med Chem 20: 2845-9 (2012) | Merck Research Laboratories | 2D 3D TSV |
22494098 | 8 | Dabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2). | J Med Chem 55: 3934-44 (2012) | Caprotec Bioanalytics GmbH | 2D 3D TSV |
22490229 | 7 | Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1. | Drug Metab Dispos 40: 1328-35 (2012) | University of Michigan | 2D 3D TSV |
22490067 | 69 | Optimization of (2,3-dihydro-1-benzofuran-3-yl)acetic acids: discovery of a non-free fatty acid-like, highly bioavailable G protein-coupled receptor 40/free fatty acid receptor 1 agonist as a glucose-dependent insulinotropic agent. | J Med Chem 55: 3960-74 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22490048 | 59 | Synthesis, structure-activity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether-a-go-go-related gene (hERG) associated liabilities. | J Med Chem 55: 4336-51 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22490010 | 8 | A 20S combined with a 22R configuration markedly increases both in vivo and in vitro biological activity of 1a,25-dihydroxy-22-methyl-2-methylene-19-norvitamin D3. | J Med Chem 55: 4352-66 (2012) | University of Wisconsin-Madison | 2D 3D TSV |
22489952 | 38 | Synthesis and biological evaluation of 4-phenylquinazoline-2-carboxamides designed as a novel class of potent ligands of the translocator protein. | J Med Chem 55: 4506-10 (2012) | Universit£ di Salerno | 2D 3D TSV |
22489897 | 41 | Discovery of novel potent and highly selective glycogen synthase kinase-3ß (GSK3ß) inhibitors for Alzheimer's disease: design, synthesis, and characterization of pyrazines. | J Med Chem 55: 9107-19 (2012) | AstraZeneca | 2D 3D TSV |
22487182 | 102 | Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists. | Bioorg Med Chem Lett 22: 3157-62 (2012) | Dr. Reddy's Laboratories Ltd | 2D 3D TSV |
22487179 | 50 | Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P3-sparing S1P1 agonists. | Bioorg Med Chem Lett 22: 3083-8 (2012) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
22487176 | 109 | Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins. | Bioorg Med Chem Lett 22: 3063-6 (2012) | Universit£ degli Studi di Cagliari | 2D 3D TSV |
22487174 | 36 | Isothiazole and isoxazole fused pyrimidones as PDE7 inhibitors: SAR and pharmacokinetic evaluation. | Bioorg Med Chem Lett 22: 3223-8 (2012) | Glenmark Pharmaceuticals Limited | 2D 3D TSV |
22486710 | 3 | Head-to-head prenyl tranferases: anti-infective drug targets. | J Med Chem 55: 4367-72 (2012) | University of Illinois at Urbana-Champaign | 2D 3D TSV |
22486652 | 44 | Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening. | J Med Chem 55: 4297-308 (2012) | National Institute of Diabetes and Digestive and Kidney Diseases | 2D 3D TSV |
22483967 | 38 | Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold. | Eur J Med Chem 52: 284-94 (2012) | Universit£ di Pisa | 2D 3D TSV |
22483635 | 1 | Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents. | Eur J Med Chem 52: 275-83 (2012) | CNRS | 2D 3D TSV |
22483609 | 52 | Lead optimization of 4,4-biaryl piperidine amides as ?-secretase inhibitors. | Bioorg Med Chem Lett 22: 3203-7 (2012) | Merck Research Laboratories | 2D 3D TSV |
22483608 | 2 | Synthesis and evaluation of 2-[2-(phenylthiomethyl)-1H-benzo[d] imidazol-1-yl)acetohydrazide derivatives as antitumor agents. | Bioorg Med Chem Lett 22: 3122-5 (2012) | Sichuan University | 2D 3D TSV |
22483591 | 12 | Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits. | Bioorg Med Chem 20: 2930-9 (2012) | Piramal Healthcare Limited | 2D 3D TSV |
22483590 | 5 | Radiofluorinated histamine H3 receptor antagonist as a potential probe for in vivo PET imaging: radiosynthesis and pharmacological evaluation. | Bioorg Med Chem 20: 2889-96 (2012) | ETH Zurich (Swiss Federal Institute of Technology) | 2D 3D TSV |
22483586 | 10 | Moracin M from Morus alba L. is a natural phosphodiesterase-4 inhibitor. | Bioorg Med Chem Lett 22: 3261-4 (2012) | Sun Yat-sen University | 2D 3D TSV |
22483585 | 28 | Quinolinyl- and phenantridinyl-acetamides as bradykinin B1 receptor antagonists. | Bioorg Med Chem Lett 22: 3095-9 (2012) | Gedeon Richter Plc | 2D 3D TSV |
22483584 | 3 | Development of rationally designed DNA N6 adenine methyltransferase inhibitors. | Bioorg Med Chem Lett 22: 3079-82 (2012) | University of Southampton | 2D 3D TSV |
22483582 | 3 | Discovery of small molecule HIV-1 integrase dimerization inhibitors. | Bioorg Med Chem Lett 22: 3109-14 (2012) | University of Siena | 2D 3D TSV |
22483390 | 8 | An approach for differentiating isozymes. Construction of libraries containing short aromatic peptides as part of a method to design selective inhibitors against lipases. | Bioorg Med Chem Lett 22: 3147-51 (2012) | Seoul National University | 2D 3D TSV |
22483089 | 2 | Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes. | Eur J Med Chem 52: 70-81 (2012) | Sichuan University | 2D 3D TSV |
22482720 | 8 | Pentachlorophenol hydroxylase, a poorly functioning enzyme required for degradation of pentachlorophenol by Sphingobium chlorophenolicum. | Biochemistry 51: 3848-60 (2012) | University of Colorado Boulder | 2D 3D TSV |
22480851 | 6 | Discovery of novel 2-piperidinol-3-(arylsulfonyl)quinoxalines as phosphoinositide 3-kinasea (PI3Ka) inhibitors. | Bioorg Med Chem 20: 2837-44 (2012) | Zhejiang University | 2D 3D TSV |
22480850 | 4 | Synthesis, biological activity and docking study of imidazol-5-one as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. | Bioorg Med Chem 20: 3119-27 (2012) | YB Chavan College of Pharmacy | 2D 3D TSV |
22475926 | 39 | Synthesis and biological evaluation of isoxazolo[4,5-d]pyridazin-4-(5H)-one analogues as potent anti-inflammatory agents. | Bioorg Med Chem 20: 2912-22 (2012) | University of Hacettepe | 2D 3D TSV |
22475866 | 19 | Novel pyrrolopyrimidine analogues as potent dipeptidyl peptidase IV inhibitors based on pharmacokinetic property-driven optimization. | Eur J Med Chem 52: 205-12 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22475561 | 42 | Synthesis and inhibitory effect of piperine derivates on monoamine oxidase. | Bioorg Med Chem Lett 22: 3343-8 (2012) | General Hospital of PLA | 2D 3D TSV |
22475558 | 82 | Discovery of an orally-bioavailable CC Chemokine Receptor 2 antagonist derived from an acyclic diaminoalcohol backbone. | Bioorg Med Chem Lett 22: 3311-6 (2012) | Bristol-Myers Squibb Co. | 2D 3D TSV |
22475557 | 75 | Synthesis and structure-activity relationships of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones as novel series of potentß isoform selective phosphatidylinositol 3-kinase inhibitors. | Bioorg Med Chem Lett 22: 3198-202 (2012) | GlaxoSmithKline | 2D 3D TSV |
22475308 | 3 | Bis-spirolabdane diterpenoids from Leonotis nepetaefolia. | J Nat Prod 75: 728-34 (2012) | University of Mississippi | 2D 3D TSV |
22475216 | 13 | New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation. | J Med Chem 55: 3992-4002 (2012) | University of Coimbra | 2D 3D TSV |
22472693 | 17 | Discovery of a novel acetylcholinesterase inhibitor by structure-based virtual screening techniques. | Bioorg Med Chem Lett 22: 3181-7 (2012) | China Pharmaceutical University | 2D 3D TSV |
22472167 | 11 | Studies on gambogic acid (IV): Exploring structure-activity relationship with I¿B kinase-beta (IKKß). | Eur J Med Chem 51: 110-23 (2012) | China Pharmaceutical University | 2D 3D TSV |
22472046 | 40 | Inhibition of cholinesterase activity and amyloid aggregation by berberine-phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids. | Bioorg Med Chem 20: 3038-48 (2012) | Sun Yat-sen University | 2D 3D TSV |
22469703 | 32 | Isoquinoline derivatives as potent CRTH2 receptor antagonists: synthesis and SAR. | Bioorg Med Chem Lett 22: 3305-10 (2012) | Taisho Pharmaceutical Co., Ltd | 2D 3D TSV |
22469702 | 36 | Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis. | Bioorg Med Chem Lett 22: 3349-53 (2012) | MRC Technology | 2D 3D TSV |
22468999 | 20 | Discovery and optimization of a novel spiropyrrolidine inhibitor ofß-secretase (BACE1) through fragment-based drug design. | J Med Chem 55: 9069-88 (2012) | Pfizer Inc | 2D 3D TSV |
22468970 | 2 | Development of a novel class of glucose transporter inhibitors. | J Med Chem 55: 3827-36 (2012) | The Ohio State University | 2D 3D TSV |
22468936 | 49 | Discovery of a novel alpha-7 nicotinic acetylcholine receptor agonist series and characterization of the potent, selective, and orally efficacious agonist 5-(4-acetyl[1,4]diazepan-1-yl)pentanoic acid [5-(4-methoxyphenyl)-1H-pyrazol-3-yl] amide (SEN15924, WAY-361789). | J Med Chem 55: 4806-23 (2012) | Siena Biotech SpA | 2D 3D TSV |
22468757 | 171 | Medicinal chemistry of A3 adenosine receptor modulators: pharmacological activities and therapeutic implications. | J Med Chem 55: 5676-703 (2012) | Universit£ di Ferrara | 2D 3D TSV |
22468751 | 2 | Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor. | J Enzyme Inhib Med Chem 28: 661-70 (2013) | Federal University of São Paulo | 2D 3D TSV |
22468750 | 3 | Tyrosinase inhibitory activities of the compounds isolated from Neolitsea aciculata (Blume) Koidz. | J Enzyme Inhib Med Chem 28: 685-9 (2013) | Jeju National University | 2D 3D TSV |
22468746 | 10 | (3,4-Dihydroxyphenyl)(2,3,4-trihydroxyphenyl)methanone and its derivatives as carbonic anhydrase isoenzymes inhibitors. | J Enzyme Inhib Med Chem 28: 402-6 (2013) | Atatürk University | 2D 3D TSV |
22468684 | 76 | Design and synthesis of potent, orally efficacious hydroxyethylamine derivedß-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors. | J Med Chem 55: 9025-44 (2012) | Amgen Inc | 2D 3D TSV |
22468639 | 26 | Design and preparation of a potent series of hydroxyethylamine containingß-secretase inhibitors that demonstrate robust reduction of centralß-amyloid. | J Med Chem 55: 9009-24 (2012) | Amgen Inc | 2D 3D TSV |
22465637 | 48 | 4-(1-Phenyl-1H-pyrazol-4-yl)quinolines as novel, selective and brain penetrant metabotropic glutamate receptor 4 positive allosteric modulators. | Bioorg Med Chem Lett 22: 3235-9 (2012) | Lundbeck Research USA, Inc. | 2D 3D TSV |
22465636 | 125 | Steroidal C-21 heteroaryl thioethers. Part 3: pregn-4-eno-[3,2-c]pyrazole fused A ring modified steroids as selective glucocorticoid receptor modulators (dissociated steroids). | Bioorg Med Chem Lett 22: 3291-5 (2012) | Merck Research Laboratories | 2D 3D TSV |
22465635 | 95 | Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families. | Bioorg Med Chem Lett 22: 3208-12 (2012) | Abbott Laboratories | 2D 3D TSV |
22465091 | 28 | A novel series of l-2-benzyloxycarbonylamino-8-(2-pyridyl)-disulfidyloctanoic acid derivatives as histone deacetylase inhibitors: design, synthesis and molecular modeling study. | Eur J Med Chem 52: 111-22 (2012) | Dalian University of Technology | 2D 3D TSV |
22464687 | 44 | Discovery of novel tricyclic compounds as squalene synthase inhibitors. | Bioorg Med Chem 20: 3072-93 (2012) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
22464684 | 85 | Semisynthetic neoclerodanes as kappa opioid receptor probes. | Bioorg Med Chem 20: 3100-10 (2012) | The University of Kansas | 2D 3D TSV |
22464458 | 8 | Novel acridinedione derivatives: design, synthesis, SIRT1 enzyme and tumor cell growth inhibition studies. | Bioorg Med Chem Lett 22: 3256-60 (2012) | Birla Institute of Technology | 2D 3D TSV |
22464456 | 27 | X-ray crystallographic structure-based design of selective thienopyrazole inhibitors for interleukin-2-inducible tyrosine kinase. | Bioorg Med Chem Lett 22: 3296-300 (2012) | Sanofi US | 2D 3D TSV |
22464134 | 1 | Conformationally restricted novel pyrazole derivatives: synthesis of 1,8-disubstituted 5,5-dimethyl-4,5-dihydro-1H-benzo[g]indazoles as a new class of PDE4 inhibitors. | Bioorg Med Chem Lett 22: 3248-55 (2012) | CiVentiChem (India) Private Limited | 2D 3D TSV |
22464133 | 5 | Penicacids A-C, three new mycophenolic acid derivatives and immunosuppressive activities from the marine-derived fungus Penicillium sp. SOF07. | Bioorg Med Chem Lett 22: 3332-5 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22464132 | 8 | Analogs of the RSK inhibitor SL0101: optimization of in vitro biological stability. | Bioorg Med Chem Lett 22: 3244-7 (2012) | University of Virginia | 2D 3D TSV |
22464131 | 1 | Design, synthesis, and biological activity of novel 1,4-disubstituted piperidine/piperazine derivatives as CCR5 antagonist-based HIV-1 entry inhibitors. | Bioorg Med Chem Lett 22: 3284-6 (2012) | Beijing Institute of Biotechnology | 2D 3D TSV |
22464130 | 27 | Fused bicycles as arylketone bioisosteres leading to potent, orally active thiadiazole H3 antagonists. | Bioorg Med Chem Lett 22: 3354-7 (2012) | Merck Research Laboratories | 2D 3D TSV |
22460951 | 7 | Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. | Nature 485: 62-68 (2012) | The Scripps Research Institute | 2D 3D TSV |
22460033 | 85 | Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells. | Bioorg Med Chem Lett 22: 3327-31 (2012) | Cylene Pharmaceuticals | 2D 3D TSV |
22460029 | 21 | Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists. | Bioorg Med Chem Lett 22: 3366-9 (2012) | GlaxoSmithKline | 2D 3D TSV |
22460026 | 39 | Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology. Part 2: Propellane derivatives with an amide side chain. | Bioorg Med Chem Lett 22: 2775-9 (2012) | Kitasato University | 2D 3D TSV |
22460025 | 12 | The chemical synthesis of metabolically stabilized 2-OMe-LPA analogues and preliminary studies of their inhibitory activity toward autotaxin. | Bioorg Med Chem Lett 22: 2698-700 (2012) | Technical University of Lodz | 2D 3D TSV |
22459213 | 29 | Design, synthesis, and pharmacological evaluation of benzamide derivatives as glucokinase activators. | Bioorg Med Chem 20: 2982-91 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22459212 | 12 | Synthesis and biological evaluation of novel human Pin1 inhibitors with benzophenone skeleton. | Bioorg Med Chem 20: 2992-9 (2012) | Chinese Academy of Medical Sciences & Peking Union Medical College | 2D 3D TSV |
22458611 | 16 | Synthesis and biological activity of potent HIV-1 protease inhibitors based on Phe-Pro dihydroxyethylene isosteres. | J Med Chem 55: 3900-10 (2012) | University of Trieste | 2D 3D TSV |
22458568 | 37 | Structure-guided design, synthesis, and evaluation of guanine-derived inhibitors of the eIF4E mRNA-cap interaction. | J Med Chem 55: 3837-51 (2012) | Amgen Inc | 2D 3D TSV |
22458531 | 58 | Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis. | J Med Chem 55: 3804-13 (2012) | Progen Pharmaceuticals Limited | 2D 3D TSV |
22455789 | 32 | Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors. | Bioorg Med Chem 20: 2506-19 (2012) | University of Bath | 2D 3D TSV |
22455444 | 93 | Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52. | J Med Chem 55: 4114-22 (2012) | Max Planck Institute of Psychiatry | 2D 3D TSV |
22455398 | 122 | Exploration of pipecolate sulfonamides as binders of the FK506-binding proteins 51 and 52. | J Med Chem 55: 4123-31 (2012) | Max Planck Institute of Psychiatry | 2D 3D TSV |
22455383 | 16 | Computational design and discovery of"minimally structured" hERG blockers. | J Med Chem 55: 4010-4 (2012) | University of Bologna | 2D 3D TSV |
22455312 | 43 | Synthesis, biological evaluation, and structure-activity relationships of a novel class of apurinic/apyrimidinic endonuclease 1 inhibitors. | J Med Chem 55: 3101-12 (2012) | National Center for Advancing Translational Sciences | 2D 3D TSV |
22452568 | 2 | Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerases. | J Med Chem 55: 3814-26 (2012) | University of Michigan | 2D 3D TSV |
22452518 | 22 | Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivo. | J Med Chem 55: 3852-66 (2012) | Sichuan University | 2D 3D TSV |
22452412 | 31 | Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein. | J Med Chem 55: 3261-73 (2012) | University of Vienna | 2D 3D TSV |
22450133 | 64 | Substituted phenoxypropyl-(R)-2-methylpyrrolidine aminomethyl ketones as histamine-3 receptor inverse agonists. | Bioorg Med Chem Lett 22: 2807-10 (2012) | Cephalon Inc | 2D 3D TSV |
22450131 | 8 | A new pancreatic lipase inhibitor from Broussonetia kanzinoki. | Bioorg Med Chem Lett 22: 2760-3 (2012) | Chungbuk National University | 2D 3D TSV |
22450130 | 87 | Design and synthesis of potent, isoxazole-containing renin inhibitors. | Bioorg Med Chem Lett 22: 2670-4 (2012) | Merck Frosst Centre for Therapeutic Research | 2D 3D TSV |
22450128 | 38 | Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors. | Bioorg Med Chem Lett 22: 2837-42 (2012) | Korea Research Institute of Chemical Technology | 2D 3D TSV |
22450127 | 64 | Pyrazolopyrimidines as dual Akt/p70S6K inhibitors. | Bioorg Med Chem Lett 22: 2693-7 (2012) | Exelixis Inc | 2D 3D TSV |
22449023 | 9 | Structure-activity relationship of nonacidic quinazolinone inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1). | J Med Chem 55: 3792-803 (2012) | Johann Wolfgang Goethe University | 2D 3D TSV |
22449016 | 6 | Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity. | J Med Chem 55: 3193-200 (2012) | BMSSI UMR 5086 CNRS/Universit£ Lyon 1 | 2D 3D TSV |
22448988 | 77 | Design of Bcl-2 and Bcl-xL inhibitors with subnanomolar binding affinities based upon a new scaffold. | J Med Chem 55: 4664-82 (2012) | University of Michigan | 2D 3D TSV |
22448770 | 1 | Discovery and optimization of 2,4-diaminoquinazoline derivatives as a new class of potent dengue virus inhibitors. | J Med Chem 55: 3135-43 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22446520 | 1 | Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liver. | Drug Metab Dispos 40: 1080-4 (2012) | Kanazawa University | 2D 3D TSV |
22445674 | 43 | Cholinestrase inhibitory effects of geranylated flavonoids from Paulownia tomentosa fruits. | Bioorg Med Chem 20: 2595-602 (2012) | Graduate School of Gyeongsang National University | 2D 3D TSV |
22445286 | 19 | Discovery and evaluation of spirocyclic derivatives as antagonists of the neuropeptide Y5 receptor. | Bioorg Med Chem Lett 22: 2738-43 (2012) | Pfizer Inc | 2D 3D TSV |
22445285 | 26 | Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton and their pharmacologies. | Bioorg Med Chem Lett 22: 2689-92 (2012) | Kitasato University | 2D 3D TSV |
22444876 | 34 | Design, synthesis and evaluation of isaindigotone derivatives as dual inhibitors for acetylcholinesterase and amyloid beta aggregation. | Bioorg Med Chem 20: 2527-34 (2012) | Sun Yat-sen University | 2D 3D TSV |
22444875 | 25 | Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives. | Bioorg Med Chem 20: 2603-13 (2012) | Northern Kentucky University | 2D 3D TSV |
22444685 | 45 | A new class of prolylcarboxypeptidase inhibitors, part 2: the aminocyclopentanes. | Bioorg Med Chem Lett 22: 2818-22 (2012) | Merck Research Laboratories | 2D 3D TSV |
22444684 | 9 | Bromophenols as inhibitors of protein tyrosine phosphatase 1B with antidiabetic properties. | Bioorg Med Chem Lett 22: 2827-32 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22444683 | 68 | A new class of prolylcarboxypeptidase inhibitors, part 1: discovery and evaluation. | Bioorg Med Chem Lett 22: 2811-7 (2012) | Merck Research Laboratories | 2D 3D TSV |
22444679 | 2 | Radioiodinated sunitinib as a potential radiotracer for imaging angiogenesis-radiosynthesis and first radiopharmacological evaluation of 5-[125I]Iodo-sunitinib. | Bioorg Med Chem Lett 22: 2850-5 (2012) | Helmholtz-Zentrum Dresden-Rossendorf eV | 2D 3D TSV |
22444677 | 45 | Discovery of S-777469: an orally available CB2 agonist as an antipruritic agent. | Bioorg Med Chem Lett 22: 2803-6 (2012) | Shionogi & Co., Ltd | 2D 3D TSV |
22444026 | 103 | Novel sulfonylurea derivatives as H3 receptor antagonists. Preliminary SAR studies. | Eur J Med Chem 52: 1-13 (2012) | Universidad de Navarra | 2D 3D TSV |
22443141 | 115 | Synthesis, structure-activity relationship studies, and X-ray crystallographic analysis of arylsulfonamides as potent carbonic anhydrase inhibitors. | J Med Chem 55: 3891-9 (2012) | Universit£ di Messina | 2D 3D TSV |
22443115 | 4 | In vitro and in vivo trypanosomicidal activity of pyrazole-containing macrocyclic and macrobicyclic polyamines: their action on acute and chronic phases of Chagas disease. | J Med Chem 55: 4231-43 (2012) | Universidad de Granada | 2D 3D TSV |
22442751 | 45 | Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A. | Medchemcomm 2: 1217-1222 (2011) | University of Kansas | 2D 3D TSV |
22440859 | 176 | Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases. | Eur J Med Chem 51: 259-70 (2012) | Vilnius University | 2D 3D TSV |
22440625 | 44 | Synthesis and evaluation of piperidine urea derivatives as efficacious 11ß-hydroxysteroid dehydrogenase type 1 inhibitors in diabetic ob/ob mice. | Bioorg Med Chem Lett 22: 2748-52 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22439974 | 79 | Design and synthesis of pyrrolo[3,2-d]pyrimidine human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors: exploration of novel back-pocket binders. | J Med Chem 55: 3975-91 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22439881 | 157 | Synthesis, binding affinity, and functional in vitro activity of 3-benzylaminomorphinan and 3-benzylaminomorphine ligands at opioid receptors. | J Med Chem 55: 3878-90 (2012) | Harvard Medical School | 2D 3D TSV |
22439863 | 21 | Synthesis and biological evaluation of 1-arylsulfonyl-5-(N-hydroxyacrylamide)indoles as potent histone deacetylase inhibitors with antitumor activity in vivo. | J Med Chem 55: 3777-91 (2012) | Taipei Medical University | 2D 3D TSV |
22439843 | 32 | Discovery of Plasmodium vivax N-myristoyltransferase inhibitors: screening, synthesis, and structural characterization of their binding mode. | J Med Chem 55: 3578-82 (2012) | Imperial College | 2D 3D TSV |
22437830 | 8 | Selective inhibition of biotin protein ligase from Staphylococcus aureus. | J Biol Chem 287: 17823-32 (2012) | University of Adelaide | 2D 3D TSV |
22437117 | 47 | Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation. | Bioorg Med Chem Lett 22: 2730-3 (2012) | GlaxoSmithKline | 2D 3D TSV |
22437115 | 66 | Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A). | Bioorg Med Chem Lett 22: 2968-72 (2012) | GlaxoSmithKline | 2D 3D TSV |
22437111 | 34 | CB 1/2 dual agonists with 3-carbamoyl 2-pyridone derivatives as antipruritics: reduction of CNS side effects by introducing polar functional groups. | Bioorg Med Chem Lett 22: 2894-7 (2012) | Shionogi & Co., Ltd | 2D 3D TSV |
22437109 | 31 | 2-anilino-4-aryl-8H-purine derivatives as inhibitors of PDK1. | Bioorg Med Chem Lett 22: 2880-4 (2012) | S*BIO Pte Ltd | 2D 3D TSV |
22436396 | 30 | Progresses in the pursuit of aldose reductase inhibitors: the structure-based lead optimization step. | Eur J Med Chem 51: 216-26 (2012) | Universit£ di Salerno | 2D 3D TSV |
22436387 | 4 | Synthesis and evaluation of [¹8F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B). | Bioorg Med Chem 20: 3065-71 (2012) | Karolinska Institutet | 2D 3D TSV |
22435740 | 43 | (1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humans. | J Med Chem 55: 3644-66 (2012) | Arena Pharmaceuticals | 2D 3D TSV |
22435669 | 16 | Discovery and extensive in vitro evaluations of NK-HDAC-1: a chiral histone deacetylase inhibitor as a promising lead. | J Med Chem 55: 3066-75 (2012) | Nankai University | 2D 3D TSV |
22435599 | 4 | Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials. | J Med Chem 55: 4205-19 (2012) | St. Jude Children's Research Hospital | 2D 3D TSV |
22432713 | 64 | Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists. | J Med Chem 55: 3521-34 (2012) | Monash University | 2D 3D TSV |
22432682 | 2 | Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors. | J Med Chem 55: 3568-72 (2012) | Universit£ degli Studi di Perugia | 2D 3D TSV |
22429471 | 64 | Calcitonin gene-related peptide (CGRP) receptor antagonists: novel aspartates and succinates. | Bioorg Med Chem Lett 22: 2912-6 (2012) | Bristol-Myers Squibb Research & Development | 2D 3D TSV |
22429470 | 75 | Calcitonin gene-related peptide (CGRP) receptor antagonists: pyridine as a replacement for a core amide group. | Bioorg Med Chem Lett 22: 2917-21 (2012) | Bristol-Myers Squibb Research & Development | 2D 3D TSV |
22429469 | 2 | Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active¿-secretase modulators. | Bioorg Med Chem Lett 22: 2906-11 (2012) | Pfizer Inc | 2D 3D TSV |
22429468 | 60 | Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonists. | Bioorg Med Chem Lett 22: 2794-7 (2012) | GlaxoSmithKline | 2D 3D TSV |
22429467 | 2 | Medicinal chemistry approaches to avoid aldehyde oxidase metabolism. | Bioorg Med Chem Lett 22: 2856-60 (2012) | Pfizer Inc | 2D 3D TSV |
22428944 | 61 | Discovery of phenylpropanoic acid derivatives containing polar functionalities as potent and orally bioavailable G protein-coupled receptor 40 agonists for the treatment of type 2 diabetes. | J Med Chem 55: 3756-76 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22425563 | 16 | Prospective acetylcholinesterase inhibitory activity of indole and its analogs. | Bioorg Med Chem Lett 22: 2885-8 (2012) | Naresuan University | 2D 3D TSV |
22425453 | 43 | Pyrazine-based Syk kinase inhibitors. | Bioorg Med Chem Lett 22: 2784-8 (2012) | Rhône-Poulenc Rorer | 2D 3D TSV |
22425346 | 28 | Synthesis and evaluation of C-11, F-18 and I-125 small molecule radioligands for detecting oxytocin receptors. | Bioorg Med Chem 20: 2721-38 (2012) | Emory University | 2D 3D TSV |
22425031 | 1 | Structure-activity relationship of selected polyphenol derivatives as inhibitors of Bax/Bcl-xL interaction. | Eur J Med Chem 51: 286-93 (2012) | Universit£ de Rennes1 | 2D 3D TSV |
22424979 | 10 | Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: potent allosteric inhibitors of the hepatitis C virus NS5B polymerase. | Bioorg Med Chem Lett 22: 2866-71 (2012) | Bristol-Myers Squibb | 2D 3D TSV |
22424978 | 23 | Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors. | Bioorg Med Chem Lett 22: 2843-9 (2012) | Advinus Therapeutics Ltd | 2D 3D TSV |
22424975 | 4 | Sesquiterpene lactones from Tithonia diversifolia act as peroxisome proliferator-activated receptor agonists. | Bioorg Med Chem Lett 22: 2954-8 (2012) | National Kaohsiung Normal University | 2D 3D TSV |
22424974 | 35 | Discovery of new piperidine amide triazolobenzodiazepinones as intestinal-selective CCK1 receptor agonists. | Bioorg Med Chem Lett 22: 2943-7 (2012) | Pfizer Inc | 2D 3D TSV |
22424612 | 29 | Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists. | Eur J Med Chem 51: 184-92 (2012) | VU University Amsterdam | 2D 3D TSV |
22424300 | 3 | Polyhydroxylated macrolides from Seimatosporium discosioides and their effects on the activation of peroxisome proliferator-activated receptor gamma. | J Nat Prod 75: 784-8 (2012) | Korea University | 2D 3D TSV |
22424239 | 42 | Molecular cloning, characterization, and inhibition studies of aß-carbonic anhydrase from Malassezia globosa, a potential antidandruff target. | J Med Chem 55: 3513-20 (2012) | Union Life Sciences Ltd. | 2D 3D TSV |
22421276 | 1 | Tyrosine modified analogues of thea4ß7 integrin inhibitor biotin-R8ERY prepared via Click Chemistry: synthesis and biological evaluation. | Bioorg Med Chem 20: 2638-44 (2012) | University of Auckland | 2D 3D TSV |
22421020 | 9 | Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain. | Bioorg Med Chem Lett 22: 2932-7 (2012) | Merck Research Laboratories | 2D 3D TSV |
22421019 | 62 | Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agent. | Bioorg Med Chem Lett 22: 2898-901 (2012) | Shionogi & Co., Ltd | 2D 3D TSV |
22421018 | 34 | The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists. | Bioorg Med Chem Lett 22: 2922-6 (2012) | Janssen Pharmaceutica NV | 2D 3D TSV |
22420884 | 21 | Application of the bicyclo[1.1.1]pentane motif as a nonclassical phenyl ring bioisostere in the design of a potent and orally active ?-secretase inhibitor. | J Med Chem 55: 3414-24 (2012) | Pfizer Inc. | 2D 3D TSV |
22420844 | 86 | First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain. | J Med Chem 55: 3488-501 (2012) | NeurAxon Inc | 2D 3D TSV |
22420827 | 14 | Multifunctional mercapto-tacrine derivatives for treatment of age-related neurodegenerative diseases. | J Med Chem 55: 3588-92 (2012) | Huazhong University of Science and Technology | 2D 3D TSV |
22420626 | 4 | Design of ?-amyloid aggregation inhibitors from a predicted structural motif. | J Med Chem 55: 3002-10 (2012) | Stanford University | 2D 3D TSV |
22418280 | 5 | Development of clickable active site-directed photoaffinity probes for ?-secretase. | Bioorg Med Chem Lett 22: 2997-3000 (2012) | Memorial Sloan-Kettering Cancer Center | 2D 3D TSV |
22417091 | 73 | Design and synthesis of novel lactate dehydrogenase a inhibitors by fragment-based lead generation. | J Med Chem 55: 3285-306 (2012) | AstraZeneca | 2D 3D TSV |
22414679 | 12 | Synthesis and structure elucidation of novel fused 1,2,4-triazine derivatives as potent inhibitors targeting CYP1A1 activity. | Bioorg Med Chem 20: 2624-37 (2012) | King Abdulaziz University | 2D 3D TSV |
22414613 | 6 | Synthesis and biological evaluation of novel small non-peptidic HIV-1 PIs: the benzothiophene ring as an effective moiety. | Bioorg Med Chem Lett 22: 2948-50 (2012) | Universit£ degli Studi della Basilicata | 2D 3D TSV |
22413863 | 21 | Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152). | J Med Chem 55: 4101-13 (2012) | Genentech | 2D 3D TSV |
22413845 | 17 | A new strategy for detection and development of tractable telomerase inhibitors. | J Med Chem 55: 3678-86 (2012) | University of California | 2D 3D TSV |
22410247 | 2 | Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases. | Bioorg Med Chem 20: 2739-46 (2012) | Hokkaido University | 2D 3D TSV |
22410083 | 17 | Consequences of linker length alteration of thea7 nicotinic acetylcholine receptor (nAChR) agonist, SEN12333. | Bioorg Med Chem Lett 22: 2380-4 (2012) | The University of Sydney | 2D 3D TSV |
22409666 | 4 | Modern phenotypic drug discovery is a viable, neoclassic pharma strategy. | J Med Chem 55: 4527-38 (2012) | Eli Lilly and Company | 2D 3D TSV |
22409629 | 15 | Discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone as a potent and selective I(Kur) inhibitor. | J Med Chem 55: 3036-48 (2012) | Bristol-Myers Squibb Co. | 2D 3D TSV |
22409598 | 28 | Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks. | J Med Chem 55: 4896-933 (2012) | Pfizer Inc | 2D 3D TSV |
22408719 | 21 | The Synthesis and Evaluation of Dihydroquinazolin-4-ones and Quinazolin-4-ones as Thyroid Stimulating Hormone Receptor Agonists. | Medchemcomm 2: 1016-1020 (2011) | NIH Chemical Genomics Center | 2D 3D TSV |
22408714 | 23 | Discovery of 1,3-Diaminobenzenes as Selective Inhibitors of Platelet Activation at the PAR1 Receptor. | ACS Med Chem Lett 3: 232-237 (2012) | TBA | 2D 3D TSV |
22406152 | 6 | Structure aided design of chimeric antibiotics. | Bioorg Med Chem Lett 22: 2428-33 (2012) | University of Queensland | 2D 3D TSV |
22406151 | 21 | Design and synthesis of orally available MEK inhibitors with potent in vivo antitumor efficacy. | Bioorg Med Chem Lett 22: 2411-4 (2012) | Takeda California Inc | 2D 3D TSV |
22406116 | 4 | Discovery of loperamide as an antagonist of angiopoietin1 and angiopoietin2 by virtual screening. | Bioorg Med Chem Lett 22: 2388-92 (2012) | Zhejiang Gongshang University | 2D 3D TSV |
22406115 | 18 | Discovery of a new binding mode for a series of liver X receptor agonists. | Bioorg Med Chem Lett 22: 2407-10 (2012) | Amgen Inc | 2D 3D TSV |
22405919 | 3 | Synthesis and biological evaluation of benzoisothiazole derivatives possessing N,N-dimethylformimidamide group as 5-HT6 receptor antagonists. | Bioorg Med Chem 20: 2707-12 (2012) | Ewha Womans University | 2D 3D TSV |
22405833 | 52 | Thiadiazoles as new inhibitors of diacylglycerol acyltransferase type 1. | Bioorg Med Chem Lett 22: 2497-502 (2012) | Sanofi-Aventis R&D | 2D 3D TSV |
22405832 | 24 | Discovery of nor-seco himbacine analogs as thrombin receptor antagonists. | Bioorg Med Chem Lett 22: 2544-9 (2012) | Pfizer Inc | 2D 3D TSV |
22405649 | 5 | Growth inhibition of Mycobacterium smegmatis by prodrugs of deoxyxylulose phosphate reducto-isomerase inhibitors, promising anti-mycobacterial agents. | Eur J Med Chem 51: 277-85 (2012) | University of Strasburg | 2D 3D TSV |
22405648 | 7 | Design and synthesis of novel 5-phenyl-N-piperidine ethanone containing 4,5-dihydropyrazole derivatives as potential antitumor agents. | Eur J Med Chem 51: 294-9 (2012) | Anhui Medical University | 2D 3D TSV |
22405291 | 11 | Synthesis and evaluation of CS-2100, a potent, orally active and S1P(3)- sparing S1P(1) agonist. | Eur J Med Chem 51: 92-8 (2012) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
22405288 | 5 | Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors. | Eur J Med Chem 51: 60-6 (2012) | Shandong University | 2D 3D TSV |
22405286 | 10 | Recent advances in the synthesis of raloxifene: a selective estrogen receptor modulator. | Eur J Med Chem 51: 17-34 (2012) | Torrey Pines Institute for Molecular Studies | 2D 3D TSV |
22404847 | 24 | Synthesis and Biological Evaluation of N-aryl-4-aryl-1,3-Thiazole-2-Amine Derivatives as Direct 5-Lipoxygenase Inhibitors. | Chem Biol Drug Des 80: 89-98 (2012) | Korea Research Institute of Chemical Technology | 2D 3D TSV |
22404396 | 16 | Synthesis and biological evaluation of derivatives of 2-{2-fluoro-4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid: nonsteroidal anti-inflammatory drugs with low gastric ulcerogenic activity. | J Med Chem 55: 5143-50 (2012) | Keio University | 2D 3D TSV |
22404346 | 52 | Design of potent and selective hybrid inhibitors of the mitotic kinase Nek2: structure-activity relationship, structural biology, and cellular activity. | J Med Chem 55: 3228-41 (2012) | The Institute of Cancer Research | 2D 3D TSV |
22404301 | 44 | Synthesis and discovery of N-carbonylpyrrolidine- or N-sulfonylpyrrolidine-containing uracil derivatives as potent human deoxyuridine triphosphatase inhibitors. | J Med Chem 55: 2960-9 (2012) | Taiho Pharmaceutical Co., Ltd | 2D 3D TSV |
22401864 | 61 | Discovery of oxazole-based PDE4 inhibitors with picomolar potency. | Bioorg Med Chem Lett 22: 2594-7 (2012) | Merck Research Laboratories | 2D 3D TSV |
22401863 | 30 | Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC. | Bioorg Med Chem Lett 22: 2536-43 (2012) | Pfizer Inc. | 2D 3D TSV |
22401672 | 6 | Potent antiviral HIV-1 protease inhibitor GRL-02031 adapts to the structures of drug resistant mutants with its P1'-pyrrolidinone ring. | J Med Chem 55: 3387-97 (2012) | Georgia State University | 2D 3D TSV |
22400713 | 39 | Structure-activity relationships and optimization of 3,5-dichloropyridine derivatives as novel P2X(7) receptor antagonists. | J Med Chem 55: 3687-98 (2012) | Gwangju Institute of Science and Technology (GIST) | 2D 3D TSV |
22398259 | 87 | Synthesis and structure-activity relationship studies of 3-biaryl-8-oxabicyclo[3.2.1]octane-2-carboxylic acid methyl esters. | Bioorg Med Chem 20: 2762-72 (2012) | TUBITAK MAM Chemistry Institute P K 21 Gebze | 2D 3D TSV |
22397393 | 5 | Synthesis of a-oxycarbanilinophosphonates and their anticholinesterase activities: the most potent derivative is bound to the peripheral site of acetylcholinesterase. | J Enzyme Inhib Med Chem 28: 576-82 (2013) | Institute for Advanced Studies in Basic Sciences (IASBS) | 2D 3D TSV |
22394120 | 7 | The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues. | J Med Chem 55: 3027-35 (2012) | Universit£ di Chieti-Pescara G. d'Annunzio | 2D 3D TSV |
22394077 | 19 | Bruton's tyrosine kinase inhibitors: approaches to potent and selective inhibition, preclinical and clinical evaluation for inflammatory diseases and B cell malignancies. | J Med Chem 55: 4539-50 (2012) | Hoffmann-La Roche Inc | 2D 3D TSV |
22391033 | 69 | Design, synthesis, and biological evaluation of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole derivatives as novel androgen receptor antagonists. | Bioorg Med Chem 20: 2338-52 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22390835 | 80 | Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor. | Bioorg Med Chem Lett 22: 2444-9 (2012) | Merck Research Laboratories | 2D 3D TSV |
22390627 | 1 | Tyrosyl-DNA phosphodiesterase 1 inhibitor from an anamorphic fungus. | J Nat Prod 75: 764-7 (2012) | Biomedicinal Information Research Center (BIRC) | 2D 3D TSV |
22390538 | 2 | 3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential. | J Med Chem 55: 3479-87 (2012) | University of Cape Town | 2D 3D TSV |
22390415 | 28 | Design and synthesis of active site inhibitors of the human farnesyl pyrophosphate synthase: apoptosis and inhibition of ERK phosphorylation in multiple myeloma cells. | J Med Chem 55: 3201-15 (2012) | McGill University | 2D 3D TSV |
22386984 | 67 | In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors. | Bioorg Med Chem 20: 2323-37 (2012) | Colosseum Combinatorial Chemistry Centre for Technology (C4T SCarl) | 2D 3D TSV |
22386983 | 25 | Synthesis and evaluation of fluorobenzoylated di- and tripeptides as inhibitors of cyclooxygenase-2 (COX-2). | Bioorg Med Chem 20: 2221-6 (2012) | University of Alberta | 2D 3D TSV |
22386981 | 14 | Synthesis and P2Y2 receptor agonist activities of uridine 5'-phosphonate analogues. | Bioorg Med Chem 20: 2304-15 (2012) | Ghent University | 2D 3D TSV |
22386980 | 7 | Mutation of active site residues Asn67 to Ile, Gln92 to Val and Leu204 to Ser in human carbonic anhydrase II: influences on the catalytic activity and affinity for inhibitors. | Bioorg Med Chem 20: 2208-13 (2012) | Balikesir University | 2D 3D TSV |
22386979 | 104 | Discovery of novel prostaglandin analogs as potent and selective EP2/EP4 dual agonists. | Bioorg Med Chem 20: 2235-51 (2012) | Minase Research Institute | 2D 3D TSV |
22386978 | 2 | C-C bond formation at C-2 of a quinoline ring: synthesis of 2-(1H-indol-3-yl)quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors. | Bioorg Med Chem 20: 2199-207 (2012) | University of Hyderabad Campus | 2D 3D TSV |
22386665 | 23 | 3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity. | Bioorg Med Chem Lett 22: 2514-7 (2012) | Eli Lilly and Company | 2D 3D TSV |
22386564 | 43 | Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol. | Bioorg Med Chem 20: 2427-34 (2012) | Purdue University | 2D 3D TSV |
22386529 | 38 | From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151. | Bioorg Med Chem Lett 22: 2963-7 (2012) | GlaxoSmithKline | 2D 3D TSV |
22386527 | 23 | Discovery of novel aminoquinazolin-7-yl 6,7-dihydro-indol-4-ones as potent, selective inhibitors of heat shock protein 90. | Bioorg Med Chem Lett 22: 2550-4 (2012) | Serenex Inc. | 2D 3D TSV |
22386368 | 33 | Synthesis and cytotoxicity evaluation of biaryl-based chalcones and their potential in TNFa-induced nuclear factor-¿B activation inhibition. | Eur J Med Chem 50: 393-404 (2012) | Sun Yat-sen University | 2D 3D TSV |
22386260 | 9 | Use of copper(I) catalyzed azide alkyne cycloaddition (CuAAC) for the preparation of conjugated pyrrolo[2,3-a]carbazole Pim kinase inhibitors. | Eur J Med Chem 50: 304-10 (2012) | Clermont Universit£ | 2D 3D TSV |
22386244 | 4 | Human kallikrein 6 inhibitors with a para-amidobenzylanmine P1 group identified through virtual screening. | Bioorg Med Chem Lett 22: 2450-5 (2012) | Sanofi Pharmaceuticals | 2D 3D TSV |
22386243 | 83 | Discovery of thiadiazole amides as potent, S1P3-sparing agonists of sphingosine-1-phosphate 1 (S1P1) receptor. | Bioorg Med Chem Lett 22: 2456-9 (2012) | GlaxoSmithKline | 2D 3D TSV |
22386242 | 13 | N-Caffeoyl serotonin as selective COX-2 inhibitor. | Bioorg Med Chem Lett 22: 2494-6 (2012) | Kinki University | 2D 3D TSV |
22386241 | 46 | Synthesis and pharmacological evaluation of carbamic acid 1-phenyl-3-(4-phenyl-piperazine-1-yl)-propyl ester derivatives as new analgesic agents. | Bioorg Med Chem Lett 22: 2434-9 (2012) | SK Biopharmaceuticals | 2D 3D TSV |
22385507 | 20 | Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compounds. | J Med Chem 55: 3274-84 (2012) | Instituto de Qu£mica M£dica (CSIC) | 2D 3D TSV |
22385498 | 24 | Synthesis and evaluation of a set of para-substituted 4-phenylpiperidines and 4-phenylpiperazines as monoamine oxidase (MAO) inhibitors. | J Med Chem 55: 3242-9 (2012) | NeuroSearch Sweden AB | 2D 3D TSV |
22385476 | 7 | Structure-activity relationships in human Toll-like receptor 2-specific monoacyl lipopeptides. | J Med Chem 55: 3353-63 (2012) | University of Kansas | 2D 3D TSV |
22381672 | 20 | Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with ??-adrenoceptor affinities. | Bioorg Med Chem 20: 2290-303 (2012) | Jagiellonian University Medical College | 2D 3D TSV |
22381357 | 41 | New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells. | Eur J Med Chem 50: 332-43 (2012) | University of Messina | 2D 3D TSV |
22381355 | 16 | Design, synthesis and molecular docking studies of some novel spiro[indoline-3, 4'-piperidine]-2-ones as potential c-Met inhibitors. | Eur J Med Chem 50: 370-5 (2012) | Southern Medical University | 2D 3D TSV |
22381334 | 2 | In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonist. | Drug Metab Dispos 40: 1093-103 (2012) | Bristol-Myers Squibb Co. | 2D 3D TSV |
22381116 | 2 | The discovery of novel β-secretase inhibitors: pharmacophore modeling, virtual screening, and docking studies. | Chem Biol Drug Des 79: 972-80 (2012) | Peking University Health Science Center | 2D 3D TSV |
22381048 | 45 | Synthesis and SAR study of 4-arylpiperidines and 4-aryl-1,2,3,6-tetrahydropyridines as 5-HT2C agonists. | Bioorg Med Chem Lett 22: 2560-4 (2012) | Monash University (Parkville Campus) | 2D 3D TSV |
22381047 | 30 | Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii. | Bioorg Med Chem Lett 22: 2527-33 (2012) | Chungnam National University | 2D 3D TSV |
22380779 | 35 | Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors. | J Enzyme Inhib Med Chem 28: 545-51 (2013) | Shandong University | 2D 3D TSV |
22380777 | 16 | Synthesis and HIV-1 RT inhibitory action of novel (4/6-substituted benzo[d]thiazol -2-yl)thiazolidin-4-ones. Divergence from the non-competitive inhibition mechanism. | J Enzyme Inhib Med Chem 28: 113-22 (2013) | Aristotle University of Thessaloniki | 2D 3D TSV |
22380775 | 28 | 2-(2-indolyl-)-4(3H)-quinazolines derivates as new inhibitors of AChE: design, synthesis, biological evaluation and molecular modelling. | J Enzyme Inhib Med Chem 28: 583-92 (2013) | Sun Yat-sen University | 2D 3D TSV |
22380772 | 34 | Secondary/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II. | J Enzyme Inhib Med Chem 28: 294-8 (2013) | Ataturk University | 2D 3D TSV |
22380770 | 5 | Inhibition of fatty acid synthase by ginkgolic acids from the leaves of Ginkgo biloba and their cytotoxic activity. | J Enzyme Inhib Med Chem 28: 565-8 (2013) | Yeungnam University | 2D 3D TSV |
22380736 | 90 | Discovery of highly potent and selective pan-Aurora kinase inhibitors with enhanced in vivo antitumor therapeutic index. | J Med Chem 55: 3250-60 (2012) | Ambit Biosciences Corporation | 2D 3D TSV |
22380680 | 3 | Inhibition of homologous recombination in human cells by targeting RAD51 recombinase. | J Med Chem 55: 3011-20 (2012) | Drexel University College of Medicine | 2D 3D TSV |
22380653 | 69 | Lead optimization of 17ß-HSD1 inhibitors of the (hydroxyphenyl)naphthol sulfonamide type for the treatment of endometriosis. | J Med Chem 55: 3307-18 (2012) | Saarland University | 2D 3D TSV |
22380629 | 174 | Discovery of cyclic sulfone hydroxyethylamines as potent and selectiveß-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloidß-peptides. | J Med Chem 55: 3364-86 (2012) | Novartis Pharma AG | 2D 3D TSV |
22380603 | 3 | Novel cGMP efflux inhibitors identified by virtual ligand screening (VLS) and confirmed by experimental studies. | J Med Chem 55: 3049-57 (2012) | University of Troms£ | 2D 3D TSV |
22380511 | 73 | Dynamic modeling of human 5-lipoxygenase-inhibitor interactions helps to discover novel inhibitors. | J Med Chem 55: 2597-605 (2012) | Peking University | 2D 3D TSV |
22377675 | 44 | Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors. | Bioorg Med Chem 20: 2282-9 (2012) | Westf£lische Wilhelms-Universit£t M£nster | 2D 3D TSV |
22377674 | 80 | Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII. | Bioorg Med Chem 20: 2266-73 (2012) | Universit£ degli Studi di Firenze | 2D 3D TSV |
22377673 | 4 | Proteasome inhibitors for cancer therapy. | Bioorg Med Chem 20: 2362-8 (2012) | Cephalon Inc | 2D 3D TSV |
22377671 | 6 | 2-Morpholinoisoflav-3-enes as flexible intermediates in the synthesis of phenoxodiol, isophenoxodiol, equol and analogues: vasorelaxant properties, estrogen receptor binding and Rho/RhoA kinase pathway inhibition. | Bioorg Med Chem 20: 2353-61 (2012) | University of Melbourne | 2D 3D TSV |
22377519 | 23 | An example of designed multiple ligands spanning protein classes: dual MCH-1R antagonists/DPPIV inhibitors. | Bioorg Med Chem Lett 22: 2464-9 (2012) | Prosidion Ltd | 2D 3D TSV |
22377517 | 15 | Design of oxobenzimidazoles and oxindoles as novel androgen receptor antagonists. | Bioorg Med Chem Lett 22: 2572-8 (2012) | Pfizer Inc | 2D 3D TSV |
22377514 | 75 | The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia. | Bioorg Med Chem Lett 22: 2585-9 (2012) | Merck Research Laboratories | 2D 3D TSV |
22376008 | 19 | Synthesis, X-ray analysis, and biological evaluation of a new class of stereopure lactam-based HIV-1 protease inhibitors. | J Med Chem 55: 2724-36 (2012) | Uppsala University | 2D 3D TSV |
22374217 | 33 | Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation rates. | Bioorg Med Chem Lett 22: 2609-12 (2012) | Merck Research Laboratories | 2D 3D TSV |
22373734 | 42 | Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug. | Eur J Med Chem 50: 179-95 (2012) | Pfizer Inc | 2D 3D TSV |
22372864 | 25 | Synthesis and biological evaluation of pyrimidine-based dual inhibitors of human epidermal growth factor receptor 1 (HER-1) and HER-2 tyrosine kinases. | J Med Chem 55: 2846-57 (2012) | Hanmi Research Center | 2D 3D TSV |
22372835 | 71 | Design and synthesis of cannabinoid receptor 1 antagonists for peripheral selectivity. | J Med Chem 55: 2820-34 (2012) | Research Triangle Institute | 2D 3D TSV |
22372816 | 3 | Fluorophosphonylated nucleoside derivatives as new series of thymidine phosphorylase multisubstrate inhibitors. | J Med Chem 55: 2758-68 (2012) | Universit£ de Caen Basse-Normandie | 2D 3D TSV |
22370341 | 29 | Favourable involvement ofa2A-adrenoreceptor antagonism in the I2-imidazoline binding sites-mediated morphine analgesia enhancement. | Bioorg Med Chem 20: 2259-65 (2012) | University of Camerino | 2D 3D TSV |
22370340 | 91 | N¿?¿-(3-Bromophenyl)-7-(substituted benzyl) pyrrolo[2,3-d]pyrimidines as potent multiple receptor tyrosine kinase inhibitors: design, synthesis, and in vivo evaluation. | Bioorg Med Chem 20: 2444-54 (2012) | Duquesne University | 2D 3D TSV |
22370338 | 183 | Design and synthesis of thiourea compounds that inhibit transmembrane anchored carbonic anhydrases. | Bioorg Med Chem 20: 2392-404 (2012) | Griffith University | 2D 3D TSV |
22370337 | 30 | Intramolecular hydrogen bonding: a potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthase. | Bioorg Med Chem 20: 2435-43 (2012) | Northwestern University | 2D 3D TSV |
22370270 | 30 | Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS). | Bioorg Med Chem Lett 22: 2510-3 (2012) | NeurAxon Inc | 2D 3D TSV |
22370269 | 44 | Discovery of P2X3 selective antagonists for the treatment of chronic pain. | Bioorg Med Chem Lett 22: 2565-71 (2012) | AstraZeneca | 2D 3D TSV |
22370265 | 63 | Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB2 receptor agonists for pain management. | Bioorg Med Chem Lett 22: 2604-8 (2012) | Abbott Laboratories | 2D 3D TSV |
22369268 | 29 | Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1. | J Med Chem 55: 2803-10 (2012) | University of Washington | 2D 3D TSV |
22369198 | 40 | From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists. | J Med Chem 55: 2574-84 (2012) | Laboratoires Fournier | 2D 3D TSV |
22369181 | 6 | (Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARß/d-selective ligand with inverse agonistic properties. | J Med Chem 55: 2858-68 (2012) | Philipps University | 2D 3D TSV |
22368763 | 82 | Small Molecule Inhibitors of Regulator of G Protein Signalling (RGS) Proteins. | ACS Med Chem Lett 3: 146-150 (2012) | TBA | 2D 3D TSV |
22366955 | 11 | Blind prediction of host-guest binding affinities: a new SAMPL3 challenge. | J Comput Aided Mol Des 26: 475-87 (2012) | University of California San Diego | 2D 3D TSV |
22366657 | 39 | A novel series of benzimidazole NR2B-selective NMDA receptor antagonists. | Bioorg Med Chem Lett 22: 2620-3 (2012) | GlaxoSmithKline | 2D 3D TSV |
22366656 | 5 | Oroxylin A analogs exhibited strong inhibitory activities against iNOS-mediated nitric oxide (NO) production. | Bioorg Med Chem Lett 22: 2534-5 (2012) | Kangwon National University | 2D 3D TSV |
22366654 | 33 | 2-Amidino analogs of glycine-amiloride conjugates: inhibitors of urokinase-type plasminogen activator. | Bioorg Med Chem Lett 22: 2635-9 (2012) | University of Louisville | 2D 3D TSV |
22366653 | 3 | Discovery of GS-9451: an acid inhibitor of the hepatitis C virus NS3/4A protease. | Bioorg Med Chem Lett 22: 2629-34 (2012) | Gilead Sciences Inc | 2D 3D TSV |
22365911 | 3 | Synthesis and structure-activity relationship of 4-amino-2-phenylpyrimidine derivatives as a series of novel GPR119 agonists. | Bioorg Med Chem 20: 2369-75 (2012) | Astellas Pharma Inc | 2D 3D TSV |
22365762 | 64 | Pyridyl aminothiazoles as potent Chk1 inhibitors: optimization of cellular activity. | Bioorg Med Chem Lett 22: 2613-9 (2012) | Merck Research Laboratories | 2D 3D TSV |
22365761 | 144 | New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II. | Bioorg Med Chem Lett 22: 2182-5 (2012) | Universit£ degli Studi di Firenze | 2D 3D TSV |
22365760 | 6 | Pyrrolovesamicols--synthesis, structure and VAChT binding of two 4-fluorobenzoyl regioisomers. | Bioorg Med Chem Lett 22: 2163-6 (2012) | Institute of Radiopharmacy | 2D 3D TSV |
22365758 | 43 | Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPR1). | Bioorg Med Chem Lett 22: 2287-90 (2012) | Bristol-Myers Squibb Co. | 2D 3D TSV |
22365757 | 2 | Molecular modeling study of cyclic pentapeptide CXCR4 antagonists: new insight into CXCR4-FC131 interactions. | Bioorg Med Chem Lett 22: 2146-50 (2012) | PharmaDesign Inc | 2D 3D TSV |
22365755 | 42 | Discovery of potent, selective, and metabolically stable 4-(pyridin-3-yl)cinnolines as novel phosphodiesterase 10A (PDE10A) inhibitors. | Bioorg Med Chem Lett 22: 2262-5 (2012) | Amgen Inc | 2D 3D TSV |
22365751 | 45 | Synthesis and evaluation of a new series of 1'-cyclobutyl-6-(4-piperidyloxy)spiro[benzopyran-2,4'-piperidine] derivatives as high affinity and selective histamine-3 receptor (H3R) antagonists. | Bioorg Med Chem Lett 22: 2151-3 (2012) | Cephalon Inc | 2D 3D TSV |
22365563 | 29 | Synthesis and SAR optimization of quinazolin-4(3H)-ones as poly(ADP-ribose)polymerase-1 inhibitors. | Eur J Med Chem 50: 264-73 (2012) | St. John's University | 2D 3D TSV |
22365562 | 154 | Fluorinated dual antithrombotic compounds based on 1,4-benzoxazine scaffold. | Eur J Med Chem 50: 255-63 (2012) | University of Ljubljana | 2D 3D TSV |
22364952 | 4 | Synthesis and antidiabetic performance of ?-amino ketone containing nabumetone moiety. | Bioorg Med Chem 20: 2119-30 (2012) | Southwest University | 2D 3D TSV |
22364812 | 7 | Substituent effects on P2-cyclopentyltetrahydrofuranyl urethanes: design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors. | Bioorg Med Chem Lett 22: 2308-11 (2012) | Purdue University | 2D 3D TSV |
22364743 | 8 | Asymmetric synthesis and evaluation of a hydroxyphenylamide voltage-gated sodium channel blocker in human prostate cancer xenografts. | Bioorg Med Chem 20: 2180-8 (2012) | University of Virginia | 2D 3D TSV |
22364528 | 412 | 1,3,8-Triazaspiro[4.5]decane-2,4-diones as efficacious pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemia. | J Med Chem 55: 2945-59 (2012) | Merck Research Laboratories | 2D 3D TSV |
22364337 | 38 | Discovery of 1,4-disubstituted 3-cyano-2-pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor. | J Med Chem 55: 2388-405 (2012) | Janssen-Cilag S.A. | 2D 3D TSV |
22361686 | 3 | Design, synthesis and biological evaluation of novel (E)-?-benzylsulfonyl chalcone derivatives as potential BRAF inhibitors. | Eur J Med Chem 50: 288-95 (2012) | Nanjing University | 2D 3D TSV |
22361685 | 123 | Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach. | Eur J Med Chem 50: 216-29 (2012) | Universit£ degli Studi Magna Grecia di Catanzaro | 2D 3D TSV |
22361272 | 74 | Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors. | Bioorg Med Chem 20: 2010-8 (2012) | Nanjing University | 2D 3D TSV |
22361135 | 29 | Indolyl and dihydroindolyl N-glycinamides as potent and in vivo active NPY5 antagonists. | Bioorg Med Chem Lett 22: 2167-71 (2012) | Lundbeck Research USA | 2D 3D TSV |
22361134 | 26 | N-1 and C-3 substituted indole Schiff bases as selective COX-2 inhibitors: synthesis and biological evaluation. | Bioorg Med Chem Lett 22: 2154-9 (2012) | University of Alberta | 2D 3D TSV |
22361133 | 148 | Synthesis and structure-activity relationships of imidazo[1,2-a]pyrimidin-5(1H)-ones as a novel series of beta isoform selective phosphatidylinositol 3-kinase inhibitors. | Bioorg Med Chem Lett 22: 2230-4 (2012) | GlaxoSmithKline | 2D 3D TSV |
22360639 | 12 | Cycloartane and friedelane triterpenoids from the leaves of Caloncoba glauca and their evaluation for inhibition of 11ß-hydroxysteroid dehydrogenases. | J Nat Prod 75: 599-604 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22360587 | 1 | Symplocin A, a linear peptide from the Bahamian cyanobacterium Symploca sp. Configurational analysis of N,N-dimethylamino acids by chiral-phase HPLC of naphthacyl esters. | J Nat Prod 75: 425-31 (2012) | University of California | 2D 3D TSV |
22360565 | 20 | Rapid assembly of a library of lipophilic iminosugars via the thiol-ene reaction yields promising pharmacological chaperones for the treatment of Gaucher disease. | J Med Chem 55: 2737-45 (2012) | University of British Columbia | 2D 3D TSV |
22357342 | 8 | SAR and biological evaluation of 3-azabicyclo[3.1.0]hexane derivatives asµ opioid ligands. | Bioorg Med Chem Lett 22: 2200-3 (2012) | Pfizer Inc | 2D 3D TSV |
22356915 | 27 | Biological and structural characterization of Trypanosoma cruzi phosphodiesterase C and Implications for design of parasite selective inhibitors. | J Biol Chem 287: 11788-97 (2012) | University of North Carolina | 2D 3D TSV |
22356319 | 4 | Inhibition of galactosyltransferases by a novel class of donor analogues. | J Med Chem 55: 2015-24 (2012) | University of East Anglia | 2D 3D TSV |
22352892 | 42 | Synthesis, biological evaluation, and molecular modeling of natural and unnatural flavonoidal alkaloids, inhibitors of kinases. | J Med Chem 55: 2811-9 (2012) | Institut de Chimie des Substances Naturelles (ICSN) | 2D 3D TSV |
22352868 | 8 | Structure-activity relationship study of a CXC chemokine receptor type 4 antagonist, FC131, using a series of alkene dipeptide isosteres. | J Med Chem 55: 2746-57 (2012) | Kyoto University | 2D 3D TSV |
22352782 | 17 | Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor. | J Med Chem 55: 2688-701 (2012) | Janssen-Cilag S.A. | 2D 3D TSV |
22344701 | 30 | Biocatalytic synthesis and structure elucidation of cyclized metabolites of the deacetylase inhibitor panobinostat (LBH589). | Drug Metab Dispos 40: 1041-50 (2012) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
22342630 | 2 | Biotransformations of 6',7'-dihydroxybergamottin and 6',7'-epoxybergamottin by the citrus-pathogenic fungi diminish cytochrome P450 3A4 inhibitory activity. | Bioorg Med Chem Lett 22: 2279-82 (2012) | Agricultural Research Service | 2D 3D TSV |
22342627 | 36 | Rational design, synthesis and characterization of potent, drug-like monomeric Smac mimetics as pro-apoptotic anticancer agents. | Bioorg Med Chem Lett 22: 2204-8 (2012) | CISI scrl | 2D 3D TSV |
22342626 | 42 | Substituted azaquinazolinones as modulators of GHSr-1a for the treatment of type II diabetes and obesity. | Bioorg Med Chem Lett 22: 2271-8 (2012) | Prosidion Ltd | 2D 3D TSV |
22342625 | 6 | Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors. | Bioorg Med Chem Lett 22: 2195-9 (2012) | Sejong University | 2D 3D TSV |
22342624 | 2 | Acetylenic acid analogues from the edible mushroom Chanterelle (Cantharellus cibarius) and their effects on the gene expression of peroxisome proliferator-activated receptor-gamma target genes. | Bioorg Med Chem Lett 22: 2347-9 (2012) | Korea University | 2D 3D TSV |
22342268 | 98 | Design and synthesis of novel sulfonamide-containing bradykinin hB(2) receptor antagonists. Synthesis and structure-relationships ofa,a-tetrahydropyranylglycine. | Bioorg Med Chem 20: 2091-100 (2012) | Menarini Ricerche | 2D 3D TSV |
22342267 | 18 | Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus. | Bioorg Med Chem 20: 2152-7 (2012) | Chulalongkorn University | 2D 3D TSV |
22342147 | 55 | Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors. | Bioorg Med Chem Lett 22: 2330-7 (2012) | AstraZeneca R&D Boston | 2D 3D TSV |
22342144 | 72 | Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain. | Bioorg Med Chem Lett 22: 2242-6 (2012) | PanThera Biopharma, LLC | 2D 3D TSV |
22342143 | 37 | Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritis. | Bioorg Med Chem Lett 22: 2266-70 (2012) | Galapagos NV | 2D 3D TSV |
22342124 | 9 | Design and evaluation of a series of pyrazolopyrimidines as p70S6K inhibitors. | Bioorg Med Chem Lett 22: 2283-6 (2012) | Exelixis Inc | 2D 3D TSV |
22341944 | 29 | Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation. | Bioorg Med Chem Lett 22: 2257-61 (2012) | School of Chemistry & Chemical Engineering of Guangxi Normal University | 2D 3D TSV |
22341942 | 18 | Wake-promoting agents: search for next generation modafinil: part II. | Bioorg Med Chem Lett 22: 2315-7 (2012) | Cephalon Inc | 2D 3D TSV |
22341941 | 34 | Novel 5-substituted 1H-tetrazoles as cyclooxygenase-2 (COX-2) inhibitors. | Bioorg Med Chem Lett 22: 2235-8 (2012) | University of Alberta | 2D 3D TSV |
22341898 | 7 | Synthesis and inhibitory activity of ureidophosphonates, against acetylcholinesterase: pharmacological assay and molecular modeling. | Bioorg Chem 22-7 (2012) | Institute for Advanced Studies in Basic Sciences (IASBS) | 2D 3D TSV |
22341895 | 26 | Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selectiveµ-antagonist activity. | Eur J Med Chem 50: 44-54 (2012) | National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism | 2D 3D TSV |
22341573 | 39 | Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptorsa/¿ dual agonists. | Bioorg Med Chem 20: 2141-51 (2012) | Universit£ degli Studi di Bari 'Aldo Moro' | 2D 3D TSV |
22341572 | 61 | Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: steric and electronic effects of 4- and 8-halogenated naphthoyl substituents. | Bioorg Med Chem 20: 2067-81 (2012) | RTI International | 2D 3D TSV |
22341244 | 103 | Might the observeda(2A)-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? | Bioorg Med Chem 20: 2082-90 (2012) | Universit£ degli Studi di Camerino | 2D 3D TSV |
22341243 | 6 | Synthesis of propiophenone derivatives as new class of antidiabetic agents reducing body weight in db/db mice. | Bioorg Med Chem 20: 2172-9 (2012) | Central Drug Research Institute | 2D 3D TSV |
22340081 | 16 | Solid phase synthesis of 1,5-diarylpyrazole-4-carboxamides: discovery of antagonists of the CB-1 receptor. | ACS Comb Sci 14: 197-204 (2012) | Bristol-Myers Squibb Research and Development | 2D 3D TSV |
22339993 | 8 | Inhibition of bacterial virulence: drug-like molecules targeting the Salmonella enterica PhoP response regulator. | Chem Biol Drug Des 79: 1007-17 (2012) | Washington University | 2D 3D TSV |
22339472 | 148 | Discovery of the macrocycle (9E)-15-(2-(pyrrolidin-1-yl)ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2,4,9,14(26),15,17,20,22-nonaene (SB1578), a potent inhibitor of janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) for the treatment of rheumatoid arth | J Med Chem 55: 2623-40 (2012) | S BIO Pte. Ltd | 2D 3D TSV |
22339433 | 48 | Structure-based design of novel potent protein kinase CK2 (CK2) inhibitors with phenyl-azole scaffolds. | J Med Chem 55: 2899-903 (2012) | Kyoto University | 2D 3D TSV |
22339362 | 20 | Discovery of a novel class of potent human deoxyuridine triphosphatase inhibitors remarkably enhancing the antitumor activity of thymidylate synthase inhibitors. | J Med Chem 55: 2970-80 (2012) | Taiho Pharmaceutical Co., Ltd | 2D 3D TSV |
22339342 | 28 | Design, synthesis, and biological evaluation of novel conformationally constrained inhibitors targeting epidermal growth factor receptor threonine7¿°¿ methionine7¿° mutant. | J Med Chem 55: 2711-23 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22339166 | 14 | Radiolabeled cyclosaligenyl monophosphates of 5-iodo-2'-deoxyuridine, 5-iodo-3'-fluoro-2',3'-dideoxyuridine, and 3'-fluorothymidine for molecular radiotherapy of cancer: synthesis and biological evaluation. | J Med Chem 55: 2649-71 (2012) | University of Nebraska Medical Center | 2D 3D TSV |
22339127 | 14 | Implications of promiscuous Pim-1 kinase fragment inhibitor hydrophobic interactions for fragment-based drug design. | J Med Chem 55: 2641-8 (2012) | Genzyme Corp. | 2D 3D TSV |
22336385 | 4 | 1,3,4-Thiadiazole derivatives as selective inhibitors of iNOS versus nNOS: Synthesis and structure-activity dependence. | Eur J Med Chem 50: 129-39 (2012) | Universidad de Granada | 2D 3D TSV |
22336247 | 20 | Phosphodiesterase inhibitors. Part 3: Design, synthesis and structure-activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity. | Bioorg Med Chem 20: 1644-58 (2012) | Kyorin Pharmaceutical Co., Ltd | 2D 3D TSV |
22336246 | 7 | JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs. | Bioorg Med Chem 20: 1947-51 (2012) | Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics | 2D 3D TSV |
22336245 | 72 | Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol. | Bioorg Med Chem 20: 1671-8 (2012) | Florida A&M University | 2D 3D TSV |
22335897 | 2 | Characterization of TAE684 as a potent LRRK2 kinase inhibitor. | Bioorg Med Chem Lett 22: 1864-9 (2012) | University of Dundee | 2D 3D TSV |
22335895 | 41 | Structure-activity relationship study of beta-carboline derivatives as haspin kinase inhibitors. | Bioorg Med Chem Lett 22: 2015-9 (2012) | Harvard Medical School | 2D 3D TSV |
22335894 | 10 | New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series. | Bioorg Med Chem Lett 22: 1860-3 (2012) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
22335602 | 93 | Identification and in vivo and in vitro characterization of long acting and melanocortin 4 receptor (MC4-R) selectivea-melanocyte-stimulating hormone (a-MSH) analogues. | J Med Chem 55: 1969-77 (2012) | Novo Nordisk A/S | 2D 3D TSV |
22335555 | 43 | 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate. | J Med Chem 55: 2882-93 (2012) | NeurAxon Inc | 2D 3D TSV |
22335519 | 3 | Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic properties. | J Med Chem 55: 2869-81 (2012) | Genentech | 2D 3D TSV |
22331994 | 3 | Effect of albumin on human liver microsomal and recombinant CYP1A2 activities: impact on in vitro-in vivo extrapolation of drug clearance. | Drug Metab Dispos 40: 982-9 (2012) | Khon Kaen University | 2D 3D TSV |
22330635 | 25 | Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia. | Bioorg Med Chem Lett 22: 1903-7 (2012) | Janssen Pharmaceutica NV | 2D 3D TSV |
22330633 | 5 | Depigmenting activity of new kojic acid derivative obtained as a side product in the synthesis of cinnamate of kojic acid. | Bioorg Med Chem Lett 22: 2004-7 (2012) | Hanyang University | 2D 3D TSV |
22329646 | 3 | Flavimycins A and B, dimeric 1,3-dihydroisobenzofurans with peptide deformylase inhibitory activity from Aspergillus flavipes. | J Nat Prod 75: 271-4 (2012) | Korea Research Institute of Bioscience and Biotechnology | 2D 3D TSV |
22329602 | 22 | Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors. | J Med Chem 55: 2125-43 (2012) | University of Strasburg | 2D 3D TSV |
22329561 | 5 | Synthesis and biological evaluation of 1,4-diaryl-2-azetidinones as specific anticancer agents: activation of adenosine monophosphate activated protein kinase and induction of apoptosis. | J Med Chem 55: 2112-24 (2012) | University of Milan-Bicocca | 2D 3D TSV |
22329507 | 49 | Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonists. | J Med Chem 55: 1593-611 (2012) | Amgen Inc | 2D 3D TSV |
22328963 | 4 | Discovery of a Potent HIV Integrase Inhibitor that Leads to a Prodrug with Significant anti-HIV Activity. | ACS Med Chem Lett 2: 877-881 (2011) | TBA | 2D 3D TSV |
22328583 | 132 | Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. | Drug Metab Dispos 40: 943-51 (2012) | Pfizer Inc | 2D 3D TSV |
22326398 | 22 | Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei. | Bioorg Med Chem Lett 22: 1886-90 (2012) | London School of Hygiene and Tropical Medicine | 2D 3D TSV |
22326396 | 32 | Aminopyrimidinone cdc7 kinase inhibitors. | Bioorg Med Chem Lett 22: 1940-3 (2012) | Abbott Laboratories | 2D 3D TSV |
22326168 | 67 | Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1. | Bioorg Med Chem Lett 22: 2070-4 (2012) | Biogen Idec Inc | 2D 3D TSV |
22326166 | 40 | Synthesis and structure-activity relationship (SAR) study of 4-azabenzoxazole analogues as H3 antagonists. | Bioorg Med Chem Lett 22: 2075-8 (2012) | Merck Research Laboratories | 2D 3D TSV |
22326163 | 63 | SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase. | Bioorg Med Chem Lett 22: 1969-75 (2012) | ZAFES/LiFF/OSF Goethe-University Frankfurt | 2D 3D TSV |
22325951 | 41 | Structure-activity relationship of the 7-hydroxy benzimidazole analogs as glycogen synthase kinase 3ß inhibitor. | Bioorg Med Chem Lett 22: 1891-4 (2012) | CrystalGenomics, Inc. | 2D 3D TSV |
22325949 | 28 | Novel TIPP (H-Tyr-Tic-Phe-Phe-OH) analogues displaying a wide range of efficacies at thed opioid receptor. Discovery of two highly potent and selectived opioid agonists. | Bioorg Med Chem Lett 22: 1899-902 (2012) | Clinical Research Institute of Montreal | 2D 3D TSV |
22325948 | 52 | Identification of fused bicyclic heterocycles as potent and selective 5-HT(2A) receptor antagonists for the treatment of insomnia. | Bioorg Med Chem Lett 22: 1870-3 (2012) | Arena Pharmaceuticals Inc | 2D 3D TSV |
22325946 | 36 | 3,4-Diarylpiperidines as potent renin inhibitors. | Bioorg Med Chem Lett 22: 1953-7 (2012) | Merck Frosst Center for Therapeutic Research | 2D 3D TSV |
22325945 | 55 | Design, synthesis, and evaluation of novel 4-thiazolylimidazoles as inhibitors of transforming growth factor-ß type I receptor kinase. | Bioorg Med Chem Lett 22: 2024-9 (2012) | Taisho Pharmaceutical Co., Ltd | 2D 3D TSV |
22325943 | 71 | Imidazo[1,2-a]pyrazines as novel PI3K inhibitors. | Bioorg Med Chem Lett 22: 1874-8 (2012) | Spanish National Cancer Research Centre (CNIO) | 2D 3D TSV |
22325942 | 31 | Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy. | Bioorg Med Chem Lett 22: 1854-9 (2012) | AstraZeneca | 2D 3D TSV |
22325155 | 20 | 7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation. | Bioorg Med Chem 20: 1690-8 (2012) | University of Ferrara | 2D 3D TSV |
22325154 | 25 | N-(4-Substituted-benzoyl)-N'-(ß-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods. | Bioorg Med Chem 20: 1801-16 (2012) | University of Debrecen | 2D 3D TSV |
22324546 | 55 | Synthesis and evaluation of sulfonylnitrophenylthiazoles (SNPTs) as thyroid hormone receptor-coactivator interaction inhibitors. | J Med Chem 55: 2301-10 (2012) | Institut Pasteur Korea | 2D 3D TSV |
22321216 | 2 | Towards the preparation of radiolabeled 1-aryl-3-benzyl ureas: Radiosynthesis of [(11)C-carbonyl] AR-A014418 by [(11)C]CO(2) fixation. | Bioorg Med Chem Lett 22: 2099-101 (2012) | University of Toronto | 2D 3D TSV |
22321215 | 16 | Anti-tumor activity of new orally bioavailable 2-amino-5-(thiophen-2-yl)benzamide-series histone deacetylase inhibitors, possessing an aqueous soluble functional group as a surface recognition domain. | Bioorg Med Chem Lett 22: 1926-30 (2012) | Kansai University | 2D 3D TSV |
22321214 | 42 | Discovery of 4-hydroxy-1,6-naphthyridine-3-carbonitrile derivatives as novel PDE10A inhibitors. | Bioorg Med Chem Lett 22: 1944-8 (2012) | AstraZeneca | 2D 3D TSV |
22321213 | 16 | Effect of alkyl chain length on sphingosine kinase 2 selectivity. | Bioorg Med Chem Lett 22: 6817-20 (2012) | Virginia Tech | 2D 3D TSV |
22320402 | 4 | Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation. | J Med Chem 55: 1999-2014 (2012) | The Hong Kong Polytechnic University | 2D 3D TSV |
22320388 | 116 | Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity. | J Med Chem 55: 2416-26 (2012) | University of Washington | 2D 3D TSV |
22320343 | 21 | Structure-based design of novel class II c-Met inhibitors: 1. Identification of pyrazolone-based derivatives. | J Med Chem 55: 1858-67 (2012) | Amgen Inc | 2D 3D TSV |
22320327 | 250 | Structure-based design of novel class II c-Met inhibitors: 2. SAR and kinase selectivity profiles of the pyrazolone series. | J Med Chem 55: 1868-97 (2012) | Amgen Inc | 2D 3D TSV |
22318165 | 85 | Exploration ofa-aminophosphonate N-derivatives as novel, potent and selective inhibitors of protein tyrosine phosphatases. | Eur J Med Chem 49: 354-64 (2012) | Shanxi University | 2D 3D TSV |
22318160 | 12 | Radiosynthesis of PET radiotracer as a prodrug for imaging group II metabotropic glutamate receptors in vivo. | Bioorg Med Chem Lett 22: 1958-62 (2012) | Massachusetts General Hospital | 2D 3D TSV |
22318159 | 36 | 3,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase (nNOS) inhibitors. | Bioorg Med Chem Lett 22: 1980-4 (2012) | NeurAxon Inc | 2D 3D TSV |
22318156 | 128 | Discovery and hit-to-lead optimization of pyrrolopyrimidines as potent, state-dependent Na(v)1.7 antagonists. | Bioorg Med Chem Lett 22: 2052-62 (2012) | Amgen Inc | 2D 3D TSV |
22316555 | 12 | Synthesis and properties of mRNA cap analogs containing imidodiphosphate moiety--fairly mimicking natural cap structure, yet resistant to enzymatic hydrolysis. | Bioorg Med Chem 20: 1699-710 (2012) | University of Warsaw | 2D 3D TSV |
22316554 | 22 | Development of live-cell imaging probes for monitoring histone modifications. | Bioorg Med Chem 20: 1887-92 (2012) | Japan Science and Technology Agency | 2D 3D TSV |
22316553 | 1 | AlCl3 induced (hetero)arylation of 2,3-dichloroquinoxaline: a one-pot synthesis of mono/disubstituted quinoxalines as potential antitubercular agents. | Bioorg Med Chem 20: 1711-22 (2012) | University of Hyderabad Campus | 2D 3D TSV |
22316010 | 12 | Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain. | J Med Chem 55: 2342-52 (2012) | National Institute of Radiological Sciences | 2D 3D TSV |
22315332 | 1 | Preclinical disposition of GDC-0973 and prospective and retrospective analysis of human dose and efficacy predictions. | Drug Metab Dispos 40: 919-27 (2012) | Genentech | 2D 3D TSV |
22313242 | 146 | 2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonists. | J Med Chem 55: 2452-68 (2012) | Pfizer Inc | 2D 3D TSV |
22313227 | 78 | Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype. | J Med Chem 55: 2406-15 (2012) | National Institute of Mental Health | 2D 3D TSV |
22310230 | 2 | Methoxychalcone inhibitors of androgen receptor translocation and function. | Bioorg Med Chem Lett 22: 2105-9 (2012) | National Cancer Institute-Bethesda | 2D 3D TSV |
22310229 | 102 | Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH. | Bioorg Med Chem Lett 22: 1985-8 (2012) | Brandeis University | 2D 3D TSV |
22310227 | 89 | 5-Aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors. | Bioorg Med Chem Lett 22: 1989-94 (2012) | GlaxoSmithKline | 2D 3D TSV |
22309913 | 30 | Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives. | Eur J Med Chem 49: 343-53 (2012) | North-West University | 2D 3D TSV |
22309912 | 28 | Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists. | Eur J Med Chem 49: 183-90 (2012) | Beijing Institute of Technology | 2D 3D TSV |
22309911 | 13 | Synthesis and biological evaluation of quinazoline and quinoline bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential epidermal growth factor receptor(EGFR) tyrosine kinase inhibitors and EPR bio-probe agents. | Eur J Med Chem 49: 271-8 (2012) | East China University of Science and Technology | 2D 3D TSV |
22309909 | 37 | Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors. | Eur J Med Chem 49: 200-10 (2012) | National Medicines Institute | 2D 3D TSV |
22309250 | 3 | STAT-3 inhibitory bisabolanes from Carthamus glaucus. | J Nat Prod 75: 453-8 (2012) | Universit£ di Napoli Federico II | 2D 3D TSV |
22309223 | 70 | Melanin-concentrating hormone receptor 1 antagonists. Synthesis and structure-activity relationships of novel 3-(aminomethyl)quinolines. | J Med Chem 55: 2353-66 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22309208 | 8 | Receptor-ligand interaction-based virtual screening for novel Eg5/kinesin spindle protein inhibitors. | J Med Chem 55: 2561-73 (2012) | Korea Institute of Science and Technology | 2D 3D TSV |
22309188 | 2 | Small peptide inhibitors of acetyl-peptide hydrolase having an uncommon mechanism of inhibition and a stable bent conformation. | J Med Chem 55: 2102-11 (2012) | Istituto di Biostrutture e Bioimmagini | 2D 3D TSV |
22306123 | 17 | Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors. | Bioorg Med Chem Lett 22: 1976-9 (2012) | Chinese Academy of Sciences | 2D 3D TSV |
22306122 | 90 | The discovery of aminopyrazines as novel, potent Na(v)1.7 antagonists: hit-to-lead identification and SAR. | Bioorg Med Chem Lett 22: 2033-42 (2012) | Amgen Inc | 2D 3D TSV |
22305612 | 7 | Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors. | Eur J Med Chem 49: 24-40 (2012) | Dongguk University-Seoul | 2D 3D TSV |
22305584 | 145 | Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKe kinases. | Bioorg Med Chem Lett 22: 2063-9 (2012) | AstraZeneca R&D Boston | 2D 3D TSV |
22305493 | 33 | Discovery of a new class of ghrelin receptor antagonists. | Bioorg Med Chem Lett 22: 2046-51 (2012) | Amgen Inc | 2D 3D TSV |
22305342 | 33 | Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class. | Eur J Med Chem 49: 379-96 (2012) | Universit£ d'Orl£ans | 2D 3D TSV |
22304848 | 44 | Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins. | Bioorg Med Chem 20: 1779-93 (2012) | University of St. Andrews | 2D 3D TSV |
22304847 | 1 | Investigation of trypanothione reductase inhibitory activity by 1,3,4-thiadiazolium-2-aminide derivatives and molecular docking studies. | Bioorg Med Chem 20: 1760-6 (2012) | Instituto Oswaldo Cruz | 2D 3D TSV |
22304006 | 1 | Antiproliferative activity of trans-avicennol from Zanthoxylum chiloperone var. angustifolium against human cancer stem cells. | J Nat Prod 75: 257-61 (2012) | Paris-Sud University | 2D 3D TSV |
22301214 | 4 | Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I). | Eur J Med Chem 49: 310-23 (2012) | University of Lille | 2D 3D TSV |
22301213 | 7 | Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors. | Eur J Med Chem 49: 245-52 (2012) | Pusan National University | 2D 3D TSV |
22300887 | 8 | QSAR study and synthesis of new phenyltropanes as ligands of the dopamine transporter (DAT). | Bioorg Med Chem 20: 1388-95 (2012) | University of Tours | 2D 3D TSV |
22300886 | 5 | Synthesis, molecular docking and biological evaluation of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents. | Bioorg Med Chem 20: 1373-9 (2012) | Nanjing University | 2D 3D TSV |
22300884 | 9 | Selective and slow-binding inhibition of shikonin derivatives isolated from Lithospermum erythrorhizon on glycosyl hydrolase 33 and 34 sialidases. | Bioorg Med Chem 20: 1740-8 (2012) | Korea Research Institute of Bioscience and Biotechnology | 2D 3D TSV |
22300661 | 21 | Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors. | Bioorg Med Chem Lett 22: 2094-8 (2012) | University of Siena | 2D 3D TSV |
22300660 | 9 | Adamantyl N-benzylbenzamide: new series of depigmentation agents with tyrosinase inhibitory activity. | Bioorg Med Chem Lett 22: 2110-3 (2012) | AmorePacific Corporation R&D Center | 2D 3D TSV |
22300659 | 4 | Small molecule inhibitors of the HPV16-E6 interaction with caspase 8. | Bioorg Med Chem Lett 22: 2125-9 (2012) | Loma Linda University School of Medicine | 2D 3D TSV |
22300657 | 29 | Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonist. | Bioorg Med Chem Lett 22: 2020-3 (2012) | Shionogi & Co., Ltd | 2D 3D TSV |
22299588 | 33 | Inhibition of the ß-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids. | J Enzyme Inhib Med Chem 28: 392-6 (2013) | Università degli Studi di Firenze | 2D 3D TSV |
22299586 | 14 | Inhibitory effect of novel pyrazole carboxamide derivatives on human carbonic anhydrase enzyme. | J Enzyme Inhib Med Chem 28: 328-36 (2013) | Dumlupinar University | 2D 3D TSV |
22299585 | 46 | Analysis of saponins and phenolic compounds as inhibitors of a-carbonic anhydrase isoenzymes. | J Enzyme Inhib Med Chem 28: 412-7 (2013) | Ege University | 2D 3D TSV |
22299583 | 34 | Tripeptides with non-code amino acids as potential serine proteases inhibitors. | J Enzyme Inhib Med Chem 28: 639-43 (2013) | Medical University of Bialystok | 2D 3D TSV |
22299579 | 1 | Evaluation of a dithiocarbamate derivative as an inhibitor of human glutaredoxin-1. | J Enzyme Inhib Med Chem 28: 456-62 (2013) | South Dakota State University | 2D 3D TSV |
22299578 | 74 | Inhibition of the alpha- and beta-carbonic anhydrases from the gastric pathogen Helycobacter pylori with anions. | J Enzyme Inhib Med Chem 28: 388-91 (2013) | Università degli Studi di Firenze | 2D 3D TSV |
22299577 | 12 | Three new aromatic sulfonamide inhibitors of carbonic anhydrases I, II, IV and XII. | J Enzyme Inhib Med Chem 28: 289-93 (2013) | Università di Firenze | 2D 3D TSV |
22299576 | 44 | Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors. | J Enzyme Inhib Med Chem 28: 397-401 (2013) | Ecole Nationale Supérieure de Chimie de Montpellier | 2D 3D TSV |
22299575 | 2 | Inhibition of acetylpolyamine and spermine oxidases by the polyamine analogue chlorhexidine. | J Enzyme Inhib Med Chem 28: 463-7 (2013) | University Roma Tre | 2D 3D TSV |
22297115 | 37 | Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series. | Bioorg Med Chem Lett 22: 1510-9 (2012) | AstraZeneca R&D Boston | 2D 3D TSV |
22297114 | 20 | Dualß2-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD. | Bioorg Med Chem Lett 22: 1523-6 (2012) | Sun Yat-sen University | 2D 3D TSV |
22297111 | 32 | Novel morpholine ketone analogs as potent histamine H3 receptor inverse agonists with wake activity. | Bioorg Med Chem Lett 22: 1546-9 (2012) | Cephalon Inc | 2D 3D TSV |
22296826 | 4 | New active HIV-1 protease inhibitors derived from 3-hexanol: conformation study of the free inhibitors in crystalline state and in complex with the enzyme. | Chem Biol Drug Des 79: 798-809 (2012) | Technical University of Lódz | 2D 3D TSV |
22292590 | 1 | Enzymatic activity and immunoreactivity of Aca s 4, an alpha-amylase allergen from the storage mite Acarus siro. | BMC Biochem 13: 3 (2012) | Academy of Sciences of the Czech Republic | 2D 3D TSV |
22290078 | 70 | Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitors. | Bioorg Med Chem Lett 22: 1727-30 (2012) | Merck Research Laboratories | 2D 3D TSV |
22290077 | 3 | Concise synthesis of (+)-conduritol F and inositol analogues from naturally available (+)-proto-quercitol and their glucosidase inhibitory activity. | Bioorg Med Chem Lett 22: 1538-40 (2012) | Chulalongkorn University | 2D 3D TSV |
22290076 | 44 | Epiminocyclohepta[b]indole analogs as 5-HT6 antagonists. | Bioorg Med Chem Lett 22: 1494-8 (2012) | AMRI | 2D 3D TSV |
22290075 | 60 | 4-phenoxypiperidine pyridazin-3-one histamine H(3) receptor inverse agonists demonstrating potent and robust wake promoting activity. | Bioorg Med Chem Lett 22: 1504-9 (2012) | Cephalon Inc | 2D 3D TSV |
22289061 | 14 | Identification of binding specificity-determining features in protein families. | J Med Chem 55: 1926-39 (2012) | Sandia National Laboratories | 2D 3D TSV |
22285942 | 79 | 3D-QSAR and 3D-QSSR models of negative allosteric modulators facilitate the design of a novel selective antagonist of humana4ß2 neuronal nicotinic acetylcholine receptors. | Bioorg Med Chem Lett 22: 1797-813 (2012) | The Ohio State University | 2D 3D TSV |
22285571 | 49 | QSAR studies for prediction of cross-ß sheet aggregate binding affinity and selectivity. | Bioorg Med Chem 20: 1434-41 (2012) | The Ohio State University College of Medicine | 2D 3D TSV |
22285569 | 107 | Synthesis and evaluation of non-basic inhibitors of urokinase-type plasminogen activator (uPA). | Bioorg Med Chem 20: 1557-68 (2012) | University of Antwerp | 2D 3D TSV |
22285172 | 124 | Cloning, characterization and sulfonamide inhibition studies of ana-carbonic anhydrase from the living fossil sponge Astrosclera willeyana. | Bioorg Med Chem 20: 1403-10 (2012) | Slovak Academy of Sciences | 2D 3D TSV |
22285028 | 22 | Synthesis and evaluation of debromohymenialdisine-derived Chk2 inhibitors. | Bioorg Med Chem 20: 1475-81 (2012) | Michigan State University | 2D 3D TSV |
22284818 | 4 | First enantioselective syntheses of the dopamine D1 and D2 receptor modulators, (+)- and (-)-govadine. | Bioorg Med Chem Lett 22: 1557-9 (2012) | University of British Columbia | 2D 3D TSV |
22284817 | 82 | ¿-Carbolines: a novel class of cannabinoid agonists with high aqueous solubility and restricted CNS penetration. | Bioorg Med Chem Lett 22: 1619-24 (2012) | AstraZeneca R&D Montreal | 2D 3D TSV |
22284362 | 91 | Identification of biologically active PDE11-selective inhibitors using a yeast-based high-throughput screen. | Chem Biol 19: 155-63 (2012) | Boston College | 2D 3D TSV |
22284361 | 37 | Discovery of potent and selective covalent inhibitors of JNK. | Chem Biol 19: 140-54 (2012) | Harvard Medical School | 2D 3D TSV |
22283377 | 25 | Design, synthesis, and biological evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors with an improved drug resistance profile. | J Med Chem 55: 2242-50 (2012) | Peking University | 2D 3D TSV |
22283328 | 28 | Identification and structure-activity relationships of a novel series of estrogen receptor ligands based on 7-thiabicyclo[2.2.1]hept-2-ene-7-oxide. | J Med Chem 55: 2324-41 (2012) | Wuhan University | 2D 3D TSV |
22282722 | 10 | Molecular Insights into Human Monoamine Oxidase B Inhibition by the Glitazone Anti-Diabetes Drugs. | ACS Med Chem Lett 3: 39-42 (2012) | TBA | 2D 3D TSV |
22281190 | 12 | Design and synthesis of novel inhibitors of human kynurenine aminotransferase-I. | Bioorg Med Chem Lett 22: 1579-81 (2012) | The University of Sydney | 2D 3D TSV |
22281189 | 63 | SAR ofa7 nicotinic receptor agonists derived from tilorone: exploration of a novel nicotinic pharmacophore. | Bioorg Med Chem Lett 22: 1633-8 (2012) | Abbott Laboratories | 2D 3D TSV |
22281185 | 3 | Fluorinated ?F508-CFTR correctors and potentiators for PET imaging. | Bioorg Med Chem Lett 22: 1602-5 (2012) | University of California Davis | 2D 3D TSV |
22280820 | 53 | Novel inhibitors of nitric oxide synthase with antioxidant properties. | Eur J Med Chem 49: 118-26 (2012) | Universit£ degli Studi di Catania | 2D 3D TSV |
22280816 | 1 | Recent advances in antitubercular natural products. | Eur J Med Chem 49: 1-23 (2012) | Universidad Aut£noma de Nuevo Le£n | 2D 3D TSV |
22280453 | 19 | Irreversible inhibition of epidermal growth factor receptor activity by 3-aminopropanamides. | J Med Chem 55: 2251-64 (2012) | Universit£ degli Studi di Parma | 2D 3D TSV |
22280402 | 12 | "True" antiandrogens-selective non-ligand-binding pocket disruptors of androgen receptor-coactivator interactions: novel tools for prostate cancer. | J Med Chem 55: 1635-44 (2012) | Trinity College | 2D 3D TSV |
22280363 | 104 | Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets. | J Med Chem 55: 1731-50 (2012) | Imperial College | 2D 3D TSV |
22277589 | 72 | Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation. | Bioorg Med Chem 20: 1545-56 (2012) | Jagiellonian University Medical College | 2D 3D TSV |
22277588 | 25 | Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors. | Bioorg Med Chem 20: 1411-6 (2012) | Nanjing University | 2D 3D TSV |
22277279 | 9 | Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors. | Bioorg Med Chem Lett 22: 1560-4 (2012) | Istituto di Biostrutture e Bioimmagini-CNR | 2D 3D TSV |
22277094 | 59 | Optimization of hydroxybenzothiazoles as novel potent and selective inhibitors of 17ß-HSD1. | J Med Chem 55: 2469-73 (2012) | Saarland University | 2D 3D TSV |
22277057 | 11 | Highly potent and selective fluorescent antagonists of the human adenosine A3 receptor based on the 1,2,4-triazolo[4,3-a]quinoxalin-1-one scaffold. | J Med Chem 55: 1771-82 (2012) | University of Nottingham | 2D 3D TSV |
22276953 | 63 | A new strategy for the development of highly potent and selective plasmin inhibitors. | J Med Chem 55: 1171-80 (2012) | Philipps University Marburg | 2D 3D TSV |
22276851 | 4 | Caspase-1 and -3 inhibiting drimane sesquiterpenoids from the extremophilic fungus Penicillium solitum. | J Nat Prod 75: 262-6 (2012) | University of Montana | 2D 3D TSV |
22276693 | 5 | Trichostatin analogues JBIR-109, JBIR-110, and JBIR-111 from the marine sponge-derived Streptomyces sp. RM72. | J Nat Prod 75: 285-9 (2012) | Biomedicinal Information Research Center (BIRC) | 2D 3D TSV |
22276570 | 112 | Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo. | J Med Chem 55: 1721-30 (2012) | Universit£ degli Studi di Firenze | 2D 3D TSV |
22272748 | 46 | Fragment-based and structure-guided discovery and optimization of Rho kinase inhibitors. | J Med Chem 55: 2474-8 (2012) | H. Lee Moffitt Cancer Center and Research Institute | 2D 3D TSV |
22269278 | 50 | Angiogenesis inhibitors identified by cell-based high-throughput screening: synthesis, structure-activity relationships and biological evaluation of 3-[(E)-styryl]benzamides that specifically inhibit endothelial cell proliferation. | Bioorg Med Chem 20: 1442-60 (2012) | Chugai Pharmaceutical Co. Ltd | 2D 3D TSV |
22269276 | 3 | Synthesis and evaluation of malonate-based inhibitors of phosphosugar-metabolizing enzymes: class II fructose-1,6-bis-phosphate aldolases, type I phosphomannose isomerase, and phosphoglucose isomerase. | Bioorg Med Chem 20: 1511-20 (2012) | Univ Paris-Sud | 2D 3D TSV |
22268551 | 42 | Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity. | J Med Chem 55: 1559-71 (2012) | Universit£ degli Studi di Siena | 2D 3D TSV |
22268448 | 34 | New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. | J Med Chem 55: 1572-82 (2012) | University of Li£ge | 2D 3D TSV |
22267981 | 30 | CoA Adducts of 4-Oxo-4-Phenylbut-2-enoates: Inhibitors of MenB from the M. tuberculosis Menaquinone Biosynthesis Pathway. | ACS Med Chem Lett 2: 818-823 (2011) | TBA | 2D 3D TSV |
22266039 | 119 | Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors. | Bioorg Med Chem Lett 22: 1591-7 (2012) | Spanish National Cancer Research Centre (CNIO) | 2D 3D TSV |
22266038 | 55 | Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis. | Bioorg Med Chem Lett 22: 1655-9 (2012) | AstraZeneca | 2D 3D TSV |
22266037 | 2 | New inhibitor of 3-phosphoinositide dependent protein kinase-1 identified from virtual screening. | Bioorg Med Chem Lett 22: 1629-32 (2012) | Central China Normal University | 2D 3D TSV |
22266036 | 116 | Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain. | Bioorg Med Chem Lett 22: 1575-8 (2012) | Merck Research Laboratories | 2D 3D TSV |
22264754 | 36 | 17ß-Arylsulfonamides of 17ß-aminoestra-1,3,5(10)-trien-3-ol as highly potent inhibitors of steroid sulfatase. | Bioorg Med Chem 20: 1535-44 (2012) | University of Waterloo | 2D 3D TSV |
22264488 | 58 | Discovery of benzodihydroisofurans as novel, potent, bioavailable and brain-penetrant prolylcarboxypeptidase inhibitors. | Bioorg Med Chem Lett 22: 1550-6 (2012) | Merck Research Laboratories | 2D 3D TSV |
22264487 | 5 | Aß-tryptase inhibitor with a tropanylamide scaffold to improve in vitro stability and to lower hERG channel binding affinity. | Bioorg Med Chem Lett 22: 1606-10 (2012) | Sanofi Pharmaceuticals | 2D 3D TSV |
22264486 | 62 | Imidazopyridines as selective CYP3A4 inhibitors. | Bioorg Med Chem Lett 22: 1611-4 (2012) | The Scripps Research Institute | 2D 3D TSV |
22264485 | 64 | Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist. | Bioorg Med Chem Lett 22: 1788-92 (2012) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
22264484 | 28 | Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT1) antagonists. | Bioorg Med Chem Lett 22: 1649-54 (2012) | Kyung Hee University | 2D 3D TSV |
22264481 | 58 | Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile. | Bioorg Med Chem Lett 22: 1750-5 (2012) | Arena Pharmaceuticals | 2D 3D TSV |
22264479 | 56 | Design and synthesis of 6,6-fused heterocyclic amides as raf kinase inhibitors. | Bioorg Med Chem Lett 22: 1678-81 (2012) | Novartis Institutes for Biomedical Research | 2D 3D TSV |
22264478 | 36 | Optimization of phenylacetic acid derivatives for balanced CRTH2 and DP dual antagonists. | Bioorg Med Chem Lett 22: 1686-9 (2012) | Amgen Inc | 2D 3D TSV |
22264476 | 60 | Discovery of aminopiperidine-based Smac mimetics as IAP antagonists. | Bioorg Med Chem Lett 22: 1690-4 (2012) | AstraZeneca R&D Boston | 2D 3D TSV |
22264475 | 10 | Wake-promoting agents: search for next generation modafinil: part I. | Bioorg Med Chem Lett 22: 2312-4 (2012) | Cephalon Inc | 2D 3D TSV |
22264472 | 30 | Inhibition of human monoamine oxidase A and B by 5-phenoxy 8-aminoquinoline analogs. | Bioorg Med Chem Lett 22: 1701-4 (2012) | University of Mississippi | 2D 3D TSV |
22264170 | 38 | Pinophilins A and B, inhibitors of mammalian A-, B-, and Y-family DNA polymerases and human cancer cell proliferation. | J Nat Prod 75: 135-41 (2012) | Science University of Tokyo | 2D 3D TSV |
22264115 | 19 | Chemical constituents from the aerial parts of Aster koraiensis with protein glycation and aldose reductase inhibitory activities. | J Nat Prod 75: 267-70 (2012) | Korean Institute of Oriental Medicine (KIOM) | 2D 3D TSV |
22264015 | 29 | N-phosphonocarbonylpyrrolidine derivatives of guanine: a new class of bi-substrate inhibitors of human purine nucleoside phosphorylase. | J Med Chem 55: 1612-21 (2012) | Academy of Sciences of the Czech Republic | 2D 3D TSV |
22263962 | 6 | Dynamic combinatorial mass spectrometry leads to inhibitors of a 2-oxoglutarate-dependent nucleic acid demethylase. | J Med Chem 55: 2173-84 (2012) | University of Oxford | 2D 3D TSV |
22263917 | 77 | Rapid development of piperidine carboxamides as potent and selective anaplastic lymphoma kinase inhibitors. | J Med Chem 55: 1698-705 (2012) | Amgen Inc | 2D 3D TSV |
22263894 | 23 | Cyclooxygenase-1-selective inhibitors based on the (E)-2'-des-methyl-sulindac sulfide scaffold. | J Med Chem 55: 2287-300 (2012) | Vanderbilt Institute of Chemical Biology | 2D 3D TSV |
22263872 | 15 | Identification and preliminary characterization of a potent, safe, and orally efficacious inhibitor of acyl-CoA:diacylglycerol acyltransferase 1. | J Med Chem 55: 1751-7 (2012) | Abbott Laboratories | 2D 3D TSV |
22263837 | 262 | Development of potent and selective inhibitors of aldo-keto reductase 1C3 (type 5 17ß-hydroxysteroid dehydrogenase) based on N-phenyl-aminobenzoates and their structure-activity relationships. | J Med Chem 55: 2311-23 (2012) | University of Pennsylvania | 2D 3D TSV |
22261024 | 21 | Construction of an Indonesian herbal constituents database and its use in Random Forest modelling in a search for inhibitors of aldose reductase. | Bioorg Med Chem 20: 1251-8 (2012) | King's College London | 2D 3D TSV |
22261023 | 14 | Quinolone derivatives containing strained spirocycle as orally active glycogen synthase kinase 3ß (GSK-3ß) inhibitors for type 2 diabetics. | Bioorg Med Chem 20: 1188-200 (2012) | Kyorin Pharmaceutical Co., Ltd | 2D 3D TSV |
22261021 | 33 | Identification of trans-4-[1-[[7-fluoro-2-(1-methyl-3-indolyl)-6-benzoxazolyl]acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid as a potent, orally active VLA-4 antagonist. | Bioorg Med Chem 20: 1201-12 (2012) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
22260770 | 12 | Synthesis and antihormonal properties of novel 11ß-benzoxazole-substituted steroids. | Bioorg Med Chem Lett 22: 1705-8 (2012) | Research Triangle Institute | 2D 3D TSV |
22260203 | 73 | [1,2,4]triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: antagonists of the Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding. | J Med Chem 55: 1127-36 (2012) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
22260166 | 17 | Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors. | J Med Chem 55: 1465-77 (2012) | Georgia Institute of Technology | 2D 3D TSV |
22260081 | 12 | Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators. | J Med Chem 55: 4027-61 (2012) | Universit£ Lille Nord de France | 2D 3D TSV |
22257893 | 22 | Design and synthesis of 8-substituted benzamido-phenylxanthine derivatives as MAO-B inhibitors. | Bioorg Med Chem Lett 22: 1739-42 (2012) | Wenzhou Medical College | 2D 3D TSV |
22257892 | 60 | Synthesis and biological evaluation of [6]-gingerol analogues as transient receptor potential channel TRPV1 and TRPA1 modulators. | Bioorg Med Chem Lett 22: 1674-7 (2012) | Sapienza University of Rome | 2D 3D TSV |
22257889 | 52 | Isoform-selective thiazolo[5,4-b]pyridine S1P1 agonists possessing acyclic amino carboxylate head-groups. | Bioorg Med Chem Lett 22: 1779-83 (2012) | Amgen Inc | 2D 3D TSV |
22257528 | 5 | A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease. | Bioorg Med Chem 20: 1175-80 (2012) | Punjabi University | 2D 3D TSV |
22257213 | 98 | Discovery and development of spleen tyrosine kinase (SYK) inhibitors. | J Med Chem 55: 3614-43 (2012) | Rigel, Inc. | 2D 3D TSV |
22257165 | 50 | Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections. | J Med Chem 55: 1662-70 (2012) | Pfizer Inc. | 2D 3D TSV |
22257095 | 65 | 3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A2B adenosine receptor antagonists. | J Med Chem 55: 1490-9 (2012) | Universit£ di Pisa | 2D 3D TSV |
22257026 | 31 | 5-imino-1,2,4-thiadiazoles: first small molecules as substrate competitive inhibitors of glycogen synthase kinase 3. | J Med Chem 55: 1645-61 (2012) | Instituto de Qu£mica M£dica-CSIC | 2D 3D TSV |
22257012 | 21 | Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1. | J Med Chem 55: 1671-81 (2012) | The University of Melbourne | 2D 3D TSV |
22250781 | 16 | Identification of novel adenosine A(2A) receptor antagonists by virtual screening. | J Med Chem 55: 1904-9 (2012) | Heptares Therapeutics Limited | 2D 3D TSV |
22249123 | 2 | Synthesis of purine N9-[2-hydroxy-3-O-(phosphonomethoxy)propyl] derivatives and their side-chain modified analogs as potential antimalarial agents. | Bioorg Med Chem 20: 1222-30 (2012) | Academy of Sciences of the Czech Republic | 2D 3D TSV |
22249122 | 9 | Synthesis and evaluation of potent and selective human V1a receptor antagonists as potential ligands for PET or SPECT imaging. | Bioorg Med Chem 20: 1337-45 (2012) | Lehigh University | 2D 3D TSV |
22248857 | 39 | Discovery of a new class of potent prolylcarboxypeptidase inhibitors derived from alanine. | Bioorg Med Chem Lett 22: 1774-8 (2012) | Merck Research Laboratories | 2D 3D TSV |
22248361 | 24 | Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion. | J Med Chem 55: 2154-62 (2012) | Trinity College | 2D 3D TSV |
22248356 | 20 | A novel mechanism by which small molecule inhibitors induce the DFG flip in Aurora A. | ACS Chem Biol 7: 698-706 (2012) | Moffitt Cancer Center | 2D 3D TSV |
22248345 | 6 | Contribution of phosphates and adenine to the potency of adenophostins at the IP3 receptor: synthesis of all possible bisphosphates of adenophostin A. | J Med Chem 55: 1706-20 (2012) | University of Bath | 2D 3D TSV |
22248262 | 101 | Triphenylbutanamines: kinesin spindle protein inhibitors with in vivo antitumor activity. | J Med Chem 55: 1511-25 (2012) | The Beatson Institute for Cancer Research | 2D 3D TSV |
22248236 | 24 | Diverse heterocyclic scaffolds as allosteric inhibitors of AKT. | J Med Chem 55: 1261-73 (2012) | AstraZeneca | 2D 3D TSV |
22247788 | 40 | Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase Inhibitors. | ACS Med Chem Lett 2: 907-912 (2011) | TBA | 2D 3D TSV |
22245230 | 128 | Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents. | Bioorg Med Chem 20: 1291-7 (2012) | Florida A&M University | 2D 3D TSV |
22245049 | 14 | New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold. | Eur J Med Chem 49: 102-9 (2012) | Universit£ degli Studi di Torino | 2D 3D TSV |
22245047 | 135 | Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI. | Eur J Med Chem 49: 68-73 (2012) | Ondokuz Mayis University | 2D 3D TSV |
22244939 | 31 | [¹¿?¿F]GE-180: a novel fluorine-18 labelled PET tracer for imaging Translocator protein 18 kDa (TSPO). | Bioorg Med Chem Lett 22: 1308-13 (2012) | GE Healthcare | 2D 3D TSV |
22244937 | 44 | Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor. | Bioorg Med Chem Lett 22: 1433-8 (2012) | Celgene Corporation | 2D 3D TSV |
22244072 | 43 | Inhibition of the pore-forming protein perforin by a series of aryl-substituted isobenzofuran-1(3H)-ones. | Bioorg Med Chem 20: 1319-36 (2012) | University of Auckland | 2D 3D TSV |
22243962 | 17 | Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain. | Bioorg Med Chem Lett 22: 1340-3 (2012) | Stanford University School of Medicine | 2D 3D TSV |
22243960 | 88 | Structure-based design, synthesis and structure-activity relationships of dibenzosuberyl- and benzoate-substituted tropines as ligands for acetylcholine-binding protein. | Bioorg Med Chem Lett 22: 1448-54 (2012) | VU University Amsterdam | 2D 3D TSV |
22243698 | 66 | Homobivalent ligands of the atypical antipsychotic clozapine: design, synthesis, and pharmacological evaluation. | J Med Chem 55: 1622-34 (2012) | Monash University (Parkville Campus) | 2D 3D TSV |
22243648 | 112 | New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, andß-amyloid-reducing properties. | J Med Chem 55: 1303-17 (2012) | Instituto de Qu£mica M£dica | 2D 3D TSV |
22243528 | 12 | Synthesis and biological activity of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl regioisomers as inhibitors of de novo purine biosynthesis with selectivity for cellular uptake by high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier. | J Med Chem 55: 1758-70 (2012) | Duquesne University | 2D 3D TSV |
22243489 | 75 | 1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists. | J Med Chem 55: 1783-7 (2012) | Universit£ di Camerino | 2D 3D TSV |
22243413 | 7 | Structure guided development of novel thymidine mimetics targeting Pseudomonas aeruginosa thymidylate kinase: from hit to lead generation. | J Med Chem 55: 852-70 (2012) | Scripps Florida | 2D 3D TSV |
22242551 | 76 | Identification of fused-ring alkanoic acids with improved pharmacokinetic profiles that act as G protein-coupled receptor 40/free fatty acid receptor 1 agonists. | J Med Chem 55: 1538-52 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22239545 | 287 | Ligand-based design of a potent and selective inhibitor of cytochrome P450 2C19. | J Med Chem 55: 1205-14 (2012) | Amgen Inc | 2D 3D TSV |
22239465 | 26 | Design and characterization of optimized adenosine A2A/A1 receptor antagonists for the treatment of Parkinson's disease. | J Med Chem 55: 1402-17 (2012) | Janssen Research and Development LLC | 2D 3D TSV |
22239408 | 31 | Toll-like receptor (TLR)-7 and -8 modulatory activities of dimeric imidazoquinolines. | J Med Chem 55: 1106-16 (2012) | University of Kansas | 2D 3D TSV |
22239250 | 59 | Pyridyl-2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists: synthesis, pharmacokinetics, and in vivo potency. | J Med Chem 55: 783-96 (2012) | GlaxoSmithKline | 2D 3D TSV |
22239221 | 3 | Rational approaches to improving selectivity in drug design. | J Med Chem 55: 1424-44 (2012) | University of Cambridge | 2D 3D TSV |
22237251 | 4 | Synthesis and interaction with midkine of biotinylated chondroitin sulfate tetrasaccharides. | Bioorg Med Chem Lett 22: 1371-4 (2012) | Tottori University | 2D 3D TSV |
22236472 | 51 | Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10. | Eur J Med Chem 48: 321-9 (2012) | Gifu Pharmaceutical University | 2D 3D TSV |
22236250 | 16 | Exploring activity cliffs in medicinal chemistry. | J Med Chem 55: 2932-42 (2012) | Rheinische Friedrich-Wilhelms-Universit£t | 2D 3D TSV |
22236086 | 3 | Synthesis and evaluation of ¹?F-labeled styryltriazole and resveratrol derivatives for ?-amyloid plaque imaging. | J Med Chem 55: 883-92 (2012) | Sungkyunkwan University School of Medicine | 2D 3D TSV |
22233543 | 70 | New protein farnesyltransferase inhibitors in the 3-arylthiophene 2-carboxylic acid series: diversification of the aryl moiety by solid-phase synthesis. | J Enzyme Inhib Med Chem 28: 163-71 (2013) | Centre de Recherche de Gif | 2D 3D TSV |
22233540 | 7 | Kinetic characterization of a slow-binding inhibitor of Bla2: thiomaltol. | J Enzyme Inhib Med Chem 28: 137-42 (2013) | Baylor University | 2D 3D TSV |
22233539 | 90 | Nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity. | J Enzyme Inhib Med Chem 27: 628-40 (2012) | Shandong University | 2D 3D TSV |
22233320 | 19 | Structural basis of selective inhibition of human tankyrases. | J Med Chem 55: 1360-7 (2012) | Abo Akademi University | 2D 3D TSV |
22230199 | 12 | Unbiased binding assays for discovering small-molecule probes and drugs. | Bioorg Med Chem 20: 1979-89 (2012) | Broad Institute of Harvard and MIT | 2D 3D TSV |
22230050 | 82 | Synthesis and carbonic anhydrase inhibitory properties of novel cyclohexanonyl bromophenol derivatives. | Bioorg Med Chem Lett 22: 1352-7 (2012) | Artvin£oruh University | 2D 3D TSV |
22229710 | 18 | Binding evaluation of fragment-based scaffolds for probing allosteric enzymes. | J Med Chem 55: 1287-95 (2012) | Universit£ de Lyon | 2D 3D TSV |
22229669 | 130 | Synthesis and structure-activity relationships of (aryloxy)quinazoline ureas as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors. | J Med Chem 55: 1189-204 (2012) | University of Lille | 2D 3D TSV |
22229647 | 20 | Design, synthesis, and biological evaluation of new diaminoquinazolines as ?-catenin/Tcf4 pathway inhibitors. | J Med Chem 55: 1346-59 (2012) | State University of New York | 2D 3D TSV |
22227463 | 90 | 2-(4-Methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the B and C-regions. | Bioorg Med Chem 20: 1310-8 (2012) | Shenyang Pharmaceutical University | 2D 3D TSV |
22227462 | 2 | Chemical modulators working at pharmacological interface of target proteins. | Bioorg Med Chem 20: 1893-901 (2012) | Korea University College of Pharmacy Sejong-ro | 2D 3D TSV |
22227214 | 22 | Discovery of novel selective inhibitors for EGFR-T790M/L858R. | Bioorg Med Chem Lett 22: 1365-70 (2012) | Dalian University of Technology | 2D 3D TSV |
22227212 | 58 | Pyrazoloquinolines as PDE10A inhibitors: discovery of a tool compound. | Bioorg Med Chem Lett 22: 1335-9 (2012) | Merck Research Laboratories | 2D 3D TSV |
22227210 | 74 | Anion inhibition studies of ana-carbonic anhydrase from the living fossil Astrosclera willeyana. | Bioorg Med Chem Lett 22: 1314-6 (2012) | Slovak Academy of Sciences | 2D 3D TSV |
22226656 | 75 | Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT6 receptor antagonist showing activity in rat social recognition test. | Bioorg Med Chem Lett 22: 1421-6 (2012) | Cephalon Inc | 2D 3D TSV |
22226655 | 88 | Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury. | Bioorg Med Chem Lett 22: 1427-32 (2012) | Celgene Corporation | 2D 3D TSV |
22225917 | 44 | Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802). | Bioorg Med Chem 20: 1271-80 (2012) | Chugai Pharmaceutical Co. Ltd | 2D 3D TSV |
22225641 | 13 | Substituents at the naphthalene C3 position of (-)-Cercosporamide derivatives significantly affect the maximal efficacy as PPAR¿ partial agonists. | Bioorg Med Chem Lett 22: 1348-51 (2012) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
22225639 | 29 | Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2). | Bioorg Med Chem Lett 22: 1384-7 (2012) | Bristol-Myers Squibb Co. | 2D 3D TSV |
22225638 | 18 | A scaffold hopping approach to identify novel monoamine oxidase B inhibitors. | Bioorg Med Chem Lett 22: 1380-3 (2012) | Northeast Ohio Medical University | 2D 3D TSV |
22225636 | 11 | The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not aß-secretase inhibitor. | Bioorg Med Chem Lett 22: 1408-14 (2012) | Beijing Institute of Pharmacology and Toxicology | 2D 3D TSV |
22225635 | 5 | Synthesis and biological evaluation of benzo[d]imidazole derivatives as potential anti-cancer agents. | Bioorg Med Chem Lett 22: 1317-21 (2012) | University of Nottingham | 2D 3D TSV |
22225633 | 96 | Design and synthesis of boronic acid inhibitors of endothelial lipase. | Bioorg Med Chem Lett 22: 1397-401 (2012) | Tufts University School of Medicine | 2D 3D TSV |
22225576 | 11 | Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide. | J Enzyme Inhib Med Chem 28: 172-82 (2013) | Umeå University | 2D 3D TSV |
22224710 | 44 | Structure-activity relationship study of opiorphin, a human dual ectopeptidase inhibitor with antinociceptive properties. | J Med Chem 55: 1181-8 (2012) | Institute of Advanced Chemistry of Catalonia (IQAC-CSIC) | 2D 3D TSV |
22224640 | 53 | Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis. | J Med Chem 55: 2915-31 (2012) | Oxagen Ltd. | 2D 3D TSV |
22224594 | 346 | Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease. | J Med Chem 55: 1021-46 (2012) | Evotec (UK) Ltd | 2D 3D TSV |
22222157 | 55 | Structure-activity relationships for naturally occurring coumarins asß-secretase inhibitor. | Bioorg Med Chem 20: 784-8 (2012) | Kinki University | 2D 3D TSV |
22222138 | 40 | Dibasic biphenyl H3 receptor antagonists: Steric tolerance for a lipophilic side chain. | Eur J Med Chem 48: 214-30 (2012) | Universit£ degli Studi di Parma | 2D 3D TSV |
22222137 | 13 | Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B. | Eur J Med Chem 48: 284-95 (2012) | Universit£ degli Studi Magna Gr£cia di Catanzaro | 2D 3D TSV |
22222037 | 77 | Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists. | Bioorg Med Chem Lett 22: 797-800 (2012) | Janssen Pharmaceutica NV | 2D 3D TSV |
22222036 | 9 | Small molecule inhibitors of BRAF in clinical trials. | Bioorg Med Chem Lett 22: 789-92 (2012) | The Institute of Cancer Research | 2D 3D TSV |
22222034 | 35 | The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia. | Bioorg Med Chem Lett 22: 1019-22 (2012) | Merck Research Laboratories | 2D 3D TSV |
22222032 | 3 | Synthesis and binding affinity ata4ß2 anda7 nicotinic acetylcholine receptors of new analogs of epibatidine and epiboxidine containing the 7-azabicyclo[2.2.1]hept-2-ene ring system. | Bioorg Med Chem Lett 22: 829-32 (2012) | Universit£ degli Studi di Milano | 2D 3D TSV |
22221201 | 32 | VX-322: a novel dual receptor tyrosine kinase inhibitor for the treatment of acute myelogenous leukemia. | J Med Chem 55: 725-34 (2012) | University of Kentucky | 2D 3D TSV |
22220592 | 27 | Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design. | J Med Chem 55: 1898-903 (2012) | Heptares Therapeutics Limited | 2D 3D TSV |
22217933 | 6 | STAT6 phosphorylation inhibitors block eotaxin-3 secretion in bronchial epithelial cells. | Bioorg Med Chem 20: 750-8 (2012) | Massachusetts General Hospital | 2D 3D TSV |
22217876 | 21 | AMG 837: a potent, orally bioavailable GPR40 agonist. | Bioorg Med Chem Lett 22: 1267-70 (2012) | Amgen Inc | 2D 3D TSV |
22217874 | 49 | Design and synthesis of potent carboxylic acid DGAT1 inhibitors with high cell permeability. | Bioorg Med Chem Lett 22: 824-8 (2012) | Prosidion Ltd | 2D 3D TSV |
22217871 | 6 | Enzymatic transformation of caffeic acid with enhanced cyclooxygenase-2 inhibitory activity. | Bioorg Med Chem Lett 22: 793-6 (2012) | Kyungpook National University | 2D 3D TSV |
22217870 | 51 | Amides of xanthurenic acid as zinc-dependent inhibitors of Lp-PLA(2). | Bioorg Med Chem Lett 22: 868-71 (2012) | ActivX Biosciences Inc | 2D 3D TSV |
22216892 | 66 | The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists. | J Med Chem 55: 1147-60 (2012) | University of Regensburg | 2D 3D TSV |
22214395 | 14 | Structure-activity relationships of cyanoquinolines with corrector-potentiator activity in ?F508 cystic fibrosis transmembrane conductance regulator protein. | J Med Chem 55: 1242-51 (2012) | University of California Davis | 2D 3D TSV |
22214363 | 78 | Discovery of a novel class of potent and orally bioavailable sphingosine 1-phosphate receptor 1 antagonists. | J Med Chem 55: 1368-81 (2012) | Exelixis Inc | 2D 3D TSV |
22214210 | 32 | Synthesis and binding study of certain 6-arylalkanamides as molecular probes for cannabinoid receptor subtypes. | J Enzyme Inhib Med Chem 28: 436-9 (2013) | Cairo University | 2D 3D TSV |
22214209 | 33 | Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three ß-class carbonic anhydrases from Mycobacterium tuberculosis. | J Enzyme Inhib Med Chem 28: 384-7 (2013) | Università degli Studi di Firenze | 2D 3D TSV |
22211528 | 85 | Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay. | ACS Chem Biol 7: 526-34 (2012) | University of Tennessee Health Science Center | 2D 3D TSV |
22209731 | 81 | Antidiabetogenic oligostilbenoids and 3-ethyl-4-phenyl-3,4-dihydroisocoumarins from the bark of Shorea roxburghii. | Bioorg Med Chem 20: 832-40 (2012) | Kinki University | 2D 3D TSV |
22209730 | 73 | A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR)¿ agonists: design and synthesis of benzylpyrazole acylsulfonamides. | Bioorg Med Chem 20: 714-33 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22209462 | 16 | Pyrazolopyridine inhibitors of B-Raf(V600E). Part 3: an increase in aqueous solubility via the disruption of crystal packing. | Bioorg Med Chem Lett 22: 912-5 (2012) | Array BioPharma | 2D 3D TSV |
22209458 | 114 | Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activity. | Bioorg Med Chem Lett 22: 901-6 (2012) | Vernalis (R&D) Ltd | 2D 3D TSV |
22209457 | 47 | SAR studies of C2 ethers of 2H-pyrano[2,3-d]pyrimidine-2,4,7(1H,3H)-triones as nicotinic acid receptor (NAR) agonist. | Bioorg Med Chem Lett 22: 854-8 (2012) | Merck Research Laboratory | 2D 3D TSV |
22209418 | 5 | A small chemical library of 2-aminoimidazole derivatives as BACE-1 inhibitors: Structure-based design, synthesis, and biological evaluation. | Eur J Med Chem 48: 206-13 (2012) | Statistical and Biological Physics Sector, SISSA-ISAS, Via Bonomea 265, 34136 Trieste, Italy. | 2D 3D TSV |
22209272 | 10 | Pyrrole alkanoic acid derivatives as nuisance inhibitors of microsomal prostaglandin E2 synthase-1. | Eur J Med Chem 48: 153-63 (2012) | University of M£nster | 2D 3D TSV |
22209206 | 35 | Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series. | Bioorg Med Chem Lett 22: 980-4 (2012) | Merck Frosst Centre for Therapeutic Research | 2D 3D TSV |
22209205 | 38 | Discovery and optimization of aminopyrimidinones as potent and state-dependent Nav1.7 antagonists. | Bioorg Med Chem Lett 22: 1055-60 (2012) | Amgen Inc | 2D 3D TSV |
22207054 | 5 | Species differences in tissue distribution and enzyme activities of arylacetamide deacetylase in human, rat, and mouse. | Drug Metab Dispos 40: 671-9 (2012) | Kanazawa University | 2D 3D TSV |
22206607 | 9 | Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation. | Bioorg Med Chem Lett 22: 850-3 (2012) | Central South University | 2D 3D TSV |
22206546 | 42 | Nonquaternary reactivators for organophosphate-inhibited cholinesterases. | J Med Chem 55: 465-74 (2012) | Human BioMolecular Research Institute | 2D 3D TSV |
22206487 | 17 | Design, synthesis, and biological evaluation of potent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2. | J Med Chem 55: 367-77 (2012) | Purdue University | 2D 3D TSV |
22205779 | 11 | Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro. | Drug Metab Dispos 40: 655-61 (2012) | University of Oslo | 2D 3D TSV |
22204912 | 6 | Synthesis and evaluation of tetrahedral intermediate mimic inhibitors of 3-deoxy-d-manno-octulosonate 8-phosphate synthase. | Bioorg Med Chem Lett 22: 907-11 (2012) | University of Canterbury | 2D 3D TSV |
22204910 | 17 | Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues. | Bioorg Med Chem Lett 22: 1023-6 (2012) | Harvard Medical School | 2D 3D TSV |
22204908 | 22 | New benzimidazole derivatives as antiplasmodial agents and plasmepsin inhibitors: synthesis and analysis of structure-activity relationships. | Bioorg Med Chem Lett 22: 1282-6 (2012) | University of Karachi | 2D 3D TSV |
22204907 | 4 | Design and synthesis of novel photoaffinity probes for study of the target proteins of oleanolic acid. | Bioorg Med Chem Lett 22: 1036-9 (2012) | China Pharmaceutical University | 2D 3D TSV |
22204903 | 6 | Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines. | Eur J Med Chem 48: 97-107 (2012) | Quimique C£a. Ltd | 2D 3D TSV |
22204902 | 9 | Synthesis and biological activity of novel organoselenium derivatives targeting multiple kinases and capable of inhibiting cancer progression to metastases. | Eur J Med Chem 48: 143-52 (2012) | Institute of the Sir Mortimer Jewish General Hospital | 2D 3D TSV |
22204741 | 46 | N¿?¿-Aryl-6-substitutedphenylmethyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as receptor tyrosine kinase inhibitors. | Bioorg Med Chem 20: 910-4 (2012) | Duquesne University | 2D 3D TSV |
22204740 | 135 | Synthesis and evaluation of novel modified¿-lactam prostanoids as EP4 subtype-selective agonists. | Bioorg Med Chem 20: 702-13 (2012) | Minase Research Institute | 2D 3D TSV |
22204739 | 136 | Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists. | Bioorg Med Chem 20: 1046-59 (2012) | Universit£ di Ferrara | 2D 3D TSV |
22204607 | 15 | Drug-to-genome-to-drug, step 2: reversing selectivity in a series of antiplasmodial compounds. | J Med Chem 55: 1274-86 (2012) | University of Lille | 2D 3D TSV |
22202172 | 17 | 6-Position optimization of tricyclic 4-quinolone-based inhibitors of glycogen synthase kinase-3ß: discovery of nitrile derivatives with picomolar potency. | Bioorg Med Chem Lett 22: 1005-8 (2012) | ActivX Biosciences Inc | 2D 3D TSV |
22200597 | 33 | Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase. | Bioorg Med Chem Lett 22: 942-4 (2012) | University of the Punjab | 2D 3D TSV |
22200345 | 7 | An integrated computational workflow for efficient and quantitative modeling of renin inhibitors. | Bioorg Med Chem 20: 851-8 (2012) | Sanofi US | 2D 3D TSV |
22197670 | 51 | Synthesis of quinolinomorphinan-4-ol derivatives asd opioid receptor agonists. | Bioorg Med Chem 20: 949-61 (2012) | Kitasato University | 2D 3D TSV |
22197396 | 57 | Novel (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: peroxisome proliferator-activated receptor¿ selective agonists with protein-tyrosine phosphatase 1B inhibition. | Bioorg Med Chem 20: 1060-75 (2012) | Kyoto Pharmaceutical Industries | 2D 3D TSV |
22197391 | 44 | Steroidal C-21 heteroaryl thioethers (Part 2): discovery of orally bioavailable selective glucocorticoid receptor modulators (dissociated steroids). | Bioorg Med Chem Lett 22: 1086-90 (2012) | Merck Research Laboratories | 2D 3D TSV |
22197390 | 94 | The discovery of potent antagonists of NPBWR1 (GPR7). | Bioorg Med Chem Lett 22: 1014-8 (2012) | Merck & Co. | 2D 3D TSV |
22197144 | 2 | Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 1: quaternary amines. | Bioorg Med Chem Lett 22: 929-32 (2012) | Novartis Institutes of BioMedical Research | 2D 3D TSV |
22197143 | 17 | Structure-based optimization of morpholino-triazines as PI3K and mTOR inhibitors. | Bioorg Med Chem Lett 22: 1009-13 (2012) | S*BIO Pte Ltd | 2D 3D TSV |
22197142 | 42 | Development of a more highly selective M(1) antagonist from the continued optimization of the MLPCN Probe ML012. | Bioorg Med Chem Lett 22: 1044-8 (2012) | Vanderbilt University Medical Center | 2D 3D TSV |
22197141 | 64 | Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency. | Bioorg Med Chem Lett 22: 1061-7 (2012) | Amgen Inc | 2D 3D TSV |
22197140 | 15 | Discovery of 3-aryloxy-lactam analogs as potent androgen receptor full antagonists for treating castration resistant prostate cancer. | Bioorg Med Chem Lett 22: 1230-6 (2012) | Pfizer Inc | 2D 3D TSV |
22197139 | 42 | Multiparameter exploration of piperazine derivatives asd-opioid receptor agonists for CNS indications. | Bioorg Med Chem Lett 22: 1169-73 (2012) | AstraZeneca Pharmaceuticals | 2D 3D TSV |
22197137 | 61 | 4-Piperidin-4-ylidenemethyl-benzamides asd-opioid receptor agonists for CNS indications: identifying clinical candidates. | Bioorg Med Chem Lett 22: 1174-8 (2012) | AstraZeneca Pharmaceuticals | 2D 3D TSV |
22197136 | 29 | Synthesis and structure-activity relationship of 5-pyridazin-3-one phenoxypiperidines as potent, selective histamine H(3) receptor inverse agonists. | Bioorg Med Chem Lett 22: 1073-7 (2012) | Cephalon Inc | 2D 3D TSV |
22196621 | 17 | Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus. | J Med Chem 55: 1318-33 (2012) | Pfizer Inc | 2D 3D TSV |
22196515 | 14 | Design, synthesis and evaluation of polar head group containing 2-keto-oxazole inhibitors of FAAH. | Bioorg Med Chem 20: 1100-12 (2012) | Max Planck Institute of Molecular Physiology | 2D 3D TSV |
22196514 | 70 | Pyrrolo[1,2-b]pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1 (CRF¿?) receptor antagonists. | Bioorg Med Chem 20: 1122-38 (2012) | Minase Research Institute | 2D 3D TSV |
22196124 | 48 | Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-Raf(V600E) kinase with favorable physicochemical and pharmacokinetic properties. | Bioorg Med Chem Lett 22: 1165-8 (2012) | Array BioPharma, Inc. | 2D 3D TSV |
22196123 | 23 | Structure-based de novo design and biochemical evaluation of novel BRAF kinase inhibitors. | Bioorg Med Chem Lett 22: 1027-30 (2012) | Sejong University | 2D 3D TSV |
22196117 | 48 | Identification of triazolopyridazinones as potent p38a inhibitors. | Bioorg Med Chem Lett 22: 1226-9 (2012) | Amgen Inc | 2D 3D TSV |
22192591 | 17 | Design and synthesis of novel macrocyclic 2-amino-6-arylpyrimidine Hsp90 inhibitors. | Bioorg Med Chem Lett 22: 1136-41 (2012) | Chugai Pharmaceutical Co. Ltd | 2D 3D TSV |
22192588 | 9 | Structure-based library design and the discovery of a potent and selective mast cellß-tryptase inhibitor as an oral therapeutic agent. | Bioorg Med Chem Lett 22: 1049-54 (2012) | Sanofi Pharmaceuticals | 2D 3D TSV |
22191686 | 4 | Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels. | J Med Chem 55: 1418-22 (2012) | Universit£ degli Studi di Bari"Aldo Moro" | 2D 3D TSV |
22191331 | 6 | ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis. | J Med Chem 55: 515-27 (2012) | Northwestern University | 2D 3D TSV |
22189275 | 26 | Novel 3-phenylpiperidine-4-carboxamides as highly potent and orally long-acting neurokinin-1 receptor antagonists with reduced CYP3A induction. | Bioorg Med Chem 20: 962-77 (2012) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22189274 | 1 | Synthesis, SAR, and preliminary mechanistic evaluation of novel antiproliferative N¿?¿,5'-bis-ureido- and 5'-carbamoyl-N¿?¿-ureidoadenosine derivatives. | Bioorg Med Chem 20: 1008-19 (2012) | Brigham Young University | 2D 3D TSV |
22189141 | 2 | In vitro and in silico studies on substrate recognition and acceptance of human PKMYT1, a Cdk1 inhibitory kinase. | Bioorg Med Chem Lett 22: 1219-23 (2012) | Martin-Luther-University Halle-Wittenberg | 2D 3D TSV |
22189138 | 62 | Synthesis of novel histamine H4 receptor antagonists. | Bioorg Med Chem Lett 22: 1156-9 (2012) | Pfizer Inc | 2D 3D TSV |
22189137 | 2 | Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. | Bioorg Med Chem Lett 22: 1125-9 (2012) | University of Genoa | 2D 3D TSV |
22189136 | 25 | Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors. | Bioorg Med Chem Lett 22: 1111-7 (2012) | M.S. University of Baroda | 2D 3D TSV |
22189135 | 15 | High-affinity fluorescent ligands for the 5-HT(3) receptor. | Bioorg Med Chem Lett 22: 1151-5 (2012) | University of Bern | 2D 3D TSV |
22188522 | 45 | Sulfapyridine-like benzenesulfonamide derivatives as inhibitors of carbonic anhydrase isoenzymes I, II and VI. | J Enzyme Inhib Med Chem 27: 818-24 (2012) | Ataturk University | 2D 3D TSV |
22185670 | 73 | Oxadiazoles in medicinal chemistry. | J Med Chem 55: 1817-30 (2012) | AstraZeneca | 2D 3D TSV |
22185640 | 15 | Tailoring of integrin ligands: probing the charge capability of the metal ion-dependent adhesion site. | J Med Chem 55: 871-82 (2012) | Technische Universit£t M£nchen | 2D 3D TSV |
22185619 | 50 | Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases. | J Med Chem 55: 661-9 (2012) | Universitat de Barcelona | 2D 3D TSV |
22185522 | 159 | Structure-activity relationship of a new series of reversible dual monoacylglycerol lipase/fatty acid amide hydrolase inhibitors. | J Med Chem 55: 824-36 (2012) | Universidad Complutense de Madrid | 2D 3D TSV |
22185476 | 3 | Synthesis and structure-activity relationship study of antimicrotubule agents phenylahistin derivatives with a didehydropiperazine-2,5-dione structure. | J Med Chem 55: 1056-71 (2012) | Tokyo University of Pharmacy and Life Sciences | 2D 3D TSV |
22185282 | 32 | Tri- and tetrasubstituted pyrazole derivates: regioisomerism switches activity from p38MAP kinase to important cancer kinases. | J Med Chem 55: 961-5 (2012) | Islamic University of Gaza | 2D 3D TSV |
22185225 | 2 | Peroxisome proliferator-activated receptors (PPARs) have multiple binding points that accommodate ligands in various conformations: phenylpropanoic acid-type PPAR ligands bind to PPAR in different conformations, depending on the subtype. | J Med Chem 55: 893-902 (2012) | The University of Tokyo | 2D 3D TSV |
22182581 | 36 | Synthesis and biological evaluation of 4-[3-chloro-4-(3-fluorobenzyloxy)anilino]-6-(3-substituted-phenoxy)pyrimidines as dual EGFR/ErbB-2 kinase inhibitors. | Bioorg Med Chem 20: 877-85 (2012) | East China University of Science and Technology | 2D 3D TSV |
22182579 | 110 | Synthesis and biochemical analysis of 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoro-N-hydroxy-octanediamides as inhibitors of human histone deacetylases. | Bioorg Med Chem 20: 985-95 (2012) | University of Applied Sciences | 2D 3D TSV |
22182578 | 13 | Cell-based and in-silico studies on the high intrinsic activity of two boron-containing salbutamol derivatives at the humanß2-adrenoceptor. | Bioorg Med Chem 20: 933-41 (2012) | Instituto Polit£cnico Nacional (IPN) | 2D 3D TSV |
22182575 | 1 | Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A¿? adenosine receptor. | Bioorg Med Chem 20: 996-1007 (2012) | Universit£ di Ferrara | 2D 3D TSV |
22182499 | 20 | Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors. | Bioorg Med Chem Lett 22: 1068-72 (2012) | Merck Research Laboratories | 2D 3D TSV |
22182498 | 71 | Heteroaromatic-aminomethyl quinolones: potent and selective iNOS inhibitors. | Bioorg Med Chem Lett 22: 1237-41 (2012) | Afraxis | 2D 3D TSV |
22180837 | 7 | Structure-function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097. | Medchemcomm 2: 424-429 (2011) | Centre National de la Recherche Scientifique | 2D 3D TSV |
22180836 | 5 | Development of a phosphatase-resistant, L-tyrosine derived LPA1/LPA3 dual antagonist. | Medchemcomm 2: 325-330 (2011) | University of Virginia | 2D 3D TSV |
22178554 | 29 | Discovery of novel and potent CRTH2 antagonists. | Bioorg Med Chem Lett 22: 1194-7 (2012) | Astellas Pharma Inc | 2D 3D TSV |
22178553 | 10 | Tripeptidic BACE1 inhibitors devised by in-silico conformational structure-based design. | Bioorg Med Chem Lett 22: 1130-5 (2012) | Kobe Gakuin University | 2D 3D TSV |
22178551 | 46 | A multivalent approach to the discovery of long-actingß(2)-adrenoceptor agonists for the treatment of asthma and COPD. | Bioorg Med Chem Lett 22: 1213-8 (2012) | Theravance, Inc. | 2D 3D TSV |
22178188 | 19 | Synthesis of 9-phosphonoalkyl and 9-phosphonoalkoxyalkyl purines: evaluation of their ability to act as inhibitors of Plasmodium falciparum, Plasmodium vivax and human hypoxanthine-guanine-(xanthine) phosphoribosyltransferases. | Bioorg Med Chem 20: 1076-89 (2012) | Academy of Sciences of the Czech Republic | 2D 3D TSV |
22177784 | 2 | In vivo evaluation of oral anti-tumoral effect of 3,4-dihydroquinazoline derivative on solid tumor. | Bioorg Med Chem Lett 22: 1198-201 (2012) | Kyung Hee University | 2D 3D TSV |
22177783 | 122 | Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes. | Bioorg Med Chem Lett 22: 1464-8 (2012) | Argenta Discovery Ltd | 2D 3D TSV |
22177408 | 25 | Synthesis and biological evaluation of (4H-1,2,4-triazol-4-yl)isoquinoline derivatives as selective glycine transporter 1 inhibitors. | Bioorg Med Chem 20: 34-41 (2011) | Astellas Pharma Inc | 2D 3D TSV |
22177407 | 104 | Novel pyrazolo[1,5-a]pyridines as p110a-selective PI3 kinase inhibitors: Exploring the benzenesulfonohydrazide SAR. | Bioorg Med Chem 20: 58-68 (2011) | University of Auckland | 2D 3D TSV |
22177405 | 104 | Discovery of pyrazolo[1,5-a]pyridines as p110a-selective PI3 kinase inhibitors. | Bioorg Med Chem 20: 69-85 (2011) | University of Auckland | 2D 3D TSV |
22177081 | 2 | Discovery of novela7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogs. | Bioorg Med Chem Lett 22: 1179-86 (2012) | Targacept Inc | 2D 3D TSV |
22175825 | 19 | Potent inhibitors of LpxC for the treatment of Gram-negative infections. | J Med Chem 55: 914-23 (2012) | Pfizer Inc | 2D 3D TSV |
22175799 | 22 | Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis. | J Med Chem 55: 709-16 (2012) | Alantos Pharmaceuticals AG | 2D 3D TSV |
22175766 | 45 | Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities. | J Med Chem 55: 943-55 (2012) | NeurAxon Inc | 2D 3D TSV |
22172704 | 106 | Discovery of a new molecular probe ML228: an activator of the hypoxia inducible factor (HIF) pathway. | Bioorg Med Chem Lett 22: 76-81 (2011) | The Broad Institute Probe Development Center | 2D 3D TSV |
22172701 | 40 | Design, synthesis, and activity evaluation of broad-spectrum small-molecule inhibitors of anti-apoptotic Bcl-2 family proteins: characteristics of broad-spectrum protein binding and its effects on anti-tumor activity. | Bioorg Med Chem Lett 22: 39-44 (2011) | Second Military Medical University | 2D 3D TSV |
22172700 | 6 | The design, synthesis and in vitro immunosuppressive evaluation of novel isobenzofuran derivatives. | Bioorg Med Chem Lett 22: 53-6 (2011) | Shenyang Pharmaceutical University | 2D 3D TSV |
22172695 | 28 | Identification of biaryl sulfone derivatives as antagonists of the histamine H3 receptor: discovery of (R)-1-(2-(4'-(3-methoxypropylsulfonyl)biphenyl-4-yl)ethyl)-2-methylpyrrolidine (APD916). | Bioorg Med Chem Lett 22: 71-5 (2011) | Arena Pharmaceuticals | 2D 3D TSV |
22172310 | 47 | Synthesis and evaluation of novel 4-[(3H,3aH,6aH)-3-phenyl)-4,6-dioxo-2-phenyldihydro-2H-pyrrolo[3,4-d]isoxazol-5(3H,6H,6aH)-yl]benzoic acid derivatives as potent acetylcholinesterase inhibitors and anti-amnestic agents. | Bioorg Med Chem 20: 521-30 (2011) | Punjabi University | 2D 3D TSV |
22172309 | 12 | Novel bioactive metabolites of dipyrone (metamizol). | Bioorg Med Chem 20: 101-7 (2011) | Philipps-Universit£t | 2D 3D TSV |
22172308 | 26 | Synthesis and biological activities of 2-[(heteroaryl)methyl]imidazolines. | Bioorg Med Chem 20: 108-16 (2011) | Medical University of Gdansk | 2D 3D TSV |
22172029 | 29 | Design, synthesis, and anaplastic lymphoma kinase (ALK) inhibitory activity for a novel series of 2,4,8,22-tetraazatetracyclo[14.3.1.1³,¿?¿.1¿?¿,¹³]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene macrocycles. | J Med Chem 55: 449-64 (2012) | Cephalon Inc | 2D 3D TSV |
22171543 | 22 | Chemistry and behavioral studies identify chiral cyclopropanes as selectivea4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile. | J Med Chem 55: 717-24 (2012) | University of Illinois at Chicago | 2D 3D TSV |
22170047 | 24 | Intersubunit bridge formation governs agonist efficacy at nicotinic acetylcholine α4β2 receptors: unique role of halogen bonding revealed. | J Biol Chem 287: 4248-59 (2012) | University of Copenhagen | 2D 3D TSV |
22169633 | 47 | N-4-t-Butylbenzyl 2-(4-methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the A-region. | Bioorg Med Chem 20: 215-24 (2011) | Seoul National University | 2D 3D TSV |
22169601 | 16 | Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4-(phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones. | Bioorg Med Chem 20: 125-36 (2011) | University of Regensburg | 2D 3D TSV |
22169600 | 6 | Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: New design with improved properties. | Bioorg Med Chem 20: 47-57 (2012) | National Cancer Institute | 2D 3D TSV |
22169265 | 22 | Activation of human RNase L by 2'- and 5'-O-methylphosphonate-modified oligoadenylates. | Bioorg Med Chem Lett 22: 181-5 (2011) | Academy of Sciences of the Czech Republic | 2D 3D TSV |
22169263 | 73 | Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases. | Bioorg Med Chem Lett 22: 133-7 (2011) | Cephalon Inc | 2D 3D TSV |
22169262 | 26 | Design, synthesis and antitumor activity of 4-aminoquinazoline derivatives targeting VEGFR-2 tyrosine kinase. | Bioorg Med Chem Lett 22: 110-4 (2011) | Shenyang Pharmaceutical University | 2D 3D TSV |
22169261 | 38 | Synthesis and SAR of inhibitors of protein kinase CK2: novel tricyclic quinoline analogs. | Bioorg Med Chem Lett 22: 45-8 (2012) | Cylene Pharmaceuticals Inc. | 2D 3D TSV |
22169260 | 36 | A three-step protocol for lead optimization: quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitors. | Bioorg Med Chem Lett 22: 65-70 (2011) | Merck Research Laboratories | 2D 3D TSV |
22168898 | 10 | Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications. | J Med Chem 55: 1789-808 (2012) | Merck Research Laboratories | 2D 3D TSV |
22168824 | 4 | Structural basis for the interaction between casein kinase 1 delta and a potent and selective inhibitor. | J Med Chem 55: 956-60 (2012) | Amgen Inc | 2D 3D TSV |
22168802 | 12 | Carbonic anhydrases inhibitory effects of new benzenesulfonamides synthesized by using superacid chemistry. | J Enzyme Inhib Med Chem 27: 886-91 (2012) | Laboratoire Synthèse et Réactivité des Substances Naturelles | 2D 3D TSV |
22168797 | 2 | Discovery and synthesis of namalide reveals a new anabaenopeptin scaffold and peptidase inhibitor. | J Med Chem 55: 735-42 (2012) | National Institute of Diabetes and Digestive and Kidney Diseases | 2D 3D TSV |
22168626 | 32 | Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E. | J Med Chem 55: 1082-105 (2012) | Ambit Biosciences | 2D 3D TSV |
22168126 | 43 | Carbonic anhydrase inhibitors: in vitro inhibition of a isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids. | J Enzyme Inhib Med Chem 28: 283-8 (2013) | Ondokuz Mayis University | 2D 3D TSV |
22165973 | 5 | 2-Arylbenzofuran, flavonoid, and tyrosinase inhibitory constituents of Morus yunnanensis. | J Nat Prod 75: 82-7 (2012) | Fudan University | 2D 3D TSV |
22165909 | 48 | Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells. | J Med Chem 55: 639-51 (2012) | University of Illinois at Chicago | 2D 3D TSV |
22165858 | 8 | Substituted chromones as highly potent nontoxic inhibitors, specific for the breast cancer resistance protein. | J Med Chem 55: 966-70 (2012) | CNRS/Universit£ Lyon 1 | 2D 3D TSV |
22165820 | 22 | Fragment based drug discovery: practical implementation based on¹¿F NMR spectroscopy. | J Med Chem 55: 678-87 (2012) | Amgen Inc | 2D 3D TSV |
22154891 | 19 | Structure-based design, synthesis and biological evaluation of N-pyrazole, N'-thiazole urea inhibitors of MAP kinase p38a. | Eur J Med Chem 48: 1-15 (2012) | Chemical Genomics Centre of the Max Planck Society | 2D 3D TSV |
22154762 | 15 | Design and synthesis of novel ?-diketo derivatives as HIV-1 integrase inhibitors. | Bioorg Med Chem 20: 177-82 (2012) | Beijing University of Technology | 2D 3D TSV |
22154664 | 7 | Discovery of potent small molecule inhibitors of DYRK1A by structure-based virtual screening and bioassay. | Bioorg Med Chem Lett 22: 168-71 (2011) | The Second Military Medical University | 2D 3D TSV |
22154558 | 22 | Structure-based redesign of an edema toxin inhibitor. | Bioorg Med Chem 20: 368-76 (2012) | UTMB | 2D 3D TSV |
22154351 | 48 | Synthesis and biological evaluation of substituted pyrazoles as blockers of divalent metal transporter 1 (DMT1). | Bioorg Med Chem Lett 22: 90-5 (2011) | Xenon Pharmaceuticals Inc | 2D 3D TSV |
22154349 | 123 | 5-(2-amino-pyrimidin-4-yl)-1H-pyrrole and 2-(2-amino-pyrimidin-4-yl)-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one derivatives as new classes of selective and orally available Polo-like kinase 1 inhibitors. | Bioorg Med Chem Lett 22: 96-101 (2011) | Nerviano Medical Sciences srl | 2D 3D TSV |
22153942 | 50 | 5-HT2c receptor selectivity and structure-activity relationship of N-methyl-N-(1-methylpiperidin-4-yl)benzenesulfonamide analogs. | Bioorg Med Chem Lett 22: 347-52 (2011) | Korea Institute of Science and Technology | 2D 3D TSV |
22153941 | 140 | Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2. | Bioorg Med Chem Lett 22: 271-7 (2011) | AstraZeneca | 2D 3D TSV |
22153937 | 52 | Novel brain penetrant benzofuropiperidine 5-HT6 receptor antagonists. | Bioorg Med Chem Lett 22: 120-3 (2011) | Cephalon Inc | 2D 3D TSV |
22153936 | 26 | Structure-activity relationship studies of S1P agonists with a dihydronaphthalene scaffold. | Bioorg Med Chem Lett 22: 144-8 (2011) | Ono Pharmaceutical Co., Ltd | 2D 3D TSV |
22153663 | 59 | Ligand based design of novel histamine H4 receptor antagonists; fragment optimization and analysis of binding kinetics. | Bioorg Med Chem Lett 22: 461-7 (2011) | Griffin Discoveries BV | 2D 3D TSV |
22153662 | 137 | Discovery of AZD2932, a new Quinazoline Ether Inhibitor with high affinity for VEGFR-2 and PDGFR tyrosine kinases. | Bioorg Med Chem Lett 22: 262-6 (2011) | AstraZeneca | 2D 3D TSV |
22153347 | 111 | Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H¿?-antihistamines for insomnia. | Bioorg Med Chem Lett 22: 421-6 (2011) | Neurocrine Biosciences Inc | 2D 3D TSV |
22153342 | 60 | Synthesis and evaluation of 4-alkoxy-[1'-cyclobutyl-spiro(3,4-dihydrobenzopyran-2,4'-piperidine)] analogues as histamine-3 receptor antagonists. | Bioorg Med Chem Lett 22: 186-9 (2011) | Cephalon Inc | 2D 3D TSV |
22153340 | 37 | Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD). | Bioorg Med Chem Lett 22: 138-43 (2011) | Pfizer Inc | 2D 3D TSV |
22153339 | 27 | Novel poly(ADP-ribose) polymerase-1 inhibitors. | Bioorg Med Chem Lett 22: 222-4 (2011) | Cephalon Inc | 2D 3D TSV |
22148957 | 8 | Structure-activity relationship (SAR) development and discovery of potent indole-based inhibitors of the hepatitis C virus (HCV) NS5B polymerase. | J Med Chem 55: 754-65 (2012) | Merck Research Laboratories | 2D 3D TSV |
22148921 | 48 | Synthesis and biological profile of the pan-vascular endothelial growth factor receptor/tyrosine kinase with immunoglobulin and epidermal growth factor-like homology domains 2 (VEGF-R/TIE-2) inhibitor 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c | J Med Chem 55: 903-13 (2012) | Cephalon Inc | 2D 3D TSV |
22148859 | 190 | Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A2B adenosine receptor antagonists. | J Med Chem 55: 797-811 (2012) | University of Ferrara | 2D 3D TSV |
22148838 | 125 | Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents. | J Med Chem 55: 106-14 (2012) | University of Michigan | 2D 3D TSV |
22148754 | 26 | Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors. | J Med Chem 55: 140-52 (2012) | University of Dundee | 2D 3D TSV |
22148748 | 23 | Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery. | J Med Chem 55: 1445-64 (2012) | Vanderbilt University Medical Center | 2D 3D TSV |
22148584 | 30 | Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity. | J Med Chem 55: 1047-55 (2012) | University of Toronto | 2D 3D TSV |
22148391 | 2 | Structure-activity relationships for amide-, carbamate-, and urea-linked analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). | J Med Chem 55: 312-26 (2012) | University of Auckland | 2D 3D TSV |
22148349 | 7 | Gliotoxin analogues from a marine-derived fungus, Penicillium sp., and their cytotoxic and histone methyltransferase inhibitory activities. | J Nat Prod 75: 111-4 (2012) | The University of Tokyo | 2D 3D TSV |
22148323 | 53 | Maximizing lipophilic efficiency: the use of Free-Wilson analysis in the design of inhibitors of acetyl-CoA carboxylase. | J Med Chem 55: 935-42 (2012) | Pfizer Inc | 2D 3D TSV |
22148278 | 132 | Discovery of kinase spectrum selective macrocycle (16E)-14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a potent inhibitor of cyclin dependent kinases (CDKs), Janus kinase 2 (JAK2), and fms-like tyrosine kinase | J Med Chem 55: 169-96 (2012) | S BIO Pte. Ltd | 2D 3D TSV |
22148253 | 12 | Nitric oxide release is not required to decrease the ulcerogenic profile of nonsteroidal anti-inflammatory drugs. | J Med Chem 55: 688-96 (2012) | University of Alberta | 2D 3D TSV |
22148241 | 3 | Cyclopeptide Alkaloids from Ziziphus apetala. | J Nat Prod 74: 2571-5 (2011) | Kunming Institute of Botany | 2D 3D TSV |
22148193 | 6 | Secondary metabolites from the roots of Neolitsea daibuensis and their anti-inflammatory activity. | J Nat Prod 74: 2489-96 (2011) | Kaohsiung Medical University | 2D 3D TSV |
22148173 | 2 | Identification of novela4ß2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity. | J Med Chem 55: 812-23 (2012) | University of Illinois at Chicago | 2D 3D TSV |
22145694 | 64 | Simple methanesulfonates are hydrolyzed by the sulfatase carbonic anhydrase activity. | J Enzyme Inhib Med Chem 27: 880-5 (2012) | Agri Ibrahim Cecen University | 2D 3D TSV |
22145674 | 18 | Inhibition of mammalian carbonic anhydrase isoforms I, II and VI with thiamine and thiamine-like molecules. | J Enzyme Inhib Med Chem 28: 316-9 (2013) | Kirklareli University | 2D 3D TSV |
22145629 | 68 | Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergica1- and serotonine 5-HT1A receptors. | J Med Chem 55: 23-36 (2012) | Universit£ degli Studi di Modena e Reggio Emilia | 2D 3D TSV |
22142613 | 15 | Amide-modified prenylcysteine based Icmt inhibitors: Structure-activity relationships, kinetic analysis and cellular characterization. | Bioorg Med Chem 20: 283-95 (2011) | Purdue University | 2D 3D TSV |
22142546 | 16 | AChE inhibitor: a regio- and stereo-selective 1,3-dipolar cycloaddition for the synthesis of novel substituted 5,6-dimethoxy spiro[5.3']-oxindole-spiro-[6.3¿]-2,3-dihydro-1H-inden-1¿-one-7-(substituted aryl)-tetrahydro-1H-pyrrolo[1,2-c][1,3]thiazole. | Bioorg Med Chem Lett 22: 508-11 (2011) | Universiti Sains Malaysia | 2D 3D TSV |
22142545 | 96 | Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia. | Bioorg Med Chem Lett 22: 235-9 (2011) | Merck Research Laboratories | 2D 3D TSV |
22142542 | 73 | 4,5-dihydropyridazin-3-one derivatives as histamine H3 receptor inverse agonists. | Bioorg Med Chem Lett 22: 194-8 (2011) | Cephalon Inc | 2D 3D TSV |
22142541 | 24 | SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitors. | Bioorg Med Chem Lett 22: 199-203 (2011) | Merck Sharp & Dohme Corp | 2D 3D TSV |
22142540 | 27 | Synthesis of bivalent lactosides and their activity as sensors for differences between lectins in inter- and intrafamily comparisons. | Bioorg Med Chem Lett 22: 313-8 (2011) | Ludwig-Maximilians-University Munich | 2D 3D TSV |
22142423 | 27 | Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A2A and A3 adenosine receptor ligands. | J Med Chem 55: 342-56 (2012) | Ewha Womans University | 2D 3D TSV |
22141460 | 12 | 2-Amino-3-cyanopyridine derivatives as carbonic anhydrase inhibitors. | J Enzyme Inhib Med Chem 28: 305-10 (2013) | Gazi University | 2D 3D TSV |
22141319 | 56 | Strategies to mitigate the bioactivation of 2-anilino-7-aryl-pyrrolo[2,1-f][1,2,4]triazines: identification of orally bioavailable, efficacious ALK inhibitors. | J Med Chem 55: 115-25 (2012) | Cephalon Inc | 2D 3D TSV |
22138308 | 18 | Identification of new aminoacid amides containing the imidazo[2,1-b]benzothiazol-2-ylphenyl moiety as inhibitors of tumorigenesis by oncogenic Met signaling. | Eur J Med Chem 47: 239-54 (2012) | University of the Mediterranean | 2D 3D TSV |
22137934 | 9 | Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1. | Bioorg Med Chem 20: 234-42 (2012) | University of Oslo | 2D 3D TSV |
22137933 | 6 | Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family. | Bioorg Med Chem 20: 1878-86 (2012) | University of Oxford | 2D 3D TSV |
22137932 | 17 | Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors. | Bioorg Med Chem 20: 183-94 (2011) | Virginia Tech | 2D 3D TSV |
22137790 | 33 | 4-arylphthalazin-1(2H)-one derivatives as potent antagonists of the melanin concentrating hormone receptor 1 (MCH-R1). | Bioorg Med Chem Lett 22: 427-30 (2011) | Korea Research Institute of Chemical Technology | 2D 3D TSV |
22137788 | 3 | Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity. | Bioorg Med Chem Lett 22: 323-6 (2011) | Korea Research Institute of Bioscience and Biotechnology | 2D 3D TSV |
22137787 | 22 | Synthesis and SAR study of imidazoquinolines as a novel structural class of microsomal prostaglandin E2 synthase-1 inhibitors. | Bioorg Med Chem Lett 22: 285-8 (2011) | Dainippon Sumitomo Pharma Co., Ltd | 2D 3D TSV |
22137786 | 9 | Hydroxycoumarins as selective MAO-B inhibitors. | Bioorg Med Chem Lett 22: 258-61 (2011) | Universit£ degli Studi di Cagliari | 2D 3D TSV |
22137785 | 6 | Inhibitors of human 2,3-oxidosqualene cyclase (OSC) discovered by virtual screening. | Bioorg Med Chem Lett 22: 231-4 (2011) | Institute of Microbial Chemistry | 2D 3D TSV |
22137598 | 15 | Stereochemical diversity of AI-2 analogs modulates quorum sensing in Vibrio harveyi and Escherichia coli. | Bioorg Med Chem 20: 249-56 (2011) | Instituto de Tecnologia Qu£mica e Biol£gica | 2D 3D TSV |
22137457 | 3 | Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase. | Eur J Med Chem 47: 493-500 (2012) | VU University Amsterdam | 2D 3D TSV |
22137345 | 36 | 5- and 6-membered (thio)lactones are prodrug type carbonic anhydrase inhibitors. | Bioorg Med Chem Lett 22: 267-70 (2011) | Universit£ degli Studi di Firenze | 2D 3D TSV |
22137342 | 26 | Discovery and optimization of thieno[2,3-d]pyrimidines as B-Raf inhibitors. | Bioorg Med Chem Lett 22: 747-52 (2011) | Celgene Corporation | 2D 3D TSV |
22137341 | 10 | Identification of oxazolidinediones and thiazolidinediones as potent 17ß-hydroxysteroid dehydrogenase type 3 inhibitors. | Bioorg Med Chem Lett 22: 504-7 (2011) | Sumitomo Chemical Co., Ltd | 2D 3D TSV |
22137339 | 23 | Design, synthesis and in vitro evaluation of novel bivalent S-adenosylmethionine analogues. | Bioorg Med Chem Lett 22: 278-84 (2011) | University of Leeds | 2D 3D TSV |
22136765 | 31 | Synthesis, radiofluorination and pharmacological evaluation of a fluoromethyl spirocyclic PET tracer for centrals1 receptors and comparison with fluoroalkyl homologs. | Bioorg Med Chem 20: 257-69 (2011) | Institute of Radiopharmacy | 2D 3D TSV |
22136469 | 148 | Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides. | J Med Chem 55: 587-96 (2012) | GlaxoSmithKline | 2D 3D TSV |
22136433 | 67 | 7,8-dichloro-1-oxo-ß-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes. | J Med Chem 55: 403-13 (2012) | Ludwig-Maximilians University of Munich | 2D 3D TSV |
22136404 | 9 | Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery. | J Med Chem 55: 576-86 (2012) | GlaxoSmithKline | 2D 3D TSV |
22136336 | 55 | Synthesis, biological evaluation, and molecular modeling of chalcone derivatives as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatases (PtpA and PtpB). | J Med Chem 55: 390-402 (2012) | Universidade Federal de Santa Catarina | 2D 3D TSV |
22133902 | 9 | Bicyclic benzofuran and indole-based salicylic acids as protein tyrosine phosphatase inhibitors. | Bioorg Med Chem 20: 1940-6 (2012) | Indiana University | 2D 3D TSV |
22133631 | 76 | Discovery of cyclic amine-substituted benzoic acids as PPARa agonists. | Bioorg Med Chem Lett 22: 334-8 (2011) | Kyorin Pharmaceutical Co., Ltd | 2D 3D TSV |
22133459 | 56 | New potent 5-HT(2A) receptor ligands containing an N'-cyanopicolinamidine nucleus: Synthesis and in vitro pharmacological evaluation. | Eur J Med Chem 47: 520-9 (2012) | Universit£ di Napoli"Federico II" | 2D 3D TSV |
22130420 | 49 | Quantitative structure-activity relationships of 1,3,4-thiadiazol-2(3H)-ones and 1,3,4-oxadiazol-2(3H)-ones as human protoporphyrinogen oxidase inhibitors. | Bioorg Med Chem 20: 296-304 (2011) | Central China Normal University | 2D 3D TSV |
22130135 | 55 | Discovery of potent and specific CXCR3 antagonists. | Bioorg Med Chem Lett 22: 357-62 (2011) | Amgen Inc | 2D 3D TSV |
22130134 | 58 | 5-sulfonyl-benzimidazoles as selective CB2 agonists-part 2. | Bioorg Med Chem Lett 22: 547-52 (2011) | Janssen Pharmaceutica NV | 2D 3D TSV |
22130133 | 9 | Discovery and bioactivity of 4-(2-arylpyrido[3',2':3,4]pyrrolo[1,2-f][1,2,4]triazin-4-yl) morpholine derivatives as novel PI3K inhibitors. | Bioorg Med Chem Lett 22: 339-42 (2011) | Chinese Academy of Sciences | 2D 3D TSV |
22130130 | 19 | Discovery of pyrrolidine-basedß-secretase inhibitors: lead advancement through conformational design for maintenance of ligand binding efficiency. | Bioorg Med Chem Lett 22: 240-4 (2011) | Merck Research Laboratories | 2D 3D TSV |
22128851 | 3 | (1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent¿-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addiction. | J Med Chem 55: 357-66 (2012) | Northwestern University | 2D 3D TSV |
22128783 | 2 | Synthesis of rocaglamide hydroxamates and related compounds as eukaryotic translation inhibitors: synthetic and biological studies. | J Med Chem 55: 558-62 (2012) | Boston University | 2D 3D TSV |
22125663 | 11 | Structure-activity analysis and cell-based optimization of human galactokinase inhibitors. | ACS Med Chem Lett 2: 667-672 (2011) | TBA | 2D 3D TSV |
22125662 | 11 | CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist. | ACS Med Chem Lett 2: 620-625 (2011) | TBA | 2D 3D TSV |
22125025 | 4 | Inactivation of glucosamine-6-phosphate synthase by N3-oxoacyl derivatives of L-2,3-diaminopropanoic acid. | Chembiochem 13: 85-96 (2012) | Gda£?sk University of Technology | 2D 3D TSV |
22123324 | 36 | Discovery and characterization of a potent and selective antagonist of melanin-concentrating hormone receptor 2. | Bioorg Med Chem Lett 22: 363-6 (2011) | Amgen Inc | 2D 3D TSV |
22122563 | 34 | Diarylpropionitrile (DPN) enantiomers: synthesis and evaluation of estrogen receptorß-selective ligands. | J Med Chem 55: 528-37 (2012) | University of Illinois | 2D 3D TSV |
22119475 | 19 | Fused thiophene derivatives as MEK inhibitors. | Bioorg Med Chem Lett 22: 472-5 (2012) | UCB Pharma | 2D 3D TSV |
22119474 | 46 | Optimization of phenylacetic acid derivatives for CRTH2 and DP selective antagonism. | Bioorg Med Chem Lett 22: 367-70 (2011) | Amgen Inc | 2D 3D TSV |
22119472 | 35 | One-pot regioselective synthesis of tetrahydroindazolones and evaluation of their antiproliferative and Src kinase inhibitory activities. | Bioorg Med Chem Lett 22: 410-4 (2011) | Birla Institute of Technology | 2D 3D TSV |
22119471 | 64 | Discovery of a novel EP2/EP4 dual agonist with high subtype-selectivity. | Bioorg Med Chem Lett 22: 396-401 (2011) | Minase Research Institute | 2D 3D TSV |
22119469 | 107 | Novel and selective spiroindoline-based inhibitors of Sky kinase. | Bioorg Med Chem Lett 22: 190-3 (2011) | Pfizer Inc | 2D 3D TSV |
22119468 | 1 | (±)-2-(N-tert-Butylamino)-3'-[(125)I]-iodo-4'-azidopropiophenone: a dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin, Zyban). | Bioorg Med Chem Lett 22: 523-6 (2011) | Duquesne University | 2D 3D TSV |
22119466 | 38 | A novel series of glucagon receptor antagonists with reduced molecular weight and lipophilicity. | Bioorg Med Chem Lett 22: 415-20 (2011) | Pfizer Inc | 2D 3D TSV |
22119465 | 18 | Structure-based design of PDK1 inhibitors. | Bioorg Med Chem Lett 22: 305-7 (2011) | S BIO Pte. Ltd | 2D 3D TSV |
22119462 | 73 | Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series. | Bioorg Med Chem Lett 22: 613-8 (2011) | Merck Research Laboratories | 2D 3D TSV |
22119461 | 31 | Discovery, design and synthesis of novel potent and selective sphingosine-1-phosphate 4 receptor (S1P4-R) agonists. | Bioorg Med Chem Lett 22: 537-42 (2011) | The Scripps Research Institute | 2D 3D TSV |
22119341 | 10 | Novel immunomodulators based on an oxazolin-2-one-4-carboxamide scaffold. | Bioorg Med Chem Lett 22: 553-7 (2011) | Institute of Pharmacology & Toxicology | 2D 3D TSV |
22119153 | 64 | Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors. | Eur J Med Chem 47: 111-24 (2012) | Alexander Technological Education Institute of Thessaloniki | 2D 3D TSV |
22119130 | 11 | Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents. | Eur J Med Chem 47: 473-8 (2012) | Nanjing University | 2D 3D TSV |
22118829 | 13 | Structure based drug design, synthesis and evaluation of 4-(benzyloxy)-1-phenylbut-2-yn-1-ol derivatives as 5-lipoxygenase inhibitors. | Eur J Med Chem 47: 351-9 (2012) | University of Hyderabad | 2D 3D TSV |
22118188 | 50 | A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography. | J Med Chem 55: 223-32 (2012) | University Hospital M£nster | 2D 3D TSV |
22115839 | 42 | Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets. | Bioorg Med Chem 20: 510-20 (2011) | Purdue University | 2D 3D TSV |
22115618 | 13 | Bis-chalcone analogues as potent NO production inhibitors and as cytotoxic agents. | Eur J Med Chem 47: 97-103 (2012) | National Cheng Kung University | 2D 3D TSV |
22115617 | 64 | CK2a and CK2a' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. | Eur J Med Chem 47: 345-50 (2012) | The John Paul II Catholic University of Lublin | 2D 3D TSV |
22115595 | 8 | 3-mercapto-1,2,4-triazoles and N-acylated thiosemicarbazides as metallo-?-lactamase inhibitors. | Bioorg Med Chem Lett 22: 380-6 (2012) | The University of Queensland | 2D 3D TSV |
22115592 | 1 | A small molecule inhibitor of p53-inducible protein phosphatase PPM1D. | Bioorg Med Chem Lett 22: 729-32 (2011) | Hokkaido University | 2D 3D TSV |
22113110 | 6 | Synthesis, characterization and activity of new phosphonate dipeptides as potential inhibitors of VanX. | Bioorg Med Chem Lett 22: 482-4 (2011) | North-West University | 2D 3D TSV |
22112542 | 1 | Molecular docking studies of a phlorotannin, dieckol isolated from Ecklonia cava with tyrosinase inhibitory activity. | Bioorg Med Chem 20: 311-6 (2011) | Jeju National University | 2D 3D TSV |
22112541 | 11 | Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activity. | Bioorg Med Chem 20: 317-23 (2011) | Soochow University | 2D 3D TSV |
22112540 | 70 | Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein. | Bioorg Med Chem 20: 346-55 (2011) | University of Bonn | 2D 3D TSV |
22112539 | 8 | Elaborate ligand-based modeling and subsequent synthetic exploration unveil new nanomolar Ca2+/calmodulin-dependent protein kinase II inhibitory leads. | Bioorg Med Chem 20: 377-400 (2011) | University of Jordan | 2D 3D TSV |
22112538 | 22 | Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen. | Bioorg Med Chem 20: 1354-63 (2012) | Macquarie University | 2D 3D TSV |
22112208 | 98 | Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein. | J Med Chem 55: 424-36 (2012) | Universit£ degli Studi di Bari"Aldo Moro" | 2D 3D TSV |
22111927 | 65 | Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphing. | J Med Chem 54: 8328-42 (2011) | The Institute of Cancer Research | 2D 3D TSV |
22111545 | 80 | Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors. | J Med Chem 55: 327-41 (2012) | University of Bristol | 2D 3D TSV |
22107736 | 8 | Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. | Chem Biol Drug Des 79: 157-65 (2012) | National Institutes of Health | 2D 3D TSV |
22107038 | 32 | Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues. | J Med Chem 55: 437-48 (2012) | Bar-Ilan University | 2D 3D TSV |
22107017 | 47 | Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity. | J Med Chem 55: 414-23 (2012) | Cephalon Inc | 2D 3D TSV |
22106937 | 83 | Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic. | J Med Chem 54: 8305-20 (2011) | Tranzyme Pharma Inc. | 2D 3D TSV |
22106171 | 9 | Stereospecific metabolism of itraconazole by CYP3A4: dioxolane ring scission of azole antifungals. | Drug Metab Dispos 40: 426-35 (2012) | University of Washington | 2D 3D TSV |
22104971 | 3 | Disubstituted quinazoline derivatives as a new type of highly selective ligands for telomeric G-quadruplex DNA. | Eur J Med Chem 47: 299-311 (2012) | Sun Yat-sen University | 2D 3D TSV |
22104435 | 54 | Design, synthesis, and biological evaluation of novel (1-thioxo-1,2,3,4-tetrahydro-ß-carbolin-9-yl)acetic acids as selective inhibitors for AKR1B1. | Bioorg Med Chem 20: 356-67 (2011) | University of Toyama | 2D 3D TSV |
22104149 | 1 | Potent adjuvantic activity of a CCR1-agonistic bis-quinoline. | Bioorg Med Chem Lett 22: 293-5 (2011) | University of Kansas | 2D 3D TSV |
22104147 | 29 | Design and combinatorial synthesis of a novel kinase-focused library using click chemistry-based fragment assembly. | Bioorg Med Chem Lett 22: 591-6 (2011) | Carna Biosciences, Inc | 2D 3D TSV |
22104145 | 6 | Synthesis and evaluation of potential inhibitors of human and Escherichia coli histidine triad nucleotide binding proteins. | Bioorg Med Chem Lett 22: 558-60 (2011) | University of Minnesota | 2D 3D TSV |
22104144 | 37 | Quinolinone-based agonists of S1P¿?: use of a N-scan SAR strategy to optimize in vitro and in vivo activity. | Bioorg Med Chem Lett 22: 527-31 (2011) | Amgen | 2D 3D TSV |
22104142 | 9 | Lead diversification. Application to existing drug molecules: mifepristone 1 and antalarmin 8. | Bioorg Med Chem Lett 22: 723-8 (2011) | Pfizer Inc | 2D 3D TSV |
22104008 | 64 | Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A2A adenosine receptor. | J Med Chem 55: 538-52 (2012) | National Institute of Diabetes and Digestive and Kidney Diseases | 2D 3D TSV |
22103243 | 81 | Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor. | J Med Chem 55: 250-67 (2012) | The National Center for Drug Screening | 2D 3D TSV |
22102940 | 3 | Separation of Betti Reaction Product Enantiomers: Absolute Configuration and Inhibition of Botulinum Neurotoxin A. | ACS Med Chem Lett 2: 396-401 (2011) | U.S. Army Medical Research Institute for Infectious Diseases | 2D 3D TSV |
22101134 | 9 | LDV peptidomimetics equipped with biotinylated spacer-arms: synthesis and biological evaluation on CCRF-CEM cell line. | Bioorg Med Chem Lett 22: 586-90 (2011) | Universit£ catholique de Louvain (UCL) | 2D 3D TSV |
22101133 | 26 | Discovery of potent and liver-selective stearoyl-CoA desaturase (SCD) inhibitors in an acyclic linker series. | Bioorg Med Chem Lett 22: 623-7 (2011) | Merck Frosst Centre for Therapeutic Research | 2D 3D TSV |
22101132 | 41 | Discovery of novel 5-alkynyl-4-anilinopyrimidines as potent, orally active dual inhibitors of EGFR and Her-2 tyrosine kinases. | Bioorg Med Chem Lett 22: 456-60 (2011) | Shionogi & Co., Ltd | 2D 3D TSV |
22100314 | 38 | Novel 5- and 6-subtituted benzothiazoles with improved physicochemical properties: potent S1P¿? agonists with in vivo lymphocyte-depleting activity. | Bioorg Med Chem Lett 22: 628-33 (2011) | Amgen Inc | 2D 3D TSV |
22100312 | 70 | Indole RSK inhibitors. Part 1: discovery and initial SAR. | Bioorg Med Chem Lett 22: 733-7 (2011) | Boehringer Ingelheim Pharmaceuticals Inc | 2D 3D TSV |
22100261 | 12 | Synthesis and biological evaluation of sialic acid derivatives containing a long hydrophobic chain at the anomeric position and their C-5 linked polymers as potent influenza virus inhibitors. | Bioorg Med Chem 20: 446-54 (2011) | Saitama University | 2D 3D TSV |
22100260 | 30 | The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokinetics. | Bioorg Med Chem 20: 498-509 (2011) | Pfizer Inc | 2D 3D TSV |
22100258 | 124 | Bivalent molecular probes for dopamine D2-like receptors. | Bioorg Med Chem 20: 455-66 (2011) | Friedrich-Alexander University | 2D 3D TSV |
22100142 | 41 | Monoamine oxidase inhibition by C4-substituted phthalonitriles. | Bioorg Chem 40: 114-24 (2012) | North-West University | 2D 3D TSV |
22100140 | 10 | Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans. | Eur J Med Chem 47: 270-7 (2012) | University of Eastern Finland | 2D 3D TSV |
22100138 | 4 | Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model. | Eur J Med Chem 47: 175-85 (2012) | Instituto de Qu£mica M£dica (CSIC) | 2D 3D TSV |
22100137 | 6 | 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site. | Eur J Med Chem 47: 337-44 (2012) | University of Groningen | 2D 3D TSV |
22098589 | 47 | Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors. | J Med Chem 55: 68-83 (2012) | University of Lille | 2D 3D TSV |
22098494 | 4 | Cyclic hydroxyamidines as amide isosteres: discovery of oxadiazolines and oxadiazines as potent and highly efficacious¿-secretase modulators in vivo. | J Med Chem 55: 489-502 (2012) | Schering-Plough Research Institute | 2D 3D TSV |
22094280 | 3 | Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases. | Bioorg Med Chem 19: 7318-37 (2011) | University of Heidelberg | 2D 3D TSV |
22094279 | 75 | Design, synthesis, and biological evaluation of 4-phenylpyrrole derivatives as novel androgen receptor antagonists. | Bioorg Med Chem 20: 422-34 (2011) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22094028 | 31 | Lead optimisation of pyrazoles as novel FPR1 antagonists. | Bioorg Med Chem Lett 22: 532-6 (2011) | AstraZeneca | 2D 3D TSV |
22091869 | 6 | Binding of ibuprofen, ketorolac, and diclofenac to COX-1 and COX-2 studied by saturation transfer difference NMR. | J Med Chem 54: 8555-62 (2011) | Faculdade de Ci�ncias e Tecnologia-UNL | 2D 3D TSV |
22088955 | 33 | Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization. | Eur J Med Chem 47: 143-52 (2012) | Universit£ di Napoli Federico II Via D. Montesano 49 | 2D 3D TSV |
22088753 | 44 | Chromenones as potent bradykinin B1 antagonists. | Bioorg Med Chem Lett 22: 619-22 (2011) | Amgen Inc | 2D 3D TSV |
22088307 | 10 | Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent. | Bioorg Med Chem 19: 7365-73 (2011) | Institute of Chemical Biology | 2D 3D TSV |
22087750 | 145 | Discovery of potent and highly selective thienopyridine Janus kinase 2 inhibitors. | J Med Chem 54: 8440-50 (2011) | Amgen Inc | 2D 3D TSV |
22087650 | 9 | Delineation of the Pasteurellaceae-specific GbpA-family of glutathione-binding proteins. | BMC Biochem 12: 59 (2011) | Ghent University | 2D 3D TSV |
22087535 | 20 | Comparative study of the affinity and metabolism of type I and type II binding quinoline carboxamide analogues by cytochrome P450 3A4. | J Med Chem 55: 280-90 (2012) | Washington State University | 2D 3D TSV |
22085405 | 54 | Inhibition of glutathione S-transferase M1 by new gabosine analogues is essential for overcoming cisplatin resistance in lung cancer cells. | J Med Chem 54: 8574-81 (2011) | Academia Sinica | 2D 3D TSV |
22085339 | 16 | Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors. | J Med Chem 54: 8421-39 (2011) | Hokkaido University | 2D 3D TSV |
22083916 | 65 | Synthesis of (glycopyranosyl-triazolyl)-purines and their inhibitory activities against protein tyrosine phosphatase 1B (PTP1B). | Chem Biodivers 8: 2035-44 (2011) | East China University of Science and Technology | 2D 3D TSV |
22082667 | 67 | Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors. | Bioorg Med Chem 19: 7338-48 (2011) | Microbiotix Inc | 2D 3D TSV |
22082562 | 3 | Methylenebissantin: a rare methylene-bridged bisflavonoid from Dodonaea viscosa which inhibits Plasmodium falciparum enoyl-ACP reductase. | Bioorg Med Chem Lett 22: 610-2 (2011) | University of Karachi | 2D 3D TSV |
22082561 | 9 | Characterisation of [¹¹C]PR04.MZ in Papio anubis baboon: a selective high-affinity radioligand for quantitative imaging of the dopamine transporter. | Bioorg Med Chem Lett 22: 679-82 (2011) | Johannes Gutenberg University | 2D 3D TSV |
22081932 | 32 | Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity. | J Med Chem 55: 37-54 (2012) | Istituto Tumori"Giovanni Paolo II" | 2D 3D TSV |
22079761 | 84 | The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors. | Bioorg Med Chem Lett 22: 658-65 (2011) | Merck Research Laboratories | 2D 3D TSV |
22079757 | 13 | Discovery of a novel class of aldol-derived 1,2,3-triazoles: potent and selective inhibitors of human cytochrome P450 19A1 (aromatase). | Bioorg Med Chem Lett 22: 718-22 (2011) | McMaster University | 2D 3D TSV |
22079756 | 219 | From libraries to candidate: the discovery of new ultra long-acting dibasicß2-adrenoceptor agonists. | Bioorg Med Chem Lett 22: 689-95 (2011) | AstraZeneca | 2D 3D TSV |
22079754 | 72 | Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase. | Bioorg Med Chem Lett 22: 601-5 (2011) | Columbia University | 2D 3D TSV |
22079253 | 16 | Discovery of selective glucocorticoid receptor modulator MK-5932. | Bioorg Med Chem 19: 7374-86 (2011) | Merck Research Laboratories | 2D 3D TSV |
22079027 | 8 | Conformationally restricted analog and biotin-labeled probe based on beauveriolide III. | Bioorg Med Chem Lett 22: 696-9 (2011) | Tohoku University | 2D 3D TSV |
22078413 | 8 | Synthesis and in vitro evaluation of fluorinated styryl benzazoles as amyloid-probes. | Bioorg Med Chem 19: 7698-710 (2011) | Instituto Tecnol£gico e Nuclear | 2D 3D TSV |
22078412 | 4 | Disulfide and amide-bridged cyclic peptide analogues of the VEGF8¿?¿9¿? fragment: synthesis, conformational analysis and biological evaluation. | Bioorg Med Chem 19: 7526-33 (2011) | Instituto de Qu£mica M£dica | 2D 3D TSV |
22078410 | 31 | Time-dependent slowly-reversible inhibition of monoamine oxidase A by N-substituted 1,2,3,6-tetrahydropyridines. | Bioorg Med Chem 19: 7482-92 (2011) | West Virginia University | 2D 3D TSV |
22078216 | 146 | 2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes. | Bioorg Med Chem Lett 21: 7367-72 (2011) | Novartis Institutes for BioMedical Research | 2D 3D TSV |
22078215 | 25 | Biaryl analogues of teriflunomide as potent DHODH inhibitors. | Bioorg Med Chem Lett 21: 7268-72 (2011) | Rhône-Poulenc Rorer | 2D 3D TSV |
22078214 | 29 | Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 2. | Bioorg Med Chem Lett 21: 7287-90 (2011) | Merck Research Laboratories | 2D 3D TSV |
22077416 | 30 | Hydroxylated analogues of ATP-sensitive potassium channel openers belonging to the group of 6- and/or 7-substituted 3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides: toward an improvement in sulfonylurea receptor 1 selectivity and metabolism stability. | J Med Chem 54: 8353-61 (2011) | Universit£ de Li£ge | 2D 3D TSV |
22077347 | 44 | Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. | J Med Chem 54: 8271-7 (2011) | Ecole Nationale Sup£rieure de Chimie de Montpellier | 2D 3D TSV |
22075234 | 35 | Synthesis and binding assays of novel 3,3-dimethylpiperidine derivatives with various lipophilicities ass¿? receptor ligands. | Bioorg Med Chem 19: 7612-22 (2011) | Universit£ degli Studi di Bari | 2D 3D TSV |
22075233 | 16 | New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds. | Bioorg Med Chem 19: 7453-63 (2011) | The University of Adelaide | 2D 3D TSV |
22074142 | 89 | Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists. | J Med Chem 54: 8616-31 (2011) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22071527 | 2 | Synthesis, structure-activity relationships, and mechanism of action of anti-HIV-1 lamellarin ? 20-sulfate analogues. | Bioorg Med Chem 19: 7541-50 (2011) | Nagasaki University | 2D 3D TSV |
22071524 | 7 | Molecular insights into human monoamine oxidase (MAO) inhibition by 1,4-naphthoquinone: evidences for menadione (vitamin K3) acting as a competitive and reversible inhibitor of MAO. | Bioorg Med Chem 19: 7416-24 (2011) | Federal University of Rio de Janeiro | 2D 3D TSV |
22071522 | 6 | Aza vinyl sulfones: synthesis and evaluation as antiplasmodial agents. | Bioorg Med Chem 19: 7635-42 (2011) | University of Lisbon | 2D 3D TSV |
22071521 | 1 | Camptothecin (CPT) directly binds to human heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) and inhibits the hnRNP A1/topoisomerase I interaction. | Bioorg Med Chem 19: 7690-7 (2011) | Tokyo University of Science | 2D 3D TSV |
22071305 | 24 | Rational design and synthesis of aminopiperazinones asß-secretase (BACE) inhibitors. | Bioorg Med Chem Lett 21: 7255-60 (2011) | Research Informatics & Integrative Genomics | 2D 3D TSV |
22071301 | 115 | Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of spirocyclic piperidines. | Bioorg Med Chem Lett 21: 7399-404 (2011) | Merck Frosst Centre for Therapeutic Research | 2D 3D TSV |
22071300 | 7 | Design and synthesis of pyridone inhibitors of non-nucleoside reverse transcriptase. | Bioorg Med Chem Lett 21: 7344-50 (2011) | Merck Research Labs. | 2D 3D TSV |
22071299 | 6 | Inhibitory activity of novel kojic acid derivative containing trolox moiety on melanogenesis. | Bioorg Med Chem Lett 21: 7466-9 (2011) | Kyung Hee University Skin Biotechnology Center | 2D 3D TSV |
22070629 | 61 | Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905). | J Med Chem 55: 197-208 (2012) | Millennium Pharmaceuticals Inc | 2D 3D TSV |
22070604 | 150 | Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor¿ (PPAR¿) modulators. | J Med Chem 54: 8541-54 (2011) | Merck Research Laboratories | 2D 3D TSV |
22066525 | 65 | Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90. | J Med Chem 54: 8592-604 (2011) | Universit£ degli Studi di Ferrara | 2D 3D TSV |
22061826 | 19 | Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase. | Bioorg Med Chem 19: 7603-11 (2011) | Ghent University | 2D 3D TSV |
22061645 | 68 | Pyrazolone-based anaplastic lymphoma kinase (ALK) inhibitors: control of selectivity by a benzyloxy group. | Bioorg Med Chem Lett 21: 7261-4 (2011) | Cephalon Inc | 2D 3D TSV |
22061644 | 10 | Investigation of the diastereomerism of dihydrobenzoxathiin SERMs for ER alpha by molecular modeling. | Bioorg Med Chem Lett 21: 7298-305 (2011) | Zhejiang University | 2D 3D TSV |
22061641 | 49 | The discovery of novel cyclohexylamide CCR2 antagonists. | Bioorg Med Chem Lett 21: 7496-501 (2011) | Johnson & Johnson Pharmaceutical Research and Development LLC | 2D 3D TSV |
22061640 | 5 | Discovery of 4-aminomethylphenylacetic acids as¿-secretase modulators via a scaffold design approach. | Bioorg Med Chem Lett 21: 7277-80 (2011) | Biogen Idec Inc | 2D 3D TSV |
22061639 | 54 | Discovery, optimisation and in vivo evaluation of novel GPR119 agonists. | Bioorg Med Chem Lett 21: 7310-6 (2011) | AstraZeneca UK | 2D 3D TSV |
22061638 | 2 | Efficient synthesis of a novel m-phenylene derivative as a selective EP4 agonist inducing follicular growth and maturation in the ovary. | Bioorg Med Chem Lett 21: 7505-8 (2011) | Toray Industries Inc | 2D 3D TSV |
22060139 | 21 | Structure-activity relationship studies of sulfonylpiperazine analogues as novel negative allosteric modulators of human neuronal nicotinic receptors. | J Med Chem 54: 8681-92 (2011) | The Ohio State University | 2D 3D TSV |
22059882 | 206 | 5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP inhibitor. | J Med Chem 54: 8013-29 (2011) | Amira Pharmaceuticals | 2D 3D TSV |
22056747 | 23 | 3D-Quantitative structure-activity relationship and docking studies of the tachykinin NK3 receptor. | Bioorg Med Chem Lett 21: 7405-11 (2011) | Northeast Ohio Medical University | 2D 3D TSV |
22056746 | 53 | Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivity. | Bioorg Med Chem Lett 22: 738-42 (2011) | Boehringer Ingelheim Pharmaceuticals Inc | 2D 3D TSV |
22056744 | 16 | Benzisothiazolinone as a useful template for the design of new monoacylglycerol lipase inhibitors: investigation of the target residues and comparison with octhilinone. | Bioorg Med Chem Lett 21: 7321-4 (2011) | Universit£ Catholique de Louvain | 2D 3D TSV |
22055716 | 45 | Further structure-activity relationship studies on 8-substituted-3-[2-(diarylmethoxyethylidenyl)]-8-azabicyclo[3.2.1]octane derivatives at monoamine transporters. | Bioorg Med Chem 19: 7551-8 (2011) | University of New Orleans | 2D 3D TSV |
22055714 | 9 | Electron-donating para-methoxy converts a benzamide-isoquinoline derivative into a highly Sigma-2 receptor selective ligand. | Bioorg Med Chem 19: 7435-40 (2011) | University of Wisconsin School of Medicine and Public Health | 2D 3D TSV |
22055712 | 33 | Thio- and aminocaffeine analogues as inhibitors of human monoamine oxidase. | Bioorg Med Chem 19: 7507-18 (2011) | North-West University | 2D 3D TSV |
22055408 | 12 | Conformationally restricted analogs of the direct thrombin inhibitor FM 19. | Bioorg Med Chem 19: 7425-34 (2011) | University of Michigan | 2D 3D TSV |
22054058 | 22 | Synthesis of monomeric derivatives to probe memoquin's bivalent interactions. | J Med Chem 54: 8299-304 (2011) | University of Bologna | 2D 3D TSV |
22051063 | 6 | Synthesis and kinetic testing of new inhibitors for a metallo-?-lactamase from Klebsiella pneumonia and Pseudomonas aeruginosa. | Eur J Med Chem 46: 6075-82 (2011) | Helwan University | 2D 3D TSV |
22051054 | 18 | Synthesis, molecular modeling studies and biological evaluation of fluorine substituted analogs of GW 501516. | Bioorg Med Chem 19: 6982-8 (2011) | University of Oslo | 2D 3D TSV |
22050606 | 36 | a-Carbonic anhydrases are sulfatases with cyclic diol monosulfate esters. | J Enzyme Inhib Med Chem 27: 148-54 (2012) | Dumlupinar University | 2D 3D TSV |
22050263 | 3 | Exploring the binding sites of glycogen synthase kinase 3. Identification and characterization of allosteric modulation cavities. | J Med Chem 54: 8461-70 (2011) | Instituto de Quimica Medica-CSIC | 2D 3D TSV |
22050212 | 12 | Synthesis and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors. | J Med Chem 54: 8702-6 (2011) | Universit£ di Messina | 2D 3D TSV |
22047802 | 8 | The arginine mimickingß-amino acidß³hPhe(3-H2N-CH2) as S1 ligand in cyclotheonamide-basedß-tryptase inhibitors. | Bioorg Med Chem 19: 7236-43 (2011) | Universit£t Bielefeld | 2D 3D TSV |
22047797 | 16 | Effect of 2',6'-dimethyl-L-tyrosine (Dmt) on pharmacological activity of cyclic endomorphin-2 and morphiceptin analogs. | Bioorg Med Chem 19: 6977-81 (2011) | Medical University of Lodz | 2D 3D TSV |
22047696 | 17 | Structure-activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors. | Bioorg Med Chem Lett 21: 7295-7 (2011) | Sepuluh Nopember Institute of Technology | 2D 3D TSV |
22047692 | 50 | Nicotinic acids: liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy. | Bioorg Med Chem Lett 21: 7281-6 (2011) | Merck Frosst Centre for Therapeutic Research | 2D 3D TSV |
22047691 | 76 | The discovery of AZD9164, a novel muscarinic M3 antagonist. | Bioorg Med Chem Lett 21: 7440-6 (2011) | AstraZeneca | 2D 3D TSV |
22047689 | 18 | Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerases. | Bioorg Med Chem Lett 21: 7489-95 (2011) | GlaxoSmithKline | 2D 3D TSV |
22047688 | 51 | CCR2 receptor antagonists: optimization of biaryl sulfonamides to increase activity in whole blood. | Bioorg Med Chem Lett 21: 7291-4 (2011) | GlaxoSmithKline | 2D 3D TSV |
22047606 | 29 | Targeting the binding function 3 (BF3) site of the human androgen receptor through virtual screening. | J Med Chem 54: 8563-73 (2011) | University of British Columbia | 2D 3D TSV |
22046493 | 15 | Exploiting the P-1 pocket of BRCT domains toward a structure guided inhibitor design. | ACS Med Chem Lett 2: 764-767 (2011) | TBA | 2D 3D TSV |
22044621 | 4 | ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide. | Bioorg Med Chem Lett 21: 7474-8 (2011) | University of North Carolina | 2D 3D TSV |
22044620 | 36 | Orally active zwitterionic factor Xa inhibitors with long duration of action. | Bioorg Med Chem Lett 21: 7337-43 (2011) | Daiichi Sankyo Co., Ltd | 2D 3D TSV |
22044245 | 4 | Cucurbitane glucosides from the root of Machilus yaoshansis. | J Nat Prod 74: 2431-7 (2011) | State Key Laboratory of Bioactive Substance and Function of Natural Medicines, and Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine | 2D 3D TSV |
22044209 | 56 | Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptor. | J Med Chem 54: 8278-88 (2011) | Universit£ degli Studi di Siena | 2D 3D TSV |
22044119 | 84 | Design, synthesis, and qualitative structure-activity evaluations of novelß-secretase inhibitors as potential Alzheimer's drug leads. | J Med Chem 54: 8373-85 (2011) | University of Sharjah | 2D 3D TSV |
22041175 | 74 | Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors. | Bioorg Med Chem 19: 6989-99 (2011) | Genkyotex S.A. | 2D 3D TSV |
22041172 | 41 | Benzenediol-berberine hybrids: multifunctional agents for Alzheimer's disease. | Bioorg Med Chem 19: 7228-35 (2011) | Guangzhou Institute of Biomedicine and Health | 2D 3D TSV |
22041171 | 44 | Synthesis and biological profile of new 1,2,3,4-tetrahydroisoquinolines as selective carbonic anhydrase inhibitors. | Bioorg Med Chem 19: 7003-7 (2011) | Universit£ di Messina | 2D 3D TSV |
22041060 | 33 | 2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: modification of target structure to minimize reactive metabolite formation. | Bioorg Med Chem Lett 21: 7325-30 (2011) | Cephalon Inc | 2D 3D TSV |
22041058 | 44 | Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitors. | Bioorg Med Chem Lett 21: 7516-21 (2011) | Bristol-Myers Squibb Co. | 2D 3D TSV |
22041057 | 14 | Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy. | Bioorg Med Chem Lett 21: 7416-20 (2011) | AstraZeneca R&D Boston | 2D 3D TSV |
22040023 | 63 | Discovery of novel, potent, and selective inhibitors of 3-phosphoinositide-dependent kinase (PDK1). | J Med Chem 54: 8490-500 (2011) | Pfizer Inc | 2D 3D TSV |
22039961 | 21 | Evaluation of 18F-labeled benzodioxine piperazine-based dopamine D4 receptor ligands: lipophilicity as a determinate of nonspecific binding. | J Med Chem 54: 8343-52 (2011) | Forschungszentrum J£lich GmbH | 2D 3D TSV |
22039836 | 188 | Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141). | J Med Chem 54: 7860-83 (2011) | Johnson & Johnson Pharmaceutical Research & Development | 2D 3D TSV |
22037378 | 31824 | Comprehensive analysis of kinase inhibitor selectivity. | Nat Biotechnol 29: 1046-51 (2011) | Ambit Biosciences | 2D 3D TSV |
22037253 | 51 | Triazole ring-opening leads to the discovery of potent nonsteroidal 17ß-hydroxysteroid dehydrogenase type 2 inhibitors. | Eur J Med Chem 46: 5978-90 (2011) | Saarland University | 2D 3D TSV |
22037049 | 62 | Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class. | Bioorg Med Chem 19: 7044-8 (2011) | Research Triangle Institute | 2D 3D TSV |
22037047 | 1 | (2-Benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-8-yl)-acetic acid: an aldose reductase inhibitor and antioxidant of zwitterionic nature. | Bioorg Med Chem 19: 7181-5 (2011) | Slovak Academy of Sciences | 2D 3D TSV |
22036212 | 8 | Synthesis of 6-(het) ary Xylocydine analogues and evaluating their inhibitory activities of CDK1 and CDK2 in vitro. | Bioorg Med Chem 19: 7100-10 (2011) | Jilin University | 2D 3D TSV |
22036211 | 4 | 1,2-Benzothiazine 1,1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase. | Bioorg Med Chem 19: 7262-9 (2011) | Beijing Institute of Technology | 2D 3D TSV |
22033461 | 4 | Synthesis and docking study of 2-phenylaminopyrimidine Abl tyrosine kinase inhibitors. | Bioorg Med Chem Lett 21: 6964-8 (2011) | Beijing National Laboratory for Molecular Sciences | 2D 3D TSV |
22033460 | 38 | Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication. | Bioorg Med Chem Lett 21: 6950-4 (2011) | Genzyme Corp. | 2D 3D TSV |
22032632 | 56 | Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway. | J Med Chem 54: 8471-89 (2011) | Georgia State University | 2D 3D TSV |
22031623 | 2 | Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine. | Drug Metab Dispos 40: 276-82 (2012) | Astellas Pharma Inc | 2D 3D TSV |
22030032 | 8 | Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases. | Bioorg Med Chem Lett 21: 7483-8 (2011) | GlaxoSmithKline | 2D 3D TSV |
22030030 | 5 | Thiophene inhibitors of PDE4: crystal structures show a second binding mode at the catalytic domain of PDE4D2. | Bioorg Med Chem Lett 21: 7089-93 (2011) | Monash University (Parkville Campus) | 2D 3D TSV |
22030028 | 55 | Discovery of N-aryl-2-acylindole human glucagon receptor antagonists. | Bioorg Med Chem Lett 21: 7124-30 (2011) | Merck Research Laboratories | 2D 3D TSV |
22030027 | 12 | Discovery of new aminopyrimidine-based phosphoinositide 3-kinase beta (PI3Kß) inhibitors with selectivity over PI3Ka. | Bioorg Med Chem Lett 21: 6977-81 (2011) | Institute of Science and Technology (KAIST) | 2D 3D TSV |
22030026 | 13 | Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: unexpected 'molecular switch' from a closely related mGlu4 positive allosteric modulator. | Bioorg Med Chem Lett 21: 6955-9 (2011) | Vanderbilt University Medical Center | 2D 3D TSV |
22029386 | 156 | New serotonin 5-HT(1A) receptor agonists with neuroprotective effect against ischemic cell damage. | J Med Chem 54: 7986-99 (2011) | Universidad Complutense de Madrid | 2D 3D TSV |
22029285 | 6 | Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonists. | J Med Chem 54: 8161-73 (2011) | Chemical Diversity Research Institute | 2D 3D TSV |
22028316 | 2 | Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution. | Drug Metab Dispos 40: 240-8 (2012) | Kanazawa University | 2D 3D TSV |
22027102 | 7 | Pharmacophore identification, virtual screening and biological evaluation of prenylated flavonoids derivatives as PKB/Akt1 inhibitors. | Eur J Med Chem 46: 5949-58 (2011) | Zhejiang University | 2D 3D TSV |
22024272 | 18 | Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors. | Bioorg Med Chem 19: 7120-8 (2011) | Southern Research Institute | 2D 3D TSV |
22024030 | 22 | Structure-based design of isoindoline-1,3-diones and 2,3-dihydrophthalazine-1,4-diones as novel B-Raf inhibitors. | Bioorg Med Chem Lett 21: 6941-4 (2011) | Pfizer Inc | 2D 3D TSV |
22023459 | 42 | Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. | J Med Chem 54: 8251-70 (2011) | Universitat Aut£noma de Barcelona | 2D 3D TSV |
22019468 | 15 | Identification of novel CYP2A6 inhibitors by virtual screening. | Bioorg Med Chem 19: 7186-93 (2011) | University of Eastern Finland | 2D 3D TSV |
22019466 | 13 | Design, synthesis and biological evaluation of peptidyl-vinylaminophosphonates as novel cysteine protease inhibitors. | Bioorg Med Chem 19: 7129-35 (2011) | National Chemical Laboratory (CSIR-NCL) | 2D 3D TSV |
22019465 | 28 | Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H3R and BACE 1 inhibitory activities. | Bioorg Med Chem 19: 7158-67 (2011) | Zhejiang University | 2D 3D TSV |
22019296 | 32 | Discovery of a novel series of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity. | Bioorg Med Chem Lett 21: 7001-5 (2011) | Amgen Inc | 2D 3D TSV |
22019228 | 52 | Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-ß aggregation. | Eur J Med Chem 46: 5885-93 (2011) | Sun Yat-sen University | 2D 3D TSV |
22019188 | 4 | Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents. | Eur J Med Chem 46: 5970-7 (2011) | Zhejiang University | 2D 3D TSV |
22019186 | 6 | Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents. | Eur J Med Chem 46: 5763-8 (2011) | Jamia Hamdard (Hamdard University) | 2D 3D TSV |
22019046 | 35 | Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor. | Bioorg Med Chem 19: 7221-7 (2011) | Sanwa Kagaku Kenkyusho Co., Ltd | 2D 3D TSV |
22018919 | 3 | Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation. | Bioorg Med Chem 19: 7168-80 (2011) | University of Innsbruck | 2D 3D TSV |
22018918 | 8 | 13,13-Dimethyl-des-C,D analogues of (20S)-1a,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): total synthesis, docking to the VDR, and biological evaluation. | Bioorg Med Chem 19: 7205-20 (2011) | University of Wisconsin-Madison | 2D 3D TSV |
22018877 | 25 | Synthesis and in vitro EGFR (ErbB1) tyrosine kinase inhibitory activity of 4-N-substituted 6-aryl-7H-pyrrolo[2,3-d]pyrimidine-4-amines. | Eur J Med Chem 46: 6002-14 (2011) | Norwegian University of Science and Technology | 2D 3D TSV |
22018876 | 4 | Synthesis and inhibition study of monoamine oxidase, indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by 3,8-substituted 5H-indeno[1,2-c]pyridazin-5-one derivatives. | Eur J Med Chem 46: 6104-11 (2011) | Facult£s Universitaires Notre-Dame de Paix | 2D 3D TSV |
22018790 | 9 | Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds. | Bioorg Med Chem Lett 21: 7180-4 (2011) | Scripps Florida | 2D 3D TSV |
22018789 | 73 | Discovery and optimization of indole and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-II). | Bioorg Med Chem Lett 21: 7113-8 (2011) | The Scripps Research Institute | 2D 3D TSV |
22018787 | 57 | Synthesis and biological evaluation of novel pyrimidine derivatives as sub-micromolar affinity ligands of GalR2. | Bioorg Med Chem Lett 21: 7210-5 (2011) | The Scripps Research Institute | 2D 3D TSV |
22018464 | 4 | Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen. | Bioorg Med Chem Lett 21: 7013-6 (2011) | Washington State University | 2D 3D TSV |
22018463 | 40 | III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl-piperazinyl-piperidine scaffold. | Bioorg Med Chem Lett 21: 6982-6 (2011) | Merck Research Laboratories | 2D 3D TSV |
22018461 | 41 | Novel tricyclic inhibitors of IKK2: discovery and SAR leading to the identification of 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-7-yl)pyridin-2-yl)methyl)acetamide (BMS-066). | Bioorg Med Chem Lett 21: 7006-12 (2011) | Bristol-Myers Squibb Research and Development | 2D 3D TSV |
22017539 | 75 | Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13. | J Med Chem 54: 8174-87 (2011) | Boehringer Ingelheim Pharmaceuticals Inc | 2D 3D TSV |
22017497 | 34 | Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones. | J Med Chem 54: 8228-32 (2011) | Sapienza University of Rome | 2D 3D TSV |
22017477 | 35 | Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases. | J Med Chem 54: 8289-98 (2011) | Instituto Superior T£cnico | 2D 3D TSV |
22014826 | 3 | A small molecule that preferentially binds the closed conformation of Hsp90. | Bioorg Med Chem Lett 21: 7068-71 (2011) | San Diego State University | 2D 3D TSV |
22014755 | 36 | Syntheses of phenylpyrazolodiazepin-7-ones as conformationally rigid analogs of aminopyrazole amide scaffold and their antiproliferative effects on cancer cells. | Bioorg Med Chem 19: 6760-7 (2011) | Hanyang University | 2D 3D TSV |
22014750 | 1 | Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum. | Bioorg Med Chem 19: 6779-91 (2011) | University of Innsbruck | 2D 3D TSV |
22014558 | 21 | New spirocyclic¿²-isoxazoline derivatives related to selective agonists ofa7 neuronal nicotinic acetylcholine receptors. | Eur J Med Chem 46: 5790-9 (2011) | Universit£ degli Studi di Milano | 2D 3D TSV |
22014551 | 33 | Synthesis and evaluation of pyridone-phenoxypropyl-R-2-methylpyrrolidine analogues as histamine H3 receptor antagonists. | Bioorg Med Chem Lett 21: 7076-80 (2011) | Cephalon Inc | 2D 3D TSV |
22014550 | 337 | Discovery of a novel class of non-ATP site DFG-out state p38 inhibitors utilizing computationally assisted virtual fragment-based drug design (vFBDD). | Bioorg Med Chem Lett 21: 7155-65 (2011) | Ansaris | 2D 3D TSV |
22014549 | 4 | Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl-7-deazapurine nucleosides, their phosphoramidate prodrugs and 5'-triphosphates. | Bioorg Med Chem Lett 21: 7094-8 (2011) | RFS Pharma, LLC | 2D 3D TSV |
22014548 | 4 | Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening. | Bioorg Med Chem Lett 21: 7064-7 (2011) | University of California | 2D 3D TSV |
22014547 | 2 | Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases. | Bioorg Med Chem Lett 21: 7041-4 (2011) | University of Cagliari | 2D 3D TSV |
22014228 | 10 | Catalytic inhibition of eukaryotic topoisomerases I and II by flavonol glycosides extracted from Vicia faba and Lotus edulis. | J Nat Prod 74: 2362-70 (2011) | University of Thessaly | 2D 3D TSV |
22014094 | 15 | Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors. | J Med Chem 54: 7962-73 (2011) | Kyoto Pharmaceutical University | 2D 3D TSV |
22011200 | 24 | Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand. | J Med Chem 54: 8078-84 (2011) | H. Lee Moffitt Cancer Center & Research Institute | 2D 3D TSV |
22011144 | 13 | Multidentate (18)F-polypegylated styrylpyridines as imaging agents for A? plaques in cerebral amyloid angiopathy (CAA). | J Med Chem 54: 8085-98 (2011) | University of Pennsylvania | 2D 3D TSV |
22007704 | 1 | Lipophosphonoxins: new modular molecular structures with significant antibacterial properties. | J Med Chem 54: 7884-98 (2011) | Academy of Sciences of the Czech Republic v.v.i. | 2D 3D TSV |
22007676 | 22 | Structure-activity relationships in toll-like receptor 2-agonists leading to simplified monoacyl lipopeptides. | J Med Chem 54: 8148-60 (2011) | University of Kansas | 2D 3D TSV |
22007643 | 25 | Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor. | J Med Chem 54: 8195-206 (2011) | VU University Amsterdam | 2D 3D TSV |
22005185 | 25 | 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins. | Eur J Med Chem 46: 5838-51 (2011) | University of Santiago de Compostela | 2D 3D TSV |
22004849 | 9 | Selection of cyclic-peptide inhibitors targeting Aurora kinase A: problems and solutions. | Bioorg Med Chem 19: 6743-9 (2011) | University of Arizona | 2D 3D TSV |
22004719 | 56 | Synthesis and SAR of 2-phenoxypyridines as novel c-Jun N-terminal kinase inhibitors. | Bioorg Med Chem Lett 21: 7072-5 (2011) | The Scripps Research Institute | 2D 3D TSV |
22004718 | 58 | Discovery and optimization of indoles and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-I). | Bioorg Med Chem Lett 21: 7107-12 (2011) | The Scripps Research Institute | 2D 3D TSV |
22003888 | 41 | Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies. | J Med Chem 54: 8136-47 (2011) | VU University Amsterdam | 2D 3D TSV |
22003817 | 71 | Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold. | J Med Chem 54: 8030-50 (2011) | Takeda Pharmaceutical Co., Ltd | 2D 3D TSV |
22003428 | 136 | Identification of Inhibitors of NOD1-Induced Nuclear Factor-¿B Activation. | ACS Med Chem Lett 2: 780-785 (2011) | TBA | 2D 3D TSV |
22001327 | 77 | Arene- and quinoline-sulfonamides as novel 5-HT7 receptor ligands. | Bioorg Med Chem 19: 6750-9 (2011) | Jagiellonian University Medical College | 2D 3D TSV |
22001326 | 51 | Small molecule probes of the receptor binding site in the Vibrio cholerae CAI-1 quorum sensing circuit. | Bioorg Med Chem 19: 6906-18 (2011) | Princeton University | 2D 3D TSV |
22001094 | 78 | Discovery of cyclic guanidines as potent, orally active, human glucagon receptor antagonists. | Bioorg Med Chem Lett 21: 7131-6 (2011) | Merck Research Laboratories | 2D 3D TSV |
22001093 | 4 | Synthesis of GSK3ß mimetic inhibitors of Akt featuring a novel extended dipeptide surrogate. | Bioorg Med Chem Lett 21: 7166-9 (2011) | H. Lee Moffitt Cancer Center and Research Institute | 2D 3D TSV |
22001092 | 37 | Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors. | Bioorg Med Chem Lett 21: 7205-9 (2011) | Roche Research Center | 2D 3D TSV |
22001090 | 4 | Transformation of quercitols into 4-methylenecyclohex-5-ene-1,2,3-triol derivatives, precursors for the chemical chaperones N-octyl-4-epi-ß-valienamine (NOEV) and N-octyl-ß-valienamine (NOV). | Bioorg Med Chem Lett 21: 7189-92 (2011) | Hokko Chemical Industry Co. Ltd | 2D 3D TSV |
22001088 | 6 | The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase. | Bioorg Med Chem Lett 21: 7137-41 (2011) | University of Victoria | 2D 3D TSV |
22001085 | 22 | Synthesis and testing of trifluoromethyl-containing phosphonate-peptide conjugates as inhibitors of serine hydrolases. | Bioorg Med Chem Lett 21: 7216-8 (2011) | Moscow State University | 2D 3D TSV |
22001031 | 6 | Usabamycins A-C: new anthramycin-type analogues from a marine-derived actinomycete. | Bioorg Med Chem Lett 21: 7099-101 (2011) | Nippon Suisan Kaisha, Ltd | 2D 3D TSV |
22001029 | 28 | Design and synthesis of triazolopyridazines substituted with methylisoquinolinone as selective c-Met kinase inhibitors. | Bioorg Med Chem Lett 21: 7185-8 (2011) | Korea Research Institute of Chemical Technology | 2D 3D TSV |
22001028 | 13 | Synthesis and antimicrobial activity of brominated resorcinol dimers. | Bioorg Med Chem Lett 21: 7142-5 (2011) | University of East Anglia | 2D 3D TSV |
22000948 | 50 | Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors. | Bioorg Med Chem 19: 6827-32 (2011) | Nanjing University | 2D 3D TSV |
22000936 | 33 | Synthesis and biological assessment of diversely substituted furo[2,3-b]quinolin-4-amine and pyrrolo[2,3-b]quinolin-4-amine derivatives, as novel tacrine analogues. | Eur J Med Chem 46: 6119-30 (2011) | University of Lisbon | 2D 3D TSV |
22000924 | 25 | Design, synthesis and biological study of novel pyrido[2,3-d]pyrimidine as anti-proliferative CDK2 inhibitors. | Eur J Med Chem 46: 5825-32 (2011) | National Organization for Drug Control & Research | 2D 3D TSV |
22000209 | 54 | Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) for the 5-HT(1A) receptor. | Eur J Med Chem 46: 5728-35 (2011) | VU University Medical Center | 2D 3D TSV |